Functional Characterization of a Novel Slow Muscle-Specific Methyltransferase - Mettl21c by Hölper, Soraya
	
	
Functional	Characterization	of	a	Novel	Slow	
Muscle-Specific	Methyltransferase	–	
Mettl21c	
	
	
INAUGURAL-DISSERTATION	
	
zur	Erlangung	des	akademischen	Grades	
doctor	rerum	naturalium	
-	Dr.	rer.	nat	-	
	
vorgelegt	dem	Fachbereich	für	Biologie	und	Chemie	(FB	08)	
an	der	Justus-Liebig-Universität	
Gießen	
	 	 	
																					
eingereicht	von	
Soraya	Hölper	
aus	Frankfurt	am	Main	
	
Gießen,	2016	
I	
	
Die	vorliegende	Arbeit	wurde	am	Max-Planck-Institut	für	Herz-	und	Lungenforschung		
(W.G.	Kerckhoff-Institut)	in	Bad	Nauheim	angefertigt.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Dekan:		 	 Prof.	Dr.	Volker	Wissemann	
Fachbereich	für	Biologie	und	Chemie	(FB	08)		
Justus-Liebig-Universität	Gießen	
	
Erstgutachter:	 	 Prof.	Dr.	Dr.	Thomas	Braun		
Abteilung	für	Entwicklung	und	Umbau	des	Herzens		
Max-Planck-Institut	für	Herz-	und	Lungenforschung,	Bad	Nauheim	
	
Zweitgutachter:		 Prof.	Dr.	Katja	Sträßer		
Fachbereich	für	Biologie	und	Chemie	(FB	08)		
Institut	für	Biochemie,	Justus-Liebig-Universität	Gießen	
	
Betreuer:		 	 Prof.	Dr.	Marcus	Krüger		
Institut	für	Genetik/CECAD		
Universität	zu	Köln,	Köln		
	
	
Datum	der	Disputation:	
	
II	
	
Schriftliche	Erklärung	
	
	
„Ich	erkläre:	 Ich	habe	die	vorgelegte	Dissertation	selbstständig	und	ohne	unerlaubte	fremde	Hilfe	
und	nur	mit	den	Hilfen	angefertigt,	die	ich	in	der	Dissertation	angegeben	habe.	Alle	Textstellen,	die	
wörtlich	oder	sinngemäß	aus	veröffentlichten	Schriften	entnommen	sind,	und	alle	Angaben,	die	auf	
mündlichen	 Auskünften	 beruhen,	 sind	 als	 solche	 kenntlich	 gemacht.	 Ich	 stimme	 einer	 evtl.	
Überprüfung	 meiner	 Dissertation	 durch	 eine	 Antiplagiat-Software	 zu.	 Bei	 den	 von	 mir	
durchgeführten	und	in	der	Dissertation	erwähnten	Untersuchungen	habe	ich	die	Grundsätze	guter	
wissenschaftlicher	Praxis,	wie	sie	in	der	„Satzung	der	Justus-Liebig-Universität	Gießen	zur	Sicherung	
guter	wissenschaftlicher	Praxis“	niedergelegt	sind,	eingehalten.“	
	
Ort,	Datum:	
	
	
Unterschrift:	 ___________________________	
	
	
	
	
	
	
	
	
	
	
	
	 	
III	
	
Contents	
	
Contents	...............................................................................................................................................	III	
Summary	.............................................................................................................................................	VII	
Zusammenfassung	..............................................................................................................................	IX	
	
1.	Introduction	......................................................................................................................................	1	
1.1.	Skeletal	muscle:	the	main	player	for	whole	body	homeostasis	...................................................	1	
1.1.1.	Skeletal	muscle	architecture	.................................................................................................	1	
1.1.2.	Skeletal	muscle	fiber-type	heterogeneity	.............................................................................	3	
1.1.3.	Muscle	plays	a	central	role	in	whole-body	protein	homeostasis	..........................................	4	
1.2.	Ubiquitin-proteasomal	system	.....................................................................................................	5	
1.3.	Autophagosomal-lysosomal	pathway	..........................................................................................	6	
1.3.1.	Autophagy	machinery	...........................................................................................................	7	
1.3.2.	Autophagy	in	skeletal	muscle	..............................................................................................	10	
1.3.3.	Valosin-containing	protein	(VCP/p97)	is	required	for	autophagy	.......................................	11	
1.4.	Methyltransferases:	an	enzymatic	group	with	diverse	functions	..............................................	12	
1.4.1.	The	“protein”	methylation	reaction	....................................................................................	13	
1.4.2.	Methylation	on	proteins	.....................................................................................................	14	
1.4.3.	Methyltransferases	share	homologue	structures	...............................................................	16	
1.4.4.	The	Methyltransferase-like	21	(METTL21)	family	...............................................................	16	
1.5.	Mass	spectrometry	based	proteomics	.......................................................................................	18	
1.5.1.	Quantitative	methods	in	mass	spectrometry	......................................................................	20	
1.5.2.	Mass	spectrometry	instrumentation	..................................................................................	21	
1.6.	Aim	of	this	thesis	........................................................................................................................	24	
	
2.	Materials	and	Methods	................................................................................................................	25	
2.1.	Materials	and	chemicals	for	biochemistry	methods	..................................................................	25	
2.2.	Materials	and	chemicals	for	mass	spectrometry	methods	........................................................	26	
2.3.	Materials	and	chemicals	for	molecular	biology	methods	..........................................................	27	
2.4.	Materials	and	chemicals	for	cell	culture	methods	.....................................................................	28	
2.5.	Materials	and	chemicals	for	mouse	methods	............................................................................	29	
2.6.	Enzymes	.....................................................................................................................................	29	
IV	
	
2.7.	Kits	..............................................................................................................................................	29	
2.8.	Antibodies	..................................................................................................................................	30	
2.8.1.	Primary	antibodies	..............................................................................................................	30	
2.8.2.	Secondary	antibodies	..........................................................................................................	30	
2.9.	Buffers	and	solutions	.................................................................................................................	31	
2.10.	Devices	used	.............................................................................................................................	34	
2.11.	Cell	lines	...................................................................................................................................	34	
2.12.	Primer	.......................................................................................................................................	35	
2.12.1.	Primers	for	genotyping	......................................................................................................	35	
2.12.2.	Primers	for	Phusion	PCR	amplification	..............................................................................	35	
2.12.3.	Primers	for	methyltransferase	domain	mutation	.............................................................	35	
2.12.4.	Empty	plasmids	used	in	this	study	....................................................................................	36	
2.12.5.	Plasmids	generated	during	this	thesis	...............................................................................	36	
2.13.	Working	with	the	model	organism	Mus	musculus	...................................................................	37	
2.13.1.	Transgenic	mouse	line	Mettl21c	.......................................................................................	37	
2.13.2.	Maintaining	of	transgene	mouse	colony	...........................................................................	37	
2.13.3.	Genotyping	-	isolation	of	genomic	DNA	from	murine	tail	biopsy	.....................................	37	
2.13.4.	Isolation	of	mouse	muscles	tissue	.....................................................................................	38	
2.13.5.	Sciatic	nerve	transection	...................................................................................................	38	
2.13.6.	Running	Wheel	..................................................................................................................	38	
2.13.7.	Treadmill	...........................................................................................................................	39	
2.14.	Sample	preparation	methods	for	mass	spectrometry	.............................................................	39	
2.14.1.	Protein	extraction	–	tissue	homogenization	and	cell	lysis	................................................	39	
2.14.2.	Myofiber	isolation	.............................................................................................................	40	
2.14.3.	Determination	of	protein	concentration	..........................................................................	40	
2.14.4.	In-solution	digestion	.........................................................................................................	40	
2.14.5.	In-gel	digestion	..................................................................................................................	41	
2.15.	Liquid	Chromatography	–	Tandem	Mass	Spectrometry	(LC-MS/MS)	......................................	42	
2.15.1.	The	Q	Exactive	series	mass	spectrometers	.......................................................................	42	
2.15.2.	Reversed	phase	liquid	chromatography	(LC)	....................................................................	44	
2.15.3.	Tandem	Mass	Spectrometry	(MS/MS)	..............................................................................	44	
2.15.4.	Data	processing	with	MaxQuant	.......................................................................................	44	
2.16.	Molecular	Biology	....................................................................................................................	45	
2.16.1.	Concentration	measurement	of	DNA	and	RNA	.................................................................	45	
2.16.2.	Polymerase	chain	reaction,	PCR	........................................................................................	45	
V	
	
2.16.3.	Agarose	gel	electrophoresis	..............................................................................................	46	
2.16.4.	Amplification	of	the	coding	sequences	of	Mettl21c	and	Mettl21e	from	mouse	cDNA	
using	Phusion	polymerase	............................................................................................................	46	
2.16.5.	Gel	elution	and	A-tailing	....................................................................................................	46	
2.16.6.	Ligation	in	pGemTeasy	and	transformation	in	XL1Blue	E.coli	...........................................	47	
2.16.7.	Subcloning	the	Mettl21	genes	from	pGemTeasy	in	the	final	expression	plasmids	...........	47	
2.16.8.	Mutation	of	the	methyltransferase	domains	of	Mettl21c	and	Mettl21e	.........................	48	
2.16.9.	Methyltransferase	domain	mutation	with	site-directed	mutagenesis	.............................	49	
2.16.10.	Chemical	competent	bacteria	.........................................................................................	50	
2.16.11.	Plasmid	DNA	isolation	.....................................................................................................	50	
2.16.12.	Sequencing	of	DNA	..........................................................................................................	51	
2.17.	Morphological	and	immunostaining	methods	.........................................................................	51	
2.17.1.	Immunofluorescence	........................................................................................................	51	
2.17.2.	Immunohistochemical	stainings	........................................................................................	51	
2.17.3.	X-Gal	staining	of	mouse	tissues	.........................................................................................	52	
2.17.4.	Clearing	of	stained	muscle	tissues	....................................................................................	52	
2.17.5.	X-Gal	staining	on	cryosections	..........................................................................................	53	
2.17.6.	Haematoxylin/Eosin	(H&E)	staining	..................................................................................	53	
2.17.7.	Masson's	Trichrome	Staining	............................................................................................	53	
2.17.8.	Lectin	staining	...................................................................................................................	54	
2.18.	Biochemistry	methods	.............................................................................................................	54	
2.18.1.	SDS	Polyacrylamide	Gel	Electrophoresis	(SDS-PAGE)	........................................................	54	
2.18.2.	Immunoprecipitation	........................................................................................................	54	
2.18.3.	Western	blotting	...............................................................................................................	54	
2.18.4.	In	vitro	methylation	assay	.................................................................................................	55	
2.19.	Cell	culture	methods	................................................................................................................	55	
2.19.1.	Maintenance	of	cell	lines	..................................................................................................	55	
2.19.2.	SILAC	labeling	....................................................................................................................	56	
2.19.3.	Cell	storage	........................................................................................................................	56	
2.19.4.	Calcium	phosphate	transfection	.......................................................................................	56	
2.19.5.	Transfection	with	TurboFect	.............................................................................................	56	
2.19.6.	Induction	of	autophagy	in	cell	culture	..............................................................................	57	
2.20.	Deep	Sequencing	......................................................................................................................	57	
2.21.	Electron	microscopy	of	muscles	...............................................................................................	57	
	
VI	
	
3.	Results	.............................................................................................................................................	59	
3.1.	Bioinformatics	and	structural	analysis	of	Mettl21c	identifies	conserved	SAM	binding	domain	
and	a	methyltransferase	domain	......................................................................................................	59	
3.2.	Characterization	of	the	Mettl21c-/-	mouse	.................................................................................	61	
3.2.1.	Mettl21c	is	expressed	in	Z-disk	structures	of	slow	muscle	fibers	.......................................	63	
3.2.2.	Deletion	of	Mettl21c	leads	to	reduced	voluntary	and	forced	running	capabilities	............	68	
3.2.3.	Proteomic	and	transcriptomic	profiling	of	Mettl21c	deletion	mutants	..............................	70	
3.3.	Mettl21c	interacts	with	autophagic	regulator	proteins	–	Valosin-containing	protein	(p97)	and	
Sequestosome-1	(p62)	......................................................................................................................	75	
3.4.	Mettl21c	trimethylates	Valosin-containing	protein	in	vitro	and	in	vivo	....................................	78	
3.5.	Electron	microscopy	reveals	changes	in	ultrastructure	of	Mettl21c	deletion	mutants	.............	82	
3.6.	Mettl21c	is	associated	to	the	autophagic	flux	upon	denervation-induced	atrophy	..................	83	
	
4.	Discussion	.......................................................................................................................................	89	
4.1.	Protein	methylation	in	skeletal	muscle	......................................................................................	89	
4.2.	Bioinformatic	analysis	associates	Mettl21c	to	cytoplasmic	Class	I	methyltransferases	............	91	
4.3	Mettl21c	is	localized	within	Z-disk	structures	of	skeletal	muscle	fibers	.....................................	92	
4.4.	Deficiency	of	slow-muscle	specific	Mettl21c	results	in	reduced	muscle	performance	..............	92	
4.5.	EM	analysis	reveals	massive	accumulation	of	multivesicular	autophagosomes	and	vacuoles	..	94	
4.6.	Global	proteome	analysis	revealed	association	to	autophagy	pathways	..................................	95	
4.7.	Protein-protein	interaction	studies	unraveled	a	Mettl21c–VCP	interaction	.............................	97	
4.8.	Trimethylation	of	lysine-315	of	VCP	facilitates	cofactor	binding	...............................................	99	
4.9.	Accumulation	of	mitochondria	in	Mettl21c	deficient	mice	.....................................................	101	
4.10.	Conclusions	............................................................................................................................	104	
	
5.	References	....................................................................................................................................	106	
6.	List	of	figures	................................................................................................................................	119	
7.	Abbreviations	...............................................................................................................................	120	
8.	Acknowledgements	.....................................................................................................................	123	
9.	Curriculum	Vitae	..........................................................................................................................	124	
10.	Publications	.....................................................................................	Error!	Bookmark	not	defined.	
	
VII	
	
Summary	
	
In	 mammals	 the	 skeletal	 muscle	 is	 not	 only	 essential	 for	 movement	 and	 force	 production	 but	
comprises	also	a	large	reservoir	of	amino	acids	and	carbohydrates.	The	maintenance	of	the	muscle	
homoeostasis	 is	 therefore	 essential	 for	 the	 whole	 body	 metabolism.	 In	 addition,	 the	 skeletal	
muscle	 is	 highly	 adaptable	 and	 responds	 rapidly	 to	 physiological	 and	 environmental	 changes,	
including	nutritional	 changes,	hormonal	 stimulation,	 and	work	 loading.	This	 flexibility	arises	 from	
the	dynamic	expression	of	signaling	molecules	and	their	reversible	post-translational	modifications	
(PTMs).	 Moreover,	 the	 skeletal	 muscle	 consists	 of	 specific	 fiber-types	 with	 different	 metabolic	
profiles	designed	for	endurance	and	fast	contraction.	In	fact,	muscle	fibers	show	cell-type	specific	
regulations	and	they	respond	differently	to	environmental	changes	[1].		
The	main	focus	of	this	thesis	was	the	characterization	of	the	putative	methyltransferase	Mettl21c	
which	 is	 highly	 expressed	 in	 slow	 type	 I	 muscle	 fibers.	 The	 inactivation	 of	 Mettl21c	 in	 mice	 by	
homologous	 recombination	 showed	 a	 clear	 association	 of	 Mettl21c	 to	 the	 skeletal	 muscle	
autophagosomal-lysosomal	 pathway.	 Notably,	 it	 is	 completely	 unclear	 how	 protein	 methylation	
regulates	proteolysis	in	a	fiber-type	specific	manner.		
Previous	 studies	 indicate	 that	protein	methylation	can	 influence	 the	 interaction,	 stability,	 cellular	
localization,	and	activity	of	proteins.	Furthermore,	a	dysregulation	of	protein	methylation	is	linked	
to	the	pathology	of	cancer,	metabolic,	inflammatory	and	neurodegenerative	diseases.	Recently,	the	
METTL21	 family	 was	 discovered	 as	 a	 novel	 Class	 I	 family	 of	 lysine	 methyltransferases	 that	
preferentially	 target	 and	 regulate	 molecular	 chaperones	 such	 as	 HSP70	 and	 Valosin-containing	
protein	(VCP,	also	known	as	p97	and	cdc48)	[2,	3].	In	addition,	the	METTL21	family	might	play	a	role	
in	 neurodegenerative	 diseases	 like	 Inclusion	 Body	 Myopathy	 with	 Paget's	 disease	 of	 bone	 and	
Fronto-temporal	Dementia	(IBMPFD)	[4]	and	some	familial	forms	of	Amyotrophic	Lateral	Sclerosis	
(ALS)	[5].		
The	presented	 study	 revealed	 that	Mettl21c	 is	highly	expressed	 in	 slow-twitch	muscle	 fibers	and	
localized	 to	Z-disk	 structures,	which	 is	not	only	a	border	of	 the	 sarcomere	but	also	an	 important	
signaling	hub	to	regulate	muscle	homeostasis	[6,	7].	The	inactivation	of	Mettl21c	in	mice	causes	a	
severe	reduction	in	muscle	performance,	including	voluntary	and	forced	running,	suggesting	a	vital	
function	 for	 Mettl21c	 in	 maintaining	 muscle	 activity.	 The	 pathological	 dysregulation	 of	 the	
autophagic	flux	 interferes	with	the	metabolism	of	the	skeletal	muscle	during	physical	exertion	[8-
10].	 To	 better	 understand	 the	molecular	 and	 cellular	 function	 of	Mettl21c,	 comprehensive	mass	
spectrometry	 based	 protein-protein	 interaction	 studies	 were	 performed	 and	 revealed	 a	 strong	
VIII	
	
interaction	 between	 Mettl21c	 and	 several	 chaperones,	 including	 the	 Valosin-containing	 protein	
(VCP).	This	finding	suggests	that	Mettl21c	is	associated	to	the	autophagy	system	since	VCP	is	a	key	
regulator	 in	 the	 maturation	 of	 autophagosomes	 and	 fusion	 of	 lysosomes.	 Moreover,	 detailed	
morphometric	analysis	using	electron	microscopy	showed	a	clear	accumulation	of	autophagosomal	
vacuoles	in	Mettl21c	deficient	slow	muscle	fibers.	In	vitro	methylation	assays	indicated	that	VCP	is	
a	direct	substrate	of	Mettl21c	and	this	was	further	confirmed	by	the	mass	spectrometric	detection	
of	Mettl21c	dependent	trimethylation	sites	(K315)	of	VCP.	Consistently,	Mettl21c	deficient	animals	
show	 reduced	 VCP	 trimethylation	 in	 slow	 soleus	 fibers,	which	might	 enhance	 the	 activity	 of	 the	
ATPase/D1	of	VCP	[2].	 Interestingly,	 the	reduced	trimethylation	of	Vcp	 in	Mettl21c	deficient	slow	
muscle	fibers	resulted	in	a	reduced	interaction	between	Vcp	and	the	inhibitory	cofactor	Nsfl1c	(also	
known	as	p47).	Nsfl1c	 is	an	 important	cofactor	 for	Vcp	and	a	 reduced	 interaction	might	enhance	
the	ATPase	activity	of	Vcp	leading	to	neurodegenerative	diseases	and	related	myopathies	[11].	
In	 summary,	 the	 expression	 of	 a	 slow	 fiber-type	 specific	 methyltransferase	 might	 be	 a	 new	
mechanism	 to	 regulate	 the	 formation	 of	 autophagosomes	 and	 the	 interaction	 of	 Mettl21c-Vcp-
Nsfl1c	represents	a	new	network	to	modulate	protein	homeostasis	in	slow	skeletal	muscle	tissue.		
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Zusammenfassung	
	
Die	 Skelettmuskulatur	 dient	 nicht	 nur	 der	 Bewegung	 und	 Kraftproduktion,	 sondern	 sie	 stellt	 das	
größte	 Aminosäure-	 und	 Kohlenhydratreservoir	 im	 Körper	 dar.	 Die	 Balance	 des	
Aminosäurestoffwechsels	 im	Muskel	spielt	eine	wichtige	Rolle	 für	den	gesamten	Organismus.	Die	
Skelettmuskulatur	 ist	 in	 der	 Lage	 schnell	 auf	 viele	 physiologische	 Impulse,	 wie	 Veränderung	 der	
Ernährungsgewohnheiten,	 hormonelle	 Stimulation,	 kontraktile	 Aktivität	 und	 körperliche	
Beanspruchung	 zu	 reagieren.	 Diese	 Flexibilität	 des	 Skelettmuskels	 wird	 durch	 unterschiedliche	
Proteinklassen	 und	 ihre	 reversiblen	 post-translationalen	 Modifikationen	 (PTMs)	 reguliert.	 Ein	
Charakteristikum	 des	 Skelettmuskels	 sind	 die	 unterschiedlichen	 Fasertypen,	 die	 für	 ausdauernde	
oder	 schnelle	 Kontraktionen	 ausgelegt	 sind.	 In	 der	 Tat	 zeigen	 Muskelfasern	 zelltyp-spezifische	
Regulationen	und	reagieren	unterschiedlich	auf	Umweltveränderungen	[1].	
Der	Schwerpunkt	dieser	Dissertation	war	die	Charakterisierung	der	potentiellen	Methyltransferase	
Mettl21c,	 welche	 primär	 in	 langsamen	 Muskelfasern	 exprimiert	 wird.	 Die	 Inaktivierung	 von	
Mettl21c	 in	 Mäusen	 durch	 homologe	 Rekombination	 konnte	 zeigen,	 dass	 Mettl21c	 den	
autophagosomalen-lysosomalen	 Signalweg	 reguliert.	 Es	 ist	 jedoch	 völlig	 unklar,	 wie	 Protein-
Methylierungen	die	Proteolyse	in	unterschiedlichen	Fasertypen	reguliert.	
Vorherige	 Studien	 zeigten,	 dass	 Methylierungen	 von	 Proteinen	 die	 Interaktionen,	 die	
Proteinstabilität	 und	 –aktivität,	 sowie	 den	 Protein-Turnover	 und	 die	 zelluläre	 Lokalisation	
beeinflussen	 können.	 Folglich	 wird	 eine	 Fehlregulation	 von	 Methylierungsmustern	 mit	 der	
Pathologie	 vieler	 bekannter	 humaner	 Krankheiten	 wie	 Krebs,	 metabolischen,	 inflammatorischen	
und	 neurodegenerativen	 Erkrankungen	 assoziiert.	 Kürzlich	 wurde	 die	 METTL21	 Familie	 als	 neue	
Klasse	 I	 Methyltransferasen	 identifiziert,	 die	 vorzugsweise	 Chaperone	 wie	 HSP70	 und	 Valosin-
containing	protein	(VCP,	auch	bekannt	als	p97	und	cdc48)	ansteuert	und	reguliert	[2,	3].	Dies	bringt	
die	 METTL21	 Familie	 in	 direkten	 Zusammenhang	 mit	 neurodegenerativen	 Erkrankungen	 wie	
Einschlusskörper-Myopathie	 assoziiert	 mit	 einem	 M.	 Paget	 der	 Knochen	 und	 einer	
frontotemporalen	 Demenz	 (IBMPFD	 -	 inclusion	 body	myopathy	 associated	with	 Paget	 disease	 of	
the	 bone	 and	 frontotemporal	 dementia)	 [4]	 sowie	 familiären	 Formen	 der	 amyotrophischen	
Lateralsklerose	[5].		
Im	 Rahmen	 dieser	 Arbeit	 konnte	 ich	 zeigen,	 dass	 Mettl21c	 stark	 in	 langsamen	 Muskelfasern	
exprimiert	wird.	Mettl21c	ist	 in	der	Z-Scheibe	lokalisiert,	 in	der	sich	viele	Signalproteine	befinden,	
die	vor	allem	die	Muskelhomöostase	regulieren	[6,	7].	Die	Deletion	des	Mettl21c	Gens	in	Mäusen	
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verursacht	 eine	 massive	 Abnahme	 der	 Skelettmuskelleistung,	 was	 klar	 auf	 Störungen	 des	
Muskelstoffwechsels	 hindeutet.	 Eine	 pathologische	 Fehlregulation	 des	 autophagischen	 Flusses	
beeinträchtigt	 den	 Stoffwechsel	 des	 Skelettmuskels	 bei	 körperlicher	 Anstrengung	 [8-10].	 Um	 die	
molekulare	 und	 zelluläre	 Funktion	 von	 Mettl21c	 genauer	 zu	 untersuchen,	 wurden	 quantitative	
Protein-Protein-Interaktionsstudien	 basierend	 auf	 massenspektrometrischen	 Analysen	
durchgeführt.	Diese	Experimente	zeigten	eine	starke	Interaktion	zwischen	Mettl21c	und	mehreren	
Chaperonen,	 darunter	 Valosin-containing	 protein	 (Vcp).	 Vcp	 wird	 eine	 zentrale	 Rolle	 bei	 der	
Reifung	 der	 Autophagosomen	 und	 Fusion	mit	 Lysosomen	 zugesprochen.	 Somit	 könnte	Mettl21c	
eine	 Funktion	 bei	 der	 Regulation	 des	 Autophagie-Prozesses	 spielen.	 Morphologische	 Analysen	
mittels	 Elektronenmikroskopie	 zeigten	 eine	 Akkumulation	 von	 autophagosomalen	 Vakuolen	 in	
Mettl21c	defizienten	Muskeln.	In-vitro	Methylierungsassays	und	massenspektrometrische	Analysen	
zeigten,	 dass	Mettl21c	 Vcp	 am	 Lysin-315	 trimethyliert.	 Diese	 Daten	waren	 in	 Einklang	mit	 einer	
verminderten	Vcp	 Trimethylierung	 in	 langsamen	 Soleus	Muskelfasern	 von	Mettl21c-/-	Mäusen.	 In	
einer	 vorangegangen	 Studie	 konnte	 gezeigt	 werden,	 dass	 eine	 Methylierung	 am	 Lysin-315	 die	
ATPase/D1	Aktivität	von	VCP	herabsetzt	[2].	Zudem	konnte	eine	verminderte	Interaktion	zwischen	
Vcp	und	dem	inhibitorischen	Kofaktor	Nsfl1c	in	Mettl21c-/-	Mäusen	aufgezeigt	werden.	Nsfl1c	ist	als	
wichtiger	Kofaktor	 für	Vcp	bekannt	und	eine	reduzierte	 Interaktion	erhöht	vermutlich	die	ATPase	
Aktivität	 von	 Vcp.	 Ein	 Verlust	 der	 ATPase-Aktivität	 von	 Vcp	 führt	 zu	 neurodegenerativen	
Erkrankungen	und	hiermit	verwandten	Myopathien,	vermutlich	ausgelöst	durch	die	Akkumulation	
„toxischer“	Proteine	[11].		
Durch	diese	Arbeit	konnte	ein	wichtiger	Beitrag	zum	Verständnis	für	die	Regulation	der	Autophagie	
im	langsamen	Skelettmuskel	durch	das	Zusammenspiel	von	Chaperonen	wie	Vcp,	deren	Kofaktoren	
und	skelettmuskelspezifischen	Methyltransferasen	wie	Mettl21c	erbracht	werden.		
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1.	Introduction	
	
1.1.	Skeletal	muscle:	the	main	player	for	whole	body	homeostasis	
Walking,	running,	sitting,	viewing,	and	even	breathing	are	all	possible	because	of	the	well-defined	
and	continuous	process	of	contraction	and	relaxation	of	skeletal	muscle.	Besides	its	role	to	produce	
force	for	maintaining	body	posture	and	movement,	skeletal	muscle	has	a	central	function	in	whole	
body	metabolism	and	glucose	homeostasis.	Moreover,	by	producing	an	enormous	amount	of	heat	
as	a	by-product	of	 its	energy	metabolism,	the	muscle	tissue	helps	us	to	maintain	a	constant	body	
temperature.	 The	mammalian	 skeletal	muscle	 accounts	 for	 40-50%	 of	 total	 body	mass	 [12]	 and	
therefore	plays	a	fundamental	role	in	whole	body	homeostasis	and	represents	a	major	reservoir	of	
amino	 acids	 for	 protein	 synthesis	 and	 energy	 production.	 Through	 evolution,	 vertebrates	
developed	a	variety	of	 skeletal	muscles	 that	differ	 in	 contractile,	biochemical,	 and	morphological	
features;	 their	 function	 ranges	 from	 slow	 contracting	 fibers	 designed	 for	 endurance	 to	 fast	
contracting	fibers	for	high-intensity	work.	In	addition,	different	skeletal	muscle	and	fiber-types	vary	
dramatically	in	their	response	to	the	same	stimulus,	reflecting	their	specialized	metabolic	function	
[1].	 The	main	 focus	 of	 this	 thesis	 is	 to	 expand	 the	 understanding	 of	 the	molecular	mechanisms	
regulating	the	plasticity	and	structure	of	different	skeletal	 fiber-types	and	the	function	of	a	novel	
class	of	methyltransferases	(Mettl21c)	in	maintaining	protein	homeostasis	of	slow-twitch	fibers	by	
modulating	the	autophagosomal-lysosomal	degradation	process.	
	
1.1.2.	Skeletal	muscle	architecture	
Skeletal	muscle	is	a	highly	organized	tissue	and	is	structured	in	bundles	(fascicles)	and	coated	with	
connective	tissue	–	the	perimysium.	Finally,	a	single	muscle	fiber	is	surrounded	by	a	cell	membrane	
or	 sarcolemma	–	 the	endomysium	 (Figure	1A).	 The	 intramuscular	 region	 is	highly	 vascularized	 to	
supply	 oxygen	 and	 substrates	 to	 produce	 energy	 and	 a	 huge	 number	 of	 nerve	 branches	 are	
connected	to	each	single	fiber	through	the	neuromuscular	junction	[13].		
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Figure	 1.	 Schematic	 representation	 of	 the	 skeletal	 muscle	 architecture.	 (A)	 Skeletal	 muscle	 is	
composed	 of	 muscle	 fibers.	 Each	 fiber	 is	 composed	 of	 myofibrils.	 (B)	 The	 myofilaments	 are	
organized	in	sarcomeres.	Each	sarcomere	is	delimited	by	the	Z-disk.	The	I-band	containing	the	thin	
actin	filaments	is	adjacent	to	the	Z-disk,	followed	by	the	A-band,	where	the	thick	myosin	filaments	
are	located.	The	thick	myosin	filaments	are	attached	end-to-end	in	the	center	of	the	A-band,	the	so	
called	M-line.	
Skeletal	muscle	does	not	consist	of	individual	cells	but	rather	forms	large,	elongated	and	cylindrical	
cells	termed	as	myofibers.	Each	myofiber	is	a	multinucleate	syncytium	up	to	several	millimeters	in	
length.	 The	 nuclei	 are	 located	 in	 the	 periphery	 underneath	 the	 plasma	 membrane	 –	 the	
sarcolemma.	 Under	 a	 light	microscope	 the	 nuclei	 from	 satellite	 cells,	 which	make	 up	 1%	 of	 the	
nuclei	 present	 in	 the	 muscle,	 are	 not	 distinguishable	 from	muscle	 cell	 nuclei.	 Satellite	 cells	 are	
muscle	progenitor	cells,	being	particular	important	in	regenerating	muscle	tissue	[14].		
Besides	the	contractile	apparatus,	the	most	important	organelles	for	skeletal	muscle	physiology	are	
mitochondria.	 They	 regulate	 a	 broad	 range	 of	 cellular	 processes,	 like	 energy	 metabolism,	 cell	
signaling,	 calcium	 homeostasis,	 and	 the	 regulation	 of	 apoptosis.	 Mitochondrial	 dysfunction	 is	
tightly	 associated	 to	 several	 diseases	 affecting	 mostly	 skeletal	 muscle	 homeostasis,	 such	 as	
Alzheimer,	Parkinson	and	amyotrophic	lateral	sclerosis.	
Muscle	 fibers	 possess	 transverse	 tubules,	 also	 called	 T-tubules,	 and	 they	 are	 essential	 for	 the	
conduction	 of	 electric	 impulses	 to	 the	 interior	 of	 the	 fiber.	 Another	 tubular	 structure	 is	 the	
sarcoplasmic	 reticulum	 (SR)	 surrounding	 each	myofibril	 and	 the	 SR	 is	 essential	 for	 calcium	 (Ca2+)	
handling	during	the	process	of	muscle	contraction	and	relaxation.	
The	striated	appearance	of	the	muscle	results	from	the	organization	of	the	myofibril.	 It	 is	marked	
by	 regularly	 parallel	 aligned	 units	 along	 its	 length.	 The	 myofibrils	 are	 consisting	 of	 bundles	 of	
myofilaments,	 which	 are	 mainly	 composed	 of	 actin	 and	 myosin	 (70-80%	 of	 total	 protein	 fiber	
content)	and	are	organized	in	thin	and	thick	bands,	respectively.	A	single	repeat	of	the	myofibrils	is	
called	sarcomere.	As	seen	in	Figure	1B	the	sarcomeres	are	delimited	by	the	Z-disk,	which	contains	
several	 proteins	 including	 alpha-actinin,	 desmin,	 nebulin	 and	 vimentin.	 They	 serve	 as	 an	
attachment	point	 for	 the	actin	 filament.	 The	broad	 light	band	between	 the	Z-disk	 is	 called	 the	 I-
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band.	It	is	mainly	composed	of	the	actin	filaments	that	extend	beyond	a	broad	band	called	A-band,	
which	is	composed	of	the	thick	filaments	(myosin).	The	myosin	filaments	are	attached	end-to-end	
in	the	center	of	the	A-band,	this	region	is	called	M-line.	Titin	filaments	are	running	from	the	Z-disk	
to	the	M-line,	thereby	supporting	the	whole	assembly	of	the	sarcomere	and	serving	as	a	molecular	
spring	[15].		
	
1.1.3.	Skeletal	muscle	fiber-type	heterogeneity	
The	 flexibility	 of	 mammalian	 skeletal	 muscles	 is	 based	 on	 its	 heterogeneity	 in	 the	 molecular	
architecture.	The	function	and	structure	can	be	correlated	to	 its	metabolic	and	contractile	needs.	
Skeletal	 muscle	 fibers	 were	 originally	 identified	 as	 oxidative	 and	 slow	 fibers	 (type	 I)	 and	 as	
glycolytic	and	fast	(type	IIa,	IIb,	IIx)	fibers	[16,	17].	Myosin	heavy	chains	(MyHC)	are	the	molecular	
motors	 for	 the	 contraction	 and	 skeletal	 muscle	 fibers	 are	 usually	 identified	 by	 their	 content	 of	
MyHC	isoforms.	Type	I	fibers,	also	known	as	slow-twitch	fibers,	are	classified	by	the	expression	of	
Myh7.	 These	 fibers	 have	 a	 slow	 velocity	 of	 shortening,	 are	 rich	 in	mitochondria	 and	mainly	 use	
oxidative	metabolism	 for	 energy	 production.	 Slow-twitch	 fibers	 are	 high	 resistant	 to	 fatigue	 and	
have	 good	 endurance.	 Type	 II	 fibers,	 known	 as	 fast-twitch	 fibers,	 are	 reflecting	 fast	 oxidative	
properties	and	can	be	subdivided	 into	 three	subtypes.	The	 fastest	myosin	 is	 the	 IIb	expressed	by	
the	gene	Myh4,	followed	by	the	 intermediate	 IIx	 isoform	(gene	Myh1).	The	“slowest”	member	of	
the	type	II	fibers	is	the	IIa	expressed	by	the	gene	Myh2.	In	comparison	to	slow-twitch	fibers,	type	II	
fibers	are	required	for	 fast	 force	production	and	are	sensitive	to	 fatigue.	 In	addition,	 they	have	a	
lower	number	of	mitochondria	and	their	metabolic	energy	production	is	mainly	based	on	glycolysis.	
Muscles	 are	 classified	 by	 the	 percentage	 of	 expression	 of	 different	 fiber-types.	 Despite	 fibers	
containing	pure	MyHC	compositions,	there	are	also	skeletal	muscle	fibers	which	express	more	than	
one	MyHC	isoform.	They	are	called	hybrid	muscle	fibers.	According	to	their	force	production	they	
are	 classified	 from	 slow-	 to	 fast-twitch	 1	↔	 1/2A	↔	 2A	↔	 2A/2X	↔	 2X	↔	 2X/2B	↔	 2B.	
Modulation	of	MyHC	molecules	allows	for	a	greater	flexibility	in	muscle	function	and	the	dynamic	
fiber-type	composition	helps	to	rapidly	respond	to	external	stimuli.		
In	order	to	understand	the	molecular	mechanisms	and	signaling	pathways	underlying	the	specific	
muscle	phenotypes,	intensive	morphological	and	molecular	studies	have	been	performed	[15,	18].	
Recently,	it	has	been	shown	that	not	only	the	MyHC	composition	reflects	the	metabolic	properties	
of	muscle	 fibers,	but	also	a	 complex	expression	pattern	of	different	 classes	of	proteins	and	 their	
reversible	 post-translational	 modifications	 determines	 the	 skeletal	 muscle	 fiber-type	 and	 its	
potential	for	adaptive	changes	[19].	
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Although	 contractile	 and	 metabolic	 characteristics	 are	 predetermined	 during	 development,	
maturated	skeletal	muscle	fiber-types	are	not	static	and	a	given	external	stimuli	as	well	as	defects	
in	 muscle	 homeostasis	 can	 induce	 an	 extensive	 fiber-type	 switching.	 This	 property	 defines	 the	
adaptive	 potential	 of	 muscle,	 also	 known	 as	 muscle	 plasticity	 and	 it	 was	 shown	 that	 fiber-type	
switching	 requires	 the	 regulation	 of	 specific	 gene	 sets	 [20-22].	 Of	 note,	 it	 was	 shown	 by	
experimental	models	that	slow-	and	fast-twitch	fibers	vary	often	drastically	in	their	response	to	the	
same	physiological	or	pathological	stimulus	[23,	24].	Examples	for	the	selective	atrophy	are	shown	
for	 instance	by	Aravamudan	and	his	colleagues	when	denervating	rat	diaphragm	[23].	This	 led	to	
atrophy	 in	 type	 IIx	and	 IIb	 fibers,	whereas	 type	 I	and	 IIa	 fibers	are	unchanged.	Similar	 results	are	
obtained	when	denervating	other	fast	rat	muscles	as	seen	by	unpublished	data	from	Schiaffino	and	
Ciciliot	[1].	But	type	I	fibers	of	the	slow	soleus	showed	a	clear	atrophy	after	denervation.		
These	 examples	 display	 that	 the	 same	 fiber-type	 can	 undergo	 opposite	 changes	 in	 different	
muscles,	probably	due	to	different	combinations	of	specific	molecular	and	functional	properties	of	
the	muscles.		
	
1.1.4.	 Muscle	 plays	 a	 central	 role	 in	 whole-body	 protein	
homeostasis	
Proteostasis	 in	skeletal	muscle	 is	regulated	by	a	broad	range	of	catabolic	and	anabolic	processes.	
The	constant	protein	synthesis	and	protein	degradation	allows	for	a	rapid	adaption	in	response	to	
different	physiological	conditions.	For	example,	hormones,	physical	activity,	neuronal	stimulation,	
and	stress	conditions	can	activate	or	 inhibit	skeletal	muscle	activity.	One	characteristic	of	skeletal	
muscle	is	the	fast	expansion	in	volume	due	to	increased	physical	activity.	This	process	is	also	known	
as	 hypertrophy	 and	 associated	 with	 upregulated	 protein	 synthesis	 or	 hyperplasia	 (increased	
proliferation)	[25].	Two	main	signaling	pathways	control	protein	synthesis.	The	insulin-like	growth	
factor	 1-phosphoinositide-3-kinase–Akt/protein	 kinase	 B-mammalian	 target	 of	 rapamycin	 (IGF1-
Akt/PKB-mTOR)	 pathway	 acts	 as	 a	 positive	 regulator.	 On	 the	 other	 hand,	 myostatin-Smad2/3	
pathway	 is	 a	 negative	 regulator	 for	 muscle	 growth.	 Furthermore,	 during	 the	 early	 postnatal	
developmental	 stage,	 the	 increase	of	myonuclei	 through	proliferation	and	 fusion	of	 satellite	cells	
regulates	muscle	growth.	
Conversely,	skeletal	muscle	atrophy	is	delineated	by	a	rapid	decrease	in	the	muscle	mass,	reduced	
cross	sectional	area	of	the	fibers,	and	less	protein	content.	The	pathological	loss	of	muscle	mass	is	
also	called	sarcopenia,	occurring	most	often	during	aging	[26].	 In	addition,	human	patients	with	a	
pathological	 muscle	 wasting	 (cachexia)	 in	 combination	 with	 systemic	 diseases	 including	 cancer,	
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diabetes,	 neurodegenerative	 and	 immune	 disorders	 [27]	 usually	 show	 a	 poor	 survival	 rate.	 This	
reflects	the	importance	of	skeletal	muscle	as	an	energy	reservoir	for	the	whole	body.	All	of	these	
examples	have	in	common	that	protein	degradation	overtakes	protein	synthesis.	
During	 catabolic	 conditions,	 several	 remodeling	 processes	 of	 signaling	 cascades	 and	 cellular	
organelles	 including	 mitochondria	 and	 lysosomes	 are	 activated.	 Although	 the	 majority	 of	
contractile	 proteins	 (myosin	 and	 actin)	 are	 rapidly	 degraded,	 a	 class	 of	 proteins	 named	 as	
“atrogenes”	are	simultaneously	activated	and/or	upregulated	to	mediate	the	coordinated	protein	
break	down.	For	example,	a	number	of	proteasomal	subunits	and	several	E3	ligases	like	MuRF1	are	
upregulated	 during	 starvation	 and	 neuronal	 denervation	 (see	 chapter	 1.2.).	 Conversely,	 energy-
producing	 systems	 like	 mitochondria	 are	 down	 regulated	 under	 those	 conditions.	 Moreover,	
physical	 overload	 or	 other	 environmental	 factors	 result	 in	 an	 increased	 level	 of	 reactive	 oxygen	
species	 (ROS),	 having	 detrimental	 effects	 on	mitochondrial	 proteins	 and	 related	 networks.	 Thus,	
skeletal	 muscle	 demands	 an	 efficient	 system	 for	 removal	 of	 unfolded	 protein	 aggregates,	
dysfunctional	 organelles,	 and	 toxic	 products	 that	 otherwise	 may	 lead	 to	 cell	 death	 [28,	 29].	 In	
skeletal	 muscle,	 there	 are	 two	 main	 proteolytic	 systems,	 the	 ubiquitin-proteasomal	 and	 the	
autophagosomal-lysosomal	 pathway,	 which	 organize	 the	 protein	 degradation	 of	 proteins	 under	
regular	and	perturbed	conditions.		
	
1.2.	Ubiquitin-proteasomal	system	
The	 ubiquitin-proteasomal	 system	 (UPS)	 in	 muscle	 is	 the	 major	 degradation	 system	 for	 single	
proteins	or	small	aggregates	and	thereby	efficiently	controls	protein	concentrations	within	the	cell.	
It	requires	the	transcription	of	components	of	the	26S	proteasome,	two	ubiquitin	ligases	atrogin-1	
and	 MuRF	 1	 and	 the	 ubiquitination	 of	 the	 substrates	 [30].	 Three	 specific	 proteins	 regulate	 the	
process	 leading	 to	 the	 selection	 of	 substrates	 for	 degradation	 by	 the	 conjugation	 of	 ubiquitin	
molecules.	 In	 brief,	 first	 by	 an	 ATP-dependent	 process	 ubiquitin	 is	 connected	 to	 the	 Ubiquitin-
activating	 enzyme	 (E1)	 via	 a	 high-energy	 thioester	 bond.	 Second	 ubiquitin	 is	 transferred	 to	 an	
Ubiquitin-conjugating	 enzyme	 (E2)	 by	 linking	 ubiquitin	 and	 a	 cysteine	 residue	 of	 the	 E2	 enzyme.	
Finally,	 although	 there	 are	 a	 few	 notable	 exceptions	 [31,	 32],	 the	 Ubiquitin-ligase	 enzyme	 (E3)	
transfers	 the	 ubiquitin	monomer	 to	 the	 substrate	 via	 an	 isopeptide	 bond	 between	 the	 ɛ-amino	
group	 of	 a	 lysine	 residue	 48	 in	 the	 substrate	 and	 the	 carboxy-terminal	 glycine	 residue	 76	 in	
ubiquitin.	In	order	for	the	substrate	to	be	recognized	by	the	26S	proteasome,	the	process	needs	to	
be	repeated	a	minimum	of	four	times,	conjugating	ubiquitin	monomers	to	lysine	residue	48	of	the	
substrate	[33]	(Figure	2).	
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Figure	 2.	Ubiquitin-proteasomal	mediated	protein	 degradation.	Three	 specific	 proteins	 regulate	
the	 process,	 which	 leads	 to	 the	 selection	 of	 substrates	 for	 degradation	 by	 the	 conjugation	 of	
ubiquitin	molecules.	 The	Ubiquitin-activating	enzyme	 (E1)	binds	 the	ubiquitin	monomer	 first	 and	
then	 transfers	 it	 to	 the	 Ubiquitin-conjugating	 enzyme	 (E2).	 In	 order	 for	 the	 substrate	 to	 be	
recognized	by	 the	26S	proteasome	the	Ubiquitin-ligase	enzyme	 (E3)	 transfers	a	minimum	of	 four	
ubiquitin	 monomers	 to	 lysine	 residue	 48	 of	 the	 substrate	 (the	 schematic	 representation	 was	
adapted	from	Murton	et	al.,	2008	[34]).	
Interestingly,	it	has	been	shown	that	the	UPS	is	unable	to	degrade	intact	myofibrils	[35].	This	leads	
to	the	assumption	that	 for	 initial	myofibril	disruption	the	activity	of	other	degradation	systems	 is	
necessary	like	caspase-3	[36]	and	calpain	[37].	
As	shown	in	previous	studies,	the	UPS	has	a	key	role	in	skeletal	muscle	atrophy	[38-40].	However,	
the	 inhibition	 of	 this	 UPS	 by	 proteasome	 inhibitors	 is	 not	 sufficient	 to	 fully	 protect	 from	 loss	 of	
muscle	 mass	 during	 catabolic	 conditions	 [41-43],	 indicating	 the	 presence	 of	 a	 further	 protein	
degradation	system.		
	
1.3.	Autophagosomal-lysosomal	pathway	
Autophagy	 is	 a	 ubiquitous	 and	 well-conserved	 process	 from	 yeast	 to	 mammals.	 The	 word	
autophagy	 derives	 from	 the	 Greek	 word	 “self-eating”.	 In	 contrast	 to	 the	 ubiquitin-proteasomal	
system,	 the	 autophagosomal-lysosomal	 system	 has	 the	 ability	 to	 degrade	 and	 recycle	 entire	
organelles	 and	 large	 protein	 aggregates.	 The	 balance	 of	 this	 degradation	 process	 is	 the	 key	 for	
muscle	health	as	it	is	detrimental	for	muscle	homeostasis	as	the	excessive	or	inhibited	activation	of	
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autophagy	flux	leads	to	rapid	loss	of	muscle	mass	[29].	Inhibition	of	autophagy	causes	many	known	
myopathies	 and	 neurodegenerative	 diseases	 like	 Pompe	 and	 Danon	 disease	 or	 Inclusion	 body	
myositis.	Neurodegenerative	diseases	are	displaying	inclusions	and	abnormal	mitochondria.			
So	 far,	 three	 independent	 types	 of	 autophagy	 are	 described:	 macroautophagy,	 microautophagy	
and	chaperone-mediated	autophagy	(CMA).	Macroautophagy	(hereafter	referred	to	as	autophagy)	
starts	with	the	formation	of	a	C-shaped	double-membrane	vacuole	called	phagophore.	It	wraps	the	
cytoplasmic	 components,	 which	 should	 be	 degraded	 and	 finally	 forms	 the	 double	 membrane	
autophagsomes.	 The	 autophagosome	 fuses	with	 the	 lysosome,	 forming	 the	 autophagolysosome.	
The	 inner	 vesicle	 of	 the	 autophagosome	 together	 with	 the	 cargo	 substrates	 are	 degraded	 by	
resistant	 hydrolases.	 The	 resulting	macromolecules	 and	 amino	 acids	 are	 recovered	 by	 lysosomal	
permeases	to	fulfill	the	energy	demands	of	the	muscle	cells.	
However,	autophagy	 is	not	a	non-selective	process	for	bulk	degradation	as	many	several	types	of	
selective	 autophagy	 for	 mitochondria,	 peroxisomes,	 endoplasmic	 reticulum,	 cytoplasmic	
aggregates,	and	invading	pathogens	have	been	described	[44].	
	
1.3.1.	Autophagy	machinery	
To	date,	38	known	autophagy-related	genes	 (Atg)	have	been	 identified	as	 regulating	 the	steps	of	
autophagosome	formation	and	breakdown.	They	are	highly	conserved	and	were	initially	identified	
in	yeast	genetic	screens	[45].	At	least	four	important	functional	groups	of	Atg	proteins	are	involved	
in	the	process	of	autophagy:	for	the	regulation	of	autophagy	initiation,	the	ULK1	protein-kinase	and	
the	VPS34–Beclin	1	complex	are	necessary.	The	Atg9–Atg2–Atg18	complex	regulates	expansion	of	
phagophore	 assembly	 site	 (PAS)	 by	 carrying	 lipids	 and	 the	Atg5–Atg12–Atg16	 and	Atg8/Map1lc3	
(microtubule	associated	protein	1	light	chain	3,	LC3)	conjugation	systems	regulate	the	elongation	of	
autophagosome	membranes.		
After	induction	of	autophagy	the	phagophore	is	formed.	The	origin	of	this	double	membrane	is	still	
under	debate.	It	is	assumed	that	highly	conserved	ubiquitin-like	conjugation	systems,	consisting	of	
the	 Atg12-Atg5	 and	 the	 Atg8-phosphatidylethanolamine	 (PE)	 system,	 are	 assembling	 at	 the	
phagophore	 assembly	 site	 or	 the	 pre-autophagosomal	 structure	 [46].	 Atg7	 activates	 Atg12	 in	 an	
ATP-dependent	manner,	 functioning	 like	 an	 E1-activating	 enzyme.	Atg12	 is	 then	 transferred	 to	 a	
cysteine	 residue	 in	 Atg10	 by	 releasing	 Atg7.	 Atg10	 functions	 like	 an	 E2-conjugating	 enzyme	 and	
links	Atg12	to	Atg5	and	finally	to	Atg16.	This	multimeric	complex	is	then	required	for	the	elongation	
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of	the	expanding	pre-autophagosomal	membrane	that	is	curved	by	the	asymmetric	recruitment	of	
Atg8.		
	
Figure	 3.	 Autophagy	 machinery.	 At	 least	 four	 important	 functional	 groups	 of	 Atg	 proteins	 are	
involved	 in	 the	 process	 of	 autophagy:	 (1)	 the	 ULK1	 protein-kinase	 complex	 and	 (2)	 the	 VPS34–
Beclin	 1	 complex	 are	 necessary	 for	 regulation	 of	 autophagy	 initiation.	 (3)	 The	 Atg9–Atg2–Atg18	
complex	regulates	expansion	of	phagophore	assembly	site	(PAS)	by	carrying	lipids	and	the	(4)	Atg5–
Atg12–Atg16	and	Atg8/Map1lc3	 (microtubule	associated	protein	1	 light	chain	3,	LC3)	conjugation	
systems	regulate	the	elongation	of	autophagosome	membranes	(the	schematic	representation	was	
adapted	from	Ding	et	al.,	2011	[47]).	
Early	 isolation	 membranes,	 autophagosomes	 and	 autophagic	 bodies	 have	 Atg8	 present	 in	 their	
membrane.	 This	 ubiquitin-like	 protein	 is	 primarily	 cleaved	 by	 Atg4,	 which	 leads	 to	 an	 exposing	
glycine	 residue	 resulting	 in	 the	 activation	 by	 binding	 to	 Atg7.	 The	 transfer	 to	 Atg3,	 an	 E2-like	
enzyme,	 initiates	 the	 conjugation	 of	 Atg8	 with	 an	 abundant	 membrane	 phospholipid,	
phosphatidylethanolamine	 (PE).	 In	 order	 to	 keep	 the	 normal	 autophagy	 process	 running,	 Atg4	 is	
able	to	reverse	the	conjugation	of	PE.	In	mammals	four	Atg8	homologs	are	identified,	among	these	
is	 LC3,	 Gate16	 (Golgi	 associated	 ATPase	 Enhancer	 16	 kDa),	 Gabarap	 (Gabba	 receptor	 associated	
protein)	and	Atg8L.	LC3	is	the	most	abundant	one	and	is	detected	in	two	forms,	the	soluble	LC3-I	
form	 and	 the	 lipidated	 LC3-II	 form.	 Lipidated	 and	 cleaved	 LC3	 is	 used	 as	 a	 general	 autophagic	
marker	[48]	to	monitor	autophagic	flux	[49].		
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The	regulation	of	autophagy	is	organized	through	a	set	of	signaling	pathways	which	are	influenced	
by	nutritional	 status,	 growth	 factors,	 hormones,	 stress	 and	 intracellular	 energy	 information.	One	
key	 regulator	 and	 autophagy	 sensor	 in	 mammals	 is	 the	 kinase	 mTOR.	 The	 ULK1	 protein-kinase	
complex	 (Atg1-Atg13-Atg17)	 works	 downstream	 of	 mTOR	 and	 is	 required	 for	 the	 early	 stage	
autophagosome	formation.	In	order	to	form	this	complex,	mTOR	coordinates	the	phosphorylation	
status	of	Atg13.	Cellular	stress	like	starvation	leads	to	the	suppression	of	mTOR,	causing	activation	
by	 dephosphorylation	 of	 the	 serine-threonine	 protein	 kinase	 ULK1.	 Active	 ULK1	 phosphorylates	
Atg13	and	recruits	other	downstream	Atg	proteins.	The	ULK1	protein-kinase	complex	recruits	Atg9,	
a	 transmembrane	 protein	 interacting	 with	 Atg18,	 a	 phosphatidylinositol-triphosphate	 (PI3-P)	
binding	protein	and	Atg2,	a	peripheral	membrane	protein.	This	complex	is	involved	in	the	cargo	of	
additional	membranes	from	trans-Golgi	network	and	the	late	endosomes	necessary	for	the	growth	
of	the	autophagosomal	membranes.				
Atg6	 and	 its	mammalian	 homolog	 Beclin	 1	 are	 also	 important	 for	 the	 initiation	 of	 autophagy.	 It	
forms	 a	 complex	 with	 VPS34,	 VPS15	 and	 Atg14.	 The	 class	 III	 PI-3-kinase	 VPS34	 is	 an	 essential	
regulator	of	autophagy	by	generating	PI3-P.	The	complex	with	Atg6/Beclin	1	significantly	increases	
the	 catalytic	 activity	 [50,	51].	 Several	 regulatory	proteins	 that	 interact	with	Atg6–VPS34	 complex	
have	 been	 identified.	 The	 interaction	 with	 Bcl-2	 and	 Bcl-xL	 leads	 to	 the	 dissociation	 of	 the	
Atg6/Beclin	1	and	Vps34	complex.	Other	 interaction	partners	 induce	autophagy	 such	as	ambra-1	
[52]	 and	 UVRAG	 (ultraviolet	 irradiation	 resistance	 associated	 gene)	 [53].	 Rubicon	 (Run	 domain	
protein	as	Beclin	1	 interacting	and	cysteine-rich	 containing)	 [54,	55]	and	3-Methyladenine	 (3MA)	
[56]	are	known	to	negatively	regulate	autophagy.		
Finally,	 the	 mature	 autophagosome	 fuses	 with	 the	 lysosomal	 compartment	 forming	 the	
autophagolysosome	 (Figure	 3).	 This	 involves	 the	 recruitment	 of	 the	 SNARE	 protein	 syntaxin	 and	
HOPS	 (homotypic	 fusion	 and	 vacuole	 protein	 sorting).	 This	 complex	 promotes	 the	 fusion	 of	
autophagosomes	with	 lysosomes	 [57-59].	This	process	 is	detrimental	 for	 the	autophagic	 flux;	any	
blockage	will	result	in	the	accumulation	of	autophagosomes.	
Noteworthy,	 post-translational	 modulation	 of	 the	 Atg	 proteins	 adds	 additional	 entry	 points	 for	
crosstalk	with	other	cellular	processes	and	helps	define	cell-type-specific	regulations	of	autophagy	
[60].	
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1.3.1.	Autophagy	in	skeletal	muscle		
Since	muscle	is	the	major	reservoir	of	amino	acids,	it	is	one	of	the	most	important	tissues	to	control	
whole	body	metabolism.	Excessive	or	insufficient	protein	degradation	by	autophagy	is	detrimental	
for	 global	muscle	 homeostasis	 as	 it	 leads	 to	 atrophy	 and	muscle	 weakness.	 The	muscle-specific	
inactivation	of	two	critical	autophagy-related	genes	in	mice,	Atg5	and	Atg7,	helped	to	understand	
the	basal	mechanisms	of	autophagy	in	skeletal	muscle.	The	inactivation	of	Atg5/7	leads	to	severe	
muscle	 wasting	 combined	 with	 ultrastructural	 alterations	 of	 cytosolic	 organelles	 and	 myofiber	
degeneration.	 Furthermore,	 the	 Atg5/7	 inactivation	 results	 in	 an	 increase	 of	 polyubiquitinated	
proteins	and	the	accumulation	of	concentric	membranous	structures	without	any	obvious	changes	
of	 the	 proteasome	 activity,	 indicating	 an	 important	 role	 of	 lysosomal	 protein	 degradation	 via	
autophagy	in	muscle	cells	[61-63].	Consistently,	collagen	VI	deletion	mutants,	a	model	for	Bethlem	
myopathy	and	Ullrich	congenital	muscular	dystrophy,	are	not	able	to	activate	autophagy	in	skeletal	
muscles	causing	the	accumulation	of	dysfunctional	organelles,	 increased	ROS	 levels	and	myofiber	
damage	[8].	
Notably,	 another	 report	 revealed	 an	 important	 link	 between	 physical	 exercise	 and	 induction	 of	
autophagy	 [10].	 Since	 exercise	 usually	 improves	 glucose	 and	 energy	metabolism	 in	 the	 liver	 and	
pancreas	in	high-fat	diet	mouse	models	of	obesity,	the	beneficial	effect	of	exercise	was	perturbed	
in	 stimulus	 (exercise-	 or	 starvation-)	 induced	 autophagy-impaired	 mice.	 These	 mice	 carry	 a	
mutation	 in	 Bcl-2	 that	 prevents	 its	 release	 from	 an	 inhibitory	 interaction	 with	 the	 autophagy	
protein	 Beclin	 1,	 resulting	 in	 a	 blockage	 of	 the	 beneficial	 metabolic	 effects.	 This	 reveals	 that	
autophagy	is	a	key	contributor	for	metabolic	benefits	of	physical	exercise.		
Reduction	 in	 autophagy	 causes	muscle	wasting	due	 to	 toxic	 accumulation	of	 protein	 aggregates,	
resulting	 in	 a	 pathological	 phenotype	 after	 several	 months	 or	 years.	 Conversely,	 an	 increase	 of	
autophagic	 flux	 causes	 a	 rapid	 loss	 of	 muscle	 mass	 within	 days	 and	 weeks	 [29].	 Although	 the	
balance	 in	 the	 autophagic	 flux	 is	 one	 key	 point	 in	 muscle	 health,	 there	 are	 still	 many	 open	
questions	about	the	role	of	autophagy	in	skeletal	muscle.	Elucidation	of	autophagy	regulators	is	of	
great	importance	as	an	imbalance	is	associated	in	several	myopathies	and	dystrophies.	
As	mentioned	before,	there	is	increasing	evidence	that	ubiquitin	is	used	as	a	signal	for	autophagic	
degradation	 of	 protein	 aggregates	 and	 other	 cellular	 substrates.	 It	 is	 still	 not	 clear	 which	
degradation	 pathway	 is	 activated	 upon	 accumulation	 of	 polyubiquitinated	 protein.	Nevertheless,	
the	 two	 main	 cargo	 proteins	 responsible	 for	 the	 selective	 recognition	 and	 delivery	 to	 the	
autophagosomes	are	p62/SQSTM1	and	NBR1.	They	contain	a	C-terminal	ubiquitin-binding	domain	
containing	(UBA)	and	a	short	LC3-interacting	region	(LIR)	sequence	responsible	for	LC3	interaction	
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[64,	 65].	 This	 enables	 the	 cargo	 proteins	 to	 bind	 polyubiquitin	 chains	 of	 proteins	 and	 LC3	 [28].	
Furthermore,	there	is	evidence	that	aggregates	containing	p62	and	ubiquitinylated	proteins	serve	
as	nucleating	scaffold	for	autophagosome	biogenesis	by	binding	multiple	Atg	proteins	[66-68].		
Arndt	 et	 al.	 depicted	 that	 chaperone-assisted	 selective	 autophagy	 is	 essential	 for	 muscle	
maintenance.	 Before	 p62	 binds	 its	 cargo,	 the	 substrate	 needs	 to	 be	 recognized	 by	 molecular	
chaperones	 or	 other	 cellular	 systems.	 The	 co-chaperone	 BAG3	 forming	 a	 complex	 with	 Hsc70,	
HspB8	and	the	ubiquitin	ligase	CHIP	binds	filamin,	a	muscle	sensitive	protein	prone	to	irreversible	
damage.	The	ubiquitination	of	 filamin	and	BAG3	by	CHIP	 results	 in	 the	binding	of	p62	and	 finally	
autophagic	clearance	 [69].	Another	chaperone	called	Valosin-containing	protein	 (VCP/p97)	seems	
to	play	a	pivotal	role	in	the	fusion	of	autophagosomes	to	lysosomes	[70]	by	regulating	the	integrity	
of	a	dynamic	tubular	lysosomal	network	[71].		
	
1.3.2.	 Valosin-containing	 protein	 (VCP/p97)	 is	 required	 for	
autophagy	
Valosin-containing	protein	 is	a	ubiquitously	expressed	hexameric	AAA-ATPase	 (ATPase	associated	
with	 various	 activities).	 It	 is	 implicated	 in	 several	 cellular	 processes,	 like	 cell	 cycle	 regulation,	
nuclear	envelope	formation,	Golgi	biogenesis	and	the	ubiquitin	proteasome	system	[72].	VCP	has	
two	ATPase	domains,	D1	and	D2,	which	are	organized	as	two	stacked	rings	with	a	central	channel.	
The	regulatory	N-domain	is	at	the	periphery	of	the	D1	ring.	Several	cofactors	have	been	shown	to	
be	responsible	for	modulating	VCP-mediated	processes	[4].	Mutations	of	VCP	gene	cause	inclusion	
body	myopathy	(IBM),	Paget’s	disease	of	the	bone	(PDB)	and	frontotemporal	dementia	(FD)	[73],	
spastic	paraplegia	[74],	scapuloperoneal	muscular	dystrophy	[75]	and	Charcot-Marie-Tooth	disease	
[76]	which	are	rare	multisystem	degenerative	disorders.	Muscle	weakness	 is	the	first	symptom	in	
over	50%	of	VCP	associated	diseases	[70].	Typical	symptoms	are	the	accumulation	of	non-digested	
autophagosomes	 that	 form	morphological	 structures	 called	 rimmed	 vacuoles	 and	 poly-ubiquitin	
aggregates	[70].	A	recent	study	of	Johnson	et	al.	depicted	a	role	for	VCP	in	the	dynamic	of	lysosome	
tubules.	 VCP	 deficiency	 causes	 defects	 in	 lysosome	 tubular	 lattice	 leading	 to	 a	 disruption	 in	
autophagic	 clearance.	 However,	 the	 exact	 mechanism	 by	 which	 VCP	 regulates	 autophagic	 and	
lysosomal	 protein	 degradation	 needs	 to	 be	 elucidated.	 Furthermore,	 it	 was	 long	 believed	 that	
autophagy	and	the	ubiquitin-proteasomal	system	act	as	complementary	systems	with	no	point	of	
intersection.	 But	 several	 studies	 revealed	 that	 ubiquitinated	 proteins	 can	 be	 degraded	 by	 both	
catalytic	pathways	[77-79]	and	ubiquitin-binding	proteins	such	as	VCP	appear	to	play	a	major	role	
in	this	crosstalk	[80].		
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Several	Atg	 proteins	were	 identified	 and	 they	 are	 regulated	by	 transcriptional,	 translational,	 and	
post-translational	 mechanisms.	 But	 the	 impact	 of	 these	 PTMs	 on	 the	 degradation	 systems	 still	
needs	to	be	elucidated.	
	
1.4.	 Methyltransferases:	 an	 enzymatic	 group	 with	 diverse	
functions	
Complex	molecular	networks	are	necessary	to	maintain	the	intracellular	homeostasis	under	normal	
and	 stimulated	 conditions.	Methyltransferases	are	 important	 regulators	 that	 keep	 the	balance	 in	
these	 critical	 cellular	 events	 by	 enzymatically	 methylating	 a	 great	 variety	 of	 substrates.	 They	
transfer	 methyl	 groups	 to	 nucleotides,	 lipids,	 small	 molecules,	 and	 proteins.	 The	 donor	 of	 the	
methyl	 group	 is	 a	 small	 cofactor	 called	 S-adenosylmethionine	 (SAM	 also	 known	 as	 AdoMet).	 In	
1887,	 the	 German	 physician	 Wilhelm	 His	 reported	 the	 results	 of	 experiments	 in	 which	 he	
administered	pyridine	to	dogs	and	found	that	they	excreted	N-methylpyridine	in	their	urine.	About	
60	 years	 later,	 it	 was	 found	 that	 the	 reaction	 is	 catalyzed	 by	 S-adenosylmethionine-dependent	
methyltransferases	 [81].	 Several	 years	 later	 it	 was	 shown	 that	 methylation	 occurs	 on	 lysine	
residues	of	proteins	[82],	 in	particular	histones	[83],	and	nucleic	acids	[84].	So	far	more	than	200	
potential	methyltransferases	 in	humans	have	been	 identified	and	 they	are	 involved	 in	epigenetic	
control,	tissue	differentiation,	and	lipid	biosynthesis	(Figure	4)	[85].	
	
Figure	4.	Composition	of	 the	methyltransferome.	Methyltransferase	domain	 containing	proteins	
were	grouped	into	biological	functions.	The	annotation	of	biological	functions	is	adopted	from	the	
Swiss-Prot	database	and	in	most	cases	the	assignments	are	based	on	similarities.		
Mammalian	 DNA	methyltransferases	 transfers	 a	 methyl	 group	 to	 DNA	 either	 at	 the	 C-5	 carbon	
atom	 of	 cytosine	 or	 the	 C-6	 nitrogen	 atom	 of	 the	 adenine	 purine	 ring.	 DNA	methylations,	 also	
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known	 as	 epigenetic	 marks,	 are	 involved	 in	 numerous	 processes	 including	 genomic	 imprinting,	
carcinogenesis,	 and	 gene	 expression	 control.	 Increased	 DNA	 methylation	 on	 regulatory	 DNA	
sequences	 is	 generally	 associated	 with	 decreased	 gene	 activity	 and	 is	 the	 basis	 for	 epigenetic	
regulation	of	gene	expression.	The	most	abundant	DNA	(cytosine-5)-methyltransferase	is	DNMT1.	
It	methylates	CpG	dinucleotides	and	the	inactivation	of	this	gene	results	in	a	clear	reduction	of	DNA	
methylation	and	to	a	lethal	phenotype	during	embryonic	mouse	development	[86].	
Another	 class	of	mammalian	methyltransferases	 transfers	 the	methyl	 group	 to	mainly	 lysine	and	
arginine	residues	of	proteins.	 In	several	cancer	types	a	dysregulation	of	 these	methyltransferases	
was	found.	SMYD2,	a	protein	lysine	methyltransferase,	is	upregulated	in	esophageal	squamous	cell	
carcinoma	 [87]	 and	 bladder	 cancer	 cells	 [88].	 Similarly,	 an	 increased	 expression	 for	 SMYD3	was	
revealed	 in	 breast	 carcinoma	 [89]	 and	 for	 G9a,	 a	 histone	 methyltransferase,	 in	 hepatocellular	
carcinoma	[90].	
The	 lack	 of	 guanidinoacetate	N-methyltransferase	 causes	 a	 deficiency	 of	 creatine	 in	 tissues	with	
high-energy	 demand	 like	 muscle	 and	 brain	 due	 to	 an	 accumulation	 of	 the	 creatine	 precursor	
guanidinoacetic	acid	(GAA)	[91].		
In	addition	to	its	function	in	cancer	SMYD2	plays	also	an	important	role	for	proper	muscle	function.	
The	 deletion	 of	 Smyd2	 in	 zebrafish	 resulted	 in	 loss	 of	 Hsp90	 methylation,	 causing	 a	 decreased	
complex	formation	of	titin	and	Hsp90.	As	a	consequence,	Smyd2	deletion	mutants	showed	reduced	
titin	stability	and	altered	muscle	function	[92].						
It	was	initially	thought	that	methyltransferases	are	highly	substrate-specific.	But	several	examples	
suggest	a	 remarkable	substrate	promiscuity	 that	 is	characterized	by	methyltransferases	acting	on	
diverse	substrates	[93-95].	This	classification	and	identification	of	substrates	of	methyltransferases	
might	be	one	of	the	biggest	challenges	in	the	characterization	of	these	proteins.		
	
1.4.1.	The	“protein”	methylation	reaction	
The	transfer	of	a	methyl	group	by	S-adenosylmethionine-dependent	methyltransferases	works	via	
a	 SN2	 displacement	 mechanism	 to	 nucleophilic	 atoms	 like	 carbon,	 oxygen,	 nitrogen,	 sulfur	 or	
halides.	 These	 residues	 are	 present	 on	 a	 wide	 range	 of	 amino	 acids	 such	 as	 lysine,	 arginine,	
glutamate,	 asparagine,	 histidine,	 and	 cysteine	 as	 well	 as	 several	 amino	 acids	 at	 the	 amino	 or	
carboxyl	terminus	of	proteins	[96].	S-adenosylmethionine	is	produced	and	regenerated	via	the	SAM	
cycle	[97].	The	by-product	of	the	methylation	reaction	S-adenosyl-homocysteine	(SAH)	 is	a	strong	
inhibitor	 of	 these	 methyltransferases.	 Thus,	 SAH	 is	 normally	 converted	 to	 homocysteine	 and	
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adenosine	by	the	action	of	SAH	hydrolase	[98].	Defects	 in	methyltransferases	are	associated	with	
elevated	 intracellular	 levels	 of	 homocysteine,	 which	 results	 in	 the	 premature	 onset	 of	
cardiovascular	 and	 neurological	 diseases	 [37,	 99].	 Furthermore,	 methyl	 groups	 can	 be	 also	
transferred	 to	 electrophilic	 carbon	 atoms	 by	 an	 indirect	 “ping-pong”	 mechanism	 with	 an	
intermediate	 methylation	 step	 on	 a	 conserved	 cysteine	 residue.	 For	 example,	 the	
methyltransferases	 RlmN	 (YfgB)	 and	 Cfr	 belong	 to	 the	 radical	 SAM-dependent	 enzymes	 and	
methylate	C-2	and	C-8	of	adenosine	2503	(A2503),	respectively.	 In	neither	case	 is	a	methyl	group	
transferred	directly	from	SAM	to	the	RNA.	Instead	this	class	of	methyltransferases	is	able	to	cleave	
SAM	 to	 a	 5ʹ-deoxyadenosyl	 5ʹ-radical	 (5ʹ-dA•),	 which	 is	 further,	 used	 to	 abstract	 key	 hydrogen	
atoms	 from	 the	 substrate.	 One	 prerequisite	 is	 at	 least	 one	 [4Fe-4S]	 cluster	 that	 is	 typically	
coordinated	 by	 the	 cysteine	 residues	 of	 a	 CxxxCxxC	 motif.	 This	 [4Fe-4S]	 cluster	 supplies	 the	
electron	for	the	reductive	cleavage	of	SAM	[100].	
	
1.4.2.	Methylation	on	proteins	
One	of	the	first	reports	about	protein	methylation	was	already	described	more	than	50	years	ago	
[82]	and	identified	the	methylation	on	core	histone	proteins.	The	methylation	of	histone	proteins	is	
part	of	the	“histone	code”	which	is	important	for	transcriptional	activation	and	the	recruitment	of	
DNA	binding	partners.			
Several	studies	also	showed	that	non-histone	proteins	are	methylated	at	lysine,	arginine	and	the	N-
terminus	 [2,	 92,	 101-104].	 The	 first	methyltransferase	 was	 identified	 twenty	 years	 ago	 and	 it	 is	
responsible	 for	 the	 trimethylation	 of	 lysine-14	 of	 the	 large	 subunit	 RUBISCO,	 the	 plant	 enzyme	
required	for	fixing	much	of	the	carbon	dioxide	in	the	biosphere	[105,	106].	This	methyltransferase	
was	later	designated	as	a	SET-domain	protein,	though	the	function	still	needs	to	be	elucidated.	The	
SET-domain	stands	for	three	Drosophila	genes	associated	with	development:	Su(var)3–9,	enhancer	
of	 zeste,	 and	 trithorax.	 The	 knowledge	 that	 the	 SET-domain	 is	 important	 for	 plant	
methyltransferases	 led	 to	 the	 understanding	 that	 it	 is	 the	 catalytic	 core	 of	 protein	
methyltransferases	and	that	each	of	these	Drosophila	proteins	catalyze	histone	lysine	methylation	
[107].		
In	contrast	to	protein	acetylation,	methylation	does	not	alter	the	overall	charge	of	the	protein	and	
the	nucleosome.	However,	the	function	of	both	modifications	is	to	recruit	proteins	responsible	for	
regulatory	processes	 like	transcription,	mRNA	splicing	and	DNA	repair	and	thereby	determine	cell	
fate	 and	 identity	 [108].	 Initially,	 protein	methylation	was	 considered	 irreversible	 due	 to	 its	 high	
thermodynamic	 stability	 of	 the	N–CH3	bond.	 The	 first	 enzyme	 identified	 that	 could	 erase	methyl	
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marks	 from	histones	was	the	amine	oxidase	LSD1	[109]	 (KDM1	according	to	the	newly	suggested	
nomenclature	[110]).	This	changed	the	understanding,	and	during	the	 last	years	many	families	of	
demethylases	have	been	identified	underscoring	the	dynamic	nature	of	methylation	[111].	
A	unique	feature	of	histone	methylation	is	that	it	leads	to	a	repression	or	activation	of	gene	activity	
depending	on	the	modification	site	and	the	modification	state.	For	example,	the	trimethylation	on	
H3K4	is	associated	with	active	genes	[112],	in	contrast	to	H3K9,	which	is	found	at	silent	loci	[113].	
Furthermore,	trimethylation	of	H3K4,	H3K9,	H3K27	and	H4K20	proved	to	be	stable	through	mitosis	
and	over	several	cell	generations	 [114,	115].	These	 features	make	histone	methylation	suited	 for	
propagation	and	inheritance	of	epigenetic	states.		
One	prominent	example	for	non-histone	protein	methylation	is	the	tumor	suppressor	p53.	It	is	the	
most	 studied	 non-histone	 protein	 being	 methylated	 at	 the	 several	 lysine	 residues.	 Clearly,	 the	
activity	 of	 p53	 is	 mainly	 regulated	 on	 post-translational	 level.	 In	 addition	 to	 phosphorylation,	
ubiquitination	 and	 acetylation,	 methylation	 can	 enhance	 or	 suppress	 the	 activity	 of	 p53.	 It	 was	
shown	that	p53	is	methylated	at	lysine	K320	and	K327,	which	regulate	its	activity	[116-118].	In	the	
methylation	 field	 it	 was	 a	 significant	 finding	 that	 Smyd2,	 a	 Set	 and	 MYND	 domain	 containing	
methyltransferase,	 is	one	of	the	methyltransferase	regulating	the	methylation	process	of	p53	and	
its	 downstream	 targets	 [118].	 Other	 examples	 for	 protein	methylation	 are	 the	 activation	 of	 the	
transcription	 factor	 TAF10	 by	 the	methyltransferase	 SET9	 [119]	 and	 the	 VEGFR1	methylation	 by	
Smyd3	 [120].	 There	 is	 a	 great	 influence	 of	 the	 Smyd	methyltransferase	 family	 (Smyd1-3)	 in	 the	
development	and	assembly	of	skeletal	muscle	tissue.	Smyd1	is	expressed	in	heart	and	fast	skeletal	
muscle	tissue,	and	it	is	localized	at	sarcomeric	M-line	structures.	In	zebrafish	flatline	mutants	where	
Smyd1	 is	mutated	 the	assembly	of	 thick	myosin	 filaments	 is	dysregulated	and	 results	 in	a	 severe	
malformation	 of	 heart	 and	 fast	 skeletal	 muscle	 tissue	 [121].	 As	 mentioned	 before,	 the	 family	
member	Smyd2	is	essential	for	the	methylation	of	the	Hsp90	protein	that	subsequently	stabilizes	Z-
disk	structures	 in	zebrafish	[92].	However,	the	 inactivation	of	the	Smyd2	gene	in	mouse	does	not	
show	any	obvious	phenotype	in	the	heart	[122].		
Another	 important	 protein	 regulating	 a	 wide	 range	 of	 physiological	 processes	 throughout	
eukaryotic	organisms	is	Calmodulin,	a	key	mediator	of	calcium-dependent	signaling,	which	has	an	
important	role	in	skeletal	muscle	excitation.	Several	studies	revealed	that	Calmodulin	is	subject	to	
many	regulatory	post-translational	modifications,	 including	trimethylation	of	lysine	115	[102,	123,	
124].	 A	 recent	 study	 revealed	 that	 an	 enzyme	 named	 Calmodulin-lysine	 N-methyltransferase	 is	
responsible	for	the	trimethylation	of	lysine	residues	on	Calmodulin	[102].	
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Taken	 together,	 these	 examples	 prove	 that	 protein	 methylation	 is	 an	 important	 regulator	 for	
protein	 stability	 [125,	 126],	 activity	 [116-120,	 127],	 turnover	 [128],	 localization	 [117,	 129-131],	
protein-protein	[92,	132-134]	and	protein-nucleic	acids	interaction	[135].		
	
1.4.3.	Methyltransferases	share	homologue	structures	
S-adenosylmethionine-dependent	 methyltransferases	 represent	 0.6-1.6%	 of	 all	 genes	 in	 the	
genomes	of	bacteria,	yeast	and	humans.	It	is	predicted	that	there	are	over	200	methyltransferases	
in	humans	[85,	136]	and	for	most	of	them	the	function/substrate	is	completely	unclear.		
These	methyltransferases	are	classified	into	five	distinct	families,	namely	Class	I-V,	based	on	their	
different	structural	features.	The	majority	of	identified	methyltransferases	contains	a	seven-strand	
twisted	beta-sheet	and	 is	summarized	as	Class	 I	enzymes.	The	smallest	 families	with	very	distinct	
structures	 are	 Class	 II	 (TIM	 beta/alpha-barrel	 alpha/beta)	 and	 III	 (tetrapyrrole	 methylase	
alpha/beta).	 Class	 IV	 (SPOUT	 alpha/beta)	 act	 as	 homodimers	 and	methylate	 RNA	 substrates	 like	
tRNA	 and	 rRNA.	One	 of	 their	 characteristics	 is	 the	 knot-like	 structure	 formed	 by	 the	 C-terminus	
compromising	 of	 several	 catalytic	 residues	 [137].	 The	 SET	 domain	 containing	 enzymes	 represent	
Class	V	also	displaying	a	knot-like	structure,	but	they	catalyze	the	methyl	transfer	to	proteins	 like	
histones	 and	 ribosomal	 proteins	 [93].	 Based	 on	 the	 yeast	methyltransferome,	Wlodarski	 and	 his	
colleagues	 claim	 for	 the	 existence	 of	 at	 least	 four	 more	 methyltransferase	 classes	 [138].	 The	
majority	of	methyltransferases,	however,	have	a	structure	similar	to	the	Class	I	fold,	and	this	group	
is	characterized	by	a	seven-stranded	beta-sheet	adjoined	by	alpha	helices.	Although	the	sequence	
similarity	 is	 rather	 low,	 their	 tertiary	 structure	 shares	 the	 well-known	 S-adenosylmethionine-
dependent	methyltransferase	 fold,	which	 is	 structurally	 similar	 to	 the	 NAD(P)-binding	 Rossmann	
fold	 [85,	93].	This	class	displays	 four	distinct	motifs,	namely	Motif	1,	Motif	Post	1,	Motif	2	and	3	
[139,	140].	 Important	 for	 the	binding	of	 cofactors	are	 two	conserved	positions;	 the	 first	one	 is	 a	
GxGxG	motif	localized	in	Motif	1.	It	is	characteristic	for	a	nucleotide-binding	site	and	is	used	to	bind	
the	 adenosyl	 part	 of	 S-adenosylmethionine.	 The	 second	 position	 is	 an	 acidic	 residue	 located	 C-
terminal	to	Motif	2	that	forms	one	hydrogen	bond	to	each	hydroxyl	of	the	S-adenosylmethionine	
ribose	part	[141].	
	
1.4.4.	The	Methyltransferase-like	21	(METTL21)	family		
Recently,	the	METTL21	family	was	discovered	as	a	novel	Class	I	family	of	lysine	methyltransferases	
that	preferentially	 target	and	regulate	molecular	chaperones	[2,	3].	 It	was	shown	that	METTL21D	
catalyzes	 the	 trimethylation	 of	 VCP,	while	METTL21A	methylates	 the	 heat	 shock	 protein	 HSP70.	
Moreover,	 it	 seems	 that	 cofactors	 play	 an	 important	 role.	 VCP	 trimethylation	 of	 lysine-315	 by	
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METTL21D	was	stimulated	by	the	direct	interaction	of	the	UBX	cofactor	ASPSCR1	[2].	Interestingly,	
the	 stimulatory	 effect	 of	 the	 of	 the	 UBX	 cofactor	 ASPSCR1	 is	 diminished	 when	 using	 the	 VCP	
mutants	 (R155H,	 R159G	 and	 R191Q)	 which	 are	 known	 to	 be	 responsible	 for	 Inclusion	 Body	
Myopathy	 with	 Paget's	 disease	 of	 bone	 and	 Fronto-temporal	 Dementia	 (IBMPFD)	 and/or	 some	
familial	forms	of	Amyotrophic	Lateral	Sclerosis	(ALS)	[2].	These	amino	acids	are	localized	to	the	N-
terminal	domain	that	 is	crucial	 for	 the	 interaction	with	several	cofactors	[142].	The	 lysine-315	on	
VCP	is	in	close	proximity	of	the	Walker	B	domain	of	the	first	ATPase/D1	domain,	and	it	is	suggested	
that	it	negatively	affects	the	ATPase	activity	[3].		
It	 has	been	 shown	 that	methylation	of	Hsp70	has	 a	beneficial	 impact	on	 the	 formation	of	 stress	
granules	 induced	 by	 arsenite	 treatment.	 In	 times	 of	 cellular	 stress	 cells	 produce	 stress	 granules.	
Several	 proteins	 (for	 example	 Ataxin-2	 [143]	 and	 the	 survival	 motor	 neurons	 [144])	 which	 are	
involved	in	neurodegeneration	are	known	to	interact	with	stress	granules	[145].	These	cytoplasmic	
inclusions	 result	 in	 the	 repression	 of	 RNA	 processing.	 Several	 studies	 implicate	 that	 the	
dysfunctional	 stress	 response	 facilitates	 the	 onset	 of	 the	 pathogenesis	 of	 neurodegenerative	
diseases	 [146,	 147].	 This	 brings	 protein	 methylation	 in	 context	 with	 degenerative	 disorders	 like	
IBMPFD	and	ALS	[2].	
Furthermore,	Huang	and	co-workers	suggested	an	important	role	for	Mettl21c	in	musculoskeletal	
biology	 and	 sarcopenia.	 They	 showed	 that	 siRNA	 mediated	 knockdown	 of	 Mettl21c	 mRNA	
expression	 in	 mouse	 myogenic	 C2C12	 precursor	 cells	 causes	 a	 slight	 reduction	 in	 myofiber	
formation,	which	was	claimed	to	be	caused	by	effects	of	the	NFκB	pathway	[148].	
In	Saccharomyces	cerevisiae,	an	uncharacterized	methyltransferase	encoded	by	the	YNL024C	gene	
shows	high	 sequence	 similarity	 to	METTL21A	and	METTL21D,	 as	well	 as	 to	 their	 uncharacterized	
paralogues	 METTL21B	 and	 METTL21C.	 The	 study	 of	 Jakobsson	 et	 al.	 provided	 evidence	 that	 it	
methylates	 the	 eukaryotic	 translation	 elongation	 factor	 eEF1A	 at	 lysine-390	 [149].	
For	 the	eukaryotic	 translation	elongation	 factor	eEF1A	 in	 yeast	 four	methylation	 sites	have	been	
reported	 (Lys30,	 Lys79,	 Lys318	 and	 Lys390).	 With	 the	 identification	 of	 YNL024C,	 all	 four	
methyltransferases	regulating	these	methyl	modifications	have	now	been	identified	[149-152].	
Taken	together,	protein	methylation	by	members	of	the	METTL21	family	is	an	important	regulator	
for	protein-protein	interactions	and	associates	most	likely	chaperone	activity	and	protein	turnover	
to	modulate	skeletal	muscle	plasticity.			
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1.5.	Mass	spectrometry	based	proteomics	
Multicellular	organisms	have	a	complete	genome	in	every	single	cell	of	their	body	and	the	diversity	
between	 different	 cell	 types	 and	 organs	 derives	 from	 epigenetics,	 transcriptional,	 post-
transcriptional	as	well	as	post-translational	processes.	 In	order	to	better	understand	the	complex	
molecular	system	and	the	crosstalk	between	signaling	pathways	 in	a	cell,	one	needs	to	survey	all	
proteins	 (termed	 proteome)	 at	 different	 physiological	 conditions	 at	 once.	 Therefore,	 mass	
spectrometry	has	emerged	as	a	powerful	tool	and	the	method	of	choice	for	the	identification	and	
quantification	 of	 proteins	 and	 post-translational	 modifications	 in	 a	 biological	 sample	 [153-155].	
Mass	spectrometry	became	popular	in	the	1980s,	when	the	two	main	techniques,	matrix-assisted	
laser	 desorption/ionization	 (MALDI)	 [156]	 and	 electrospray	 ionization	 (ESI)	 [157,	 158],	 were	
introduced.	Initially,	proteomics	was	performed	with	2-dimensional	gel	electrophoresis	techniques,	
which	suffer	from	several	limitations,	including	sensitivity	and	reproducibility	[159].	2-dimensional	
gel	 electrophoresis	 was	 later	 replaced	 by	 protein	 and	 peptide	 separation	 techniques	 based	 on	
liquid	reversed	phase	chromatography	coupled	online	to	mass	spectrometers	(LC-MS).	
Currently,	 the	 bottom-up	 approach	 is	 the	 most	 popularly	 used	 approach	 in	 mass-spectrometry	
based	 proteomics	 for	 the	 identification	 and	 quantification	 of	 proteins,	 post-translational	
modifications,	and	protein-protein	interactions	in	complex	biological	samples.	This	approach	is	also	
known	as	shotgun	proteomics.	Here,	proteins	are	 first	enzymatically	digested	 into	peptides	using	
proteases	and	purified	peptides	are	 then	 subjected	 to	LC-MS/MS	analysis	 (Figure	5).	 The	generic	
workflow	 contains	 four	 stages	 and	 starts	 usually	 with	 the	 lysis	 of	 the	 cells	 and	 solubilisation	 of	
proteins.	Within	 the	second	step	 the	proteins	are	proteolytically	digested	by	endopeptidases	 like	
trypsin	 or	 LysC.	 Protein	 digestion	 is	 performed	 either	 in	 solution	 (in-solution	 digestion)	 or	 after	
separation	of	proteins	by	1-dimensional	SDS-PAGE	(in-gel	digestion).	In	addition,	combination	of	in-
solution	 digestion	 and	 filter-based	 peptide	 separation,	 named	 as	 filter-aided	 sample	 preparation	
(FASP)	technique,	were	recently	invented.	This	third	method	for	sample	preparation	was	invented	
by	 Wisniewski	 et	 al.,	 proving	 to	 be	 the	 method	 of	 choice	 for	 single-run	 analysis	 with	 in-depth	
coverage	of	proteome	[160].		
The	major	challenge	in	shotgun	proteomics	is	the	dynamic	range	of	proteins	in	a	given	sample.	For	
example,	 the	 concentration	 of	 blood	 proteins	 comprises	 up	 to	 12	 orders	 of	 magnitude	 and	 the	
detection	limit	in	protein	concentration	differences	are	only	5	orders	magnitudes	for	modern	mass	
spectrometers	[161].	This	fact	makes	it	impossible	to	detect	very	low	abundant	proteins	in	complex	
biological	samples,	such	as	blood	and	skeletal	muscle.			
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To	bypass	this	problem,	several	different	approaches	were	developed	to	reduce	the	complexity	of	
biological	samples.	A	useful	strategy	is	the	improvement	of	peptide	separation	in	front	of	the	mass	
spectrometers.	Longer	columns	filled	with	smaller	bead	size	increase	the	resolution	of	the	reversed	
phase	chromatography	significantly.	Other	approaches	to	reduce	the	sample	complexity	are	based	
on	 size	 exclusion	 chromatography	 (SEC),	 strong	 cation	 exchange	 chromatography	 (SCX),	 strong	
anion	exchange	chromatography	(SAX)	or	(high	pH)	reversed-phase	liquid	chromatography	(RPLC).	
After	 digestion,	 peptides	 are	 cleaned	 and	 desalted	 by	 C18	 STAGE-tip	 technique	 (Stop	 and	 Go	
extraction	tips)	[162].		
During	 the	 third	 step,	 peptides	 are	 separated	 online	 by	 ultra-high	 pressure	 reversed	 phase	
chromatography	(UHPLC).	Peptides	are	separated	by	reversed	phase	chromatography	and	ionized	
by	electrospray	 (ESI)	 at	 the	 tip	of	 the	 column	and	 transferred	 into	 the	mass	 spectrometer.	Next,	
tandem	mass	spectrometry	allows	isolating	and	fragmenting	individual	peptides	(MS)	and	detecting	
the	fragment	mass	spectra	(MS/MS)	[153].	Peptide	masses	(MS)	and	the	fragment	spectra	(MS/MS)	
are	 used	 to	 accurately	 identify	 proteins	 and	 peptides.	 The	 quantification	 is	 based	 on	 peptide	
intensities.	The	spectra	are	obtained	as	raw	files	and	they	are	analyzed	using	a	search	engine	for	
comparison	to	databases,	which	were	digested	with	the	same	enzyme	in	silico.			
Figure	 5.	 Generic	 workflow	 of	 LC-MS-based	 proteomics.	 It	 is	 based	 on	 four	 different	 steps:	 1.	
Extraction	of	proteins	 from	cells	or	tissue.	2.	Proteolytic	digestion	of	proteins,	usually	 in-solution,	
in-gel	or	 in	a	 filter-aided	 sample	preparation	protocol.	 3.	 +	4.	Peptide	mixtures	are	 separated	by	
UHPLC,	ionized	by	electrospray	(electrospray	ionization,	ESI),	and	measured	in	a	mass	spectrometer	
detecting	the	masses	and	fragment	masses.		
Due	to	the	quality	of	the	MS/MS	spectrum	in	large-scale	analysis,	the	main	issue	is	to	assign	correct	
peptide	 sequences	 to	 a	 spectrum.	 This	 score-based	 result	will	 inevitably	 have	 some	mismatches	
(false	positives).	 There	are	 several	 strategies	 for	a	multiple	 testing	 correction	 to	discriminate	 the	
false	positive	hits.	The	most	frequently	used	is	the	target-decoy	database	search.	The	principle	of	
this	 is	 the	usage	of	a	combinatory	database	consisting	of	a	normal	 (target)	 fasta	 sequence	and	a	
reversed/random	(decoy)	fasta	sequence.	A	peptide	would	be	considered	to	be	a	false	positive	if	it	
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would	 be	 aligned	 to	 the	 decoy	 database.	 The	 false	 discovery	 rate	 (FDR)	 is	 finally	 calculated	 by	
dividing	the	number	of	target	and	the	decoy	peptide	spectrum	match	(PSM)	[163,	164].		
In	 comparison,	 the	 top-down	 approach	 detects	 intact	 proteins,	 including	 their	 PTM	pattern,	 and	
measures	them	directly	with	the	mass	spectrometer.		
	
1.5.1.	Quantitative	methods	in	mass	spectrometry	
Mass	 spectrometry	 is	 able	 to	 qualitatively	 analyze	 thousands	 of	 proteins	 in	 complex	 biological	
mixtures,	 but	 is	 not	 inherently	 quantitative.	 Variabilities	 in	 sample	 preparation	 and	 instrument	
performance	very	often	hamper	a	direct	comparison	of	large-scale	samples.	However,	a	number	of	
techniques	have	recently	emerged.	In	principle	there	are	three	major	quantification	techniques	I.)	
the	 label-free	 protein	 quantification	 approach,	 II.)	 the	 chemical	 modification	 and	 derivatization	
with	 labeled	 isotopes	 [165],	and	 III.)	 the	metabolic	 incorporation	of	 “SILAC”	amino	acids	 into	 the	
proteome	(stable	isotope	labeling	by	amino	acids	in	cell	culture)	(Figure	6).	
In	this	thesis,	I	either	used	stable	isotope	labeling	with	amino	acids	in	cell	culture	(SILAC)	[166],	the	
SILAC	mouse	[167]	or	label-free	quantification	techniques	[168-170].		
Relative	 quantification	 strategies	 compare	 the	 abundances	 of	 individual	 peptides	 between	 two	
samples	of	interest.	Clearly,	the	SILAC	technology	has	become	the	most	often	used	approach	for	in	
vivo	isotopic	labeling.	Cells	are	usually	labeled	with	lysine	and	arginine,	containing	stable	isotopes	
of	 carbon	 and/or	 nitrogen.	 Cells	 were	 usually	 incubated	 with	 the	 SILAC	 amino	 acids	 for	
approximately	five	cell	doublings,	resulting	in	a	complete	exchange	from	the	non-labeled	(light)	to	
the	labeled	(heavy)	form.	For	relative	protein	quantification,	both	non-labeled	and	labeled	protein	
extracts	are	mixed	1:1	according	to	their	protein	concentration.	After	mass	spectrometric	analysis	
each	peptide	is	then	measured	as	a	peptide	pair.	The	relative	intensity	of	the	light	and	heavy	peak	
indicates	the	abundance	of	the	peptide/protein	within	the	sample.	The	advantage	of	SILAC	is	that	
the	samples	are	mixed	at	the	beginning	of	the	workflow	and	each	error	will	affect	both	conditions	
equally.	This	makes	the	quantification	independent	of	variations	due	to	sample	preparation	or	the	
mass	 spectrometric	 measurement.	 Depending	 on	 the	 SILAC	 amino	 acid	 combination,	 a	
multiplexing	of	three	different	biological	conditions	can	be	performed	[166].		
Recently,	 the	SILAC	 technology	was	expanded	 to	also	 label	 living	animal	models,	 including	yeast,	
worms,	 flies,	 and	 rodents.	 For	 the	 labeling	 of	 intact	 animals,	 the	 essential	 amino	 acid	 lysine	 is	
preferred	since	this	amino	acid	does	not	get	converted	into	other	amino	acids,	contrary	to	arginine.	
Thus,	to	obtain	peptides	containing	at	 least	one	 lysine,	the	protease	LysC,	which	cleaves	proteins	
only	after	lysine,	is	used	for	proteolytic	digestion	[167].	
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Besides	 these	 labeling	 approaches,	 label-free	 quantification	 has	 emerged	 as	 a	 powerful	 tool	 by	
comparing	the	signal	intensity	from	the	extracted-ion	chromatogram	(XIC)	of	individually	measured	
peptides	 derived	 from	 any	 biological	 sample.	 Nowadays,	 the	 combination	 of	 single	 shot	 analysis	
and	sophisticated	software	tools	has	shifted	the	label-free	approach	to	the	same	level	of	accuracy	
compared	to	SILAC	quantification	[169].	In	addition,	the	absolute	concentration	or	the	amount	of	a	
given	protein	in	copy	number	per	cell	can	be	determined	with	absolute	quantification	techniques.	
This	is	mainly	done	with	spiking	in	isotopic	labeled	peptides	of	known	concentrations.		
	
Figure	 6.	 Relative	 and	 absolute	 quantification	 strategies.	 (A)	 The	 SILAC	 approach	metabolically	
labels	 the	entire	proteome	with	 isotopically	 stable	amino	acids.	Before	 the	analysis,	 the	 samples	
with	different	conditions	are	mixed.	(B)	Absolute	proteomic	quantification	uses	isotopic	peptides	of	
known	concentrations	to	analyze	the	exact	concentration	or	the	amount	of	a	given	protein	in	copy	
number	per	cell	of	a	target	protein.	(C)	Label-free	quantification	has	emerged	as	a	powerful	tool	by	
comparing	 the	 signal	 intensity	 of	 individually	 measured	 peptides	 derived	 from	 any	 biological	
sample	(the	schematic	representation	was	adapted	from	Meissner	et	al.,	2014	[171]).	
	
1.5.2.	Mass	spectrometry	instrumentation	
Mass	 spectrometry	 is	 a	 powerful	 analytical	 technology	 for	 complex	 mixtures.	 Providing	 precise	
measurements	of	mass,	composition,	and	structural	properties	of	analytes,	 it	makes	 it	a	versatile	
tool	 in	many	 fields,	 for	example	medicine,	 life	and	pharmaceutical	 sciences,	physics,	 and	organic	
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chemistry.	 The	 first	 experiments	 in	 mass	 spectrometry	 were	 made	 by	 J.J.	 Thomson	 who	 was	
interested	in	the	behavior	of	electrical	discharges	in	gases.	This	led	to	the	discovery	of	the	electron	
in	1897.	He	could	show	that	the	movement	of	charged	particles	in	vacuum	under	the	influence	of	
an	 electric	 or	 a	 magnetic	 field	 depending	 on	 the	 mass	 to	 charge	 ratio	 (m/z).	 This	 led	 to	 the	
construction	of	the	first	mass	spectrometer.	For	his	great	discovery,	he	received	the	Nobel	Prize	in	
1906	in	physics.	From	that	time	point	on	the	application	of	mass	spectrometry	rapidly	expanded.		
In	 general,	 a	mass	 spectrometric	measurement	 starts	with	 the	 ionization	of	 an	 analyte	 in	 an	 ion	
source.	 The	m/z	 ratio	 of	 the	 ions	 is	measured	 in	 a	mass	 analyzer,	while	 a	 detector	 registers	 the	
number	of	ions	at	each	m/z	value	and	outputs	them	as	intensities.	The	intensity	values	are	plotted	
as	 a	 function	of	m/z	 values	 to	obtain	 the	mass	 spectrum,	which	 is	 finally	processed	with	 several	
computational	strategies	in	order	to	correlate	the	m/z	with	the	analytes.		
The	 first	 step	 in	 any	 mass	 spectrometry	 experiment	 involves	 the	 formation	 of	 gas	 phase	 ions	
derived	from	the	solid,	liquid,	or	gas	of	interest	and	during	the	decades,	several	different	methods	
were	 developed.	 From	 the	 ion	 source,	 the	 ionized	 analyte	molecules	 are	 sprayed	 into	 the	mass	
analyzer,	 facilitated	 by	 pressure	 and	 electric	 potential	 differences.	 An	 enormous	 number	 of	
different	 ionization	methods	have	been	developed.	Currently,	mainly	soft	 ionization	methods	are	
used	 that	 do	 not	 fragment	 the	 analyte	 upon	 ionization.	 The	most	 popular	 approaches	 to	 ionize	
molecules	 are	 the	 chemical	 ionization	 or	matrix-assisted	 laser	 desorption	 (MALDI)	 [156]	 and	 the	
electrospray	 ionization	 (ESI)	 technique	 [157,	 158].	 The	 principle	 of	 ESI	 is	 based	 on	 two	 main	
theories,	 the	 Ion	 Evaporation	Model	 (IEM)	 developed	 by	 Iribarne	 and	 Thomson,	 and	 the	 charge	
residue	 model	 (CRM).	 Both	 the	 IEM	 and	 CRM	 assume	 that	 evaporation	 causes	 the	 droplets	 to	
shrink,	resulting	in	large	field	strength	at	their	surface.	In	contrast	to	the	CRM,	the	IEM	postulates	
that	the	field	strength	is	large	enough	to	cause	the	field	desorption	of	solvated	ions	[172,	173].	The	
CRM	 suggests	 that	 when	 the	 field	 strength	 increases	 at	 the	 location	 with	 the	 highest	 surface	
curvature,	a	Taylor	Cone	 is	 formed.	From	the	tip	of	 the	Taylor	Cone	other	highly	charged	smaller	
droplets	are	emitted	until	the	droplets	contain	only	one	analyte	molecule	[157,	174].	
A	great	advantage	for	the	detection	of	peptides	from	biological	samples	was	the	combination	of	ESI	
and	 liquid-chromatography	 (LC).	 This	method	 is	 the	most	 commonly	 used	 technology	 to	 analyze	
proteomes,	 and	 it	 is	 nowadays	 possible	 to	measure	 complete	 proteomes	 from	mammalian	 cells	
[163].		
There	 are	 different	 types	 of	 mass	 analyzers	 that	 can	 be	 used	 for	 the	 separation	 of	 ions	 like	
quadrupole,	 magnetic	 sector,	 time-of-flight	 (TOF),	 ion	 trap,	 and	 Fourier	 transform	 ion	 cyclotron	
resonance	analyzer	(FT-ICR).	In	principle,	the	charged	analytes	are	analyzed	by	their	motion	based	
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on	their	characteristic	mass	to	charge	ratio	under	the	influence	of	magnet	and/or	electric	field.	The	
quadrupole	and	the	linear	ion	trap	use	the	stability	of	the	ion	trajectory	in	oscillating	electric	fields.	
In	 comparison,	 the	 TOF	 and	 the	 FT-ICR	 use	 velocity	 and	 frequency	 of	 oscillation.	 After	 passing	
through	the	mass	analyzer	ion	beams	strike	on	a	detector.	The	selection	of	detector	is	based	on	the	
required	 detection	 sensitivity,	 the	 speed,	 and	 application-specific	 requirements	 [153].	 Resulting	
from	 the	 complexity	 of	 peptides	 in	 biological	 samples	 with	 high	 dynamic	 ranges,	 mass	
spectrometers	 are	 constantly	 developing	 towards	 higher	 sensitivity,	 sequencing	 speed	 and	
resolution	[175,	176].		
The	Orbitrap	 analyzer	 is	 one	 of	 the	 latest	 developments	 in	 the	 field	 of	mass	 spectrometry	 [177,	
178].	The	basic	principle	 is	 like	 the	Kingdon	trap	as	described	by	K.H.	Kingdon	 in	1920	[179].	The	
Orbitrap	 analyzer	 consists	 of	 an	 outer	 barrel-shaped	 electrode	 and	 an	 inner	 spindle-shaped	
electrode.	 The	 ions	 are	 injected	 in	 packages	 from	 the	C-trap,	 an	 ion	 storage	device.	 The	 electric	
field	 of	 the	 inner	 electrode	 is	 ramped	 and	 the	 ions	 are	 forced	 to	 enter	 a	 circular	 motion	
(electrodynamic	 squeezing)	 resulting	 from	 the	 interaction	 of	 centripetal	 and	 centrifugal	 forces	
generated	 from	 the	 tangential	 movement	 and	 the	 electric	 field	 between	 the	 electrodes.	 The	
oscillating	frequency	by	the	axial	motion	of	the	ions	is	a	direct	value	for	the	mass	of	the	ions.	The	
generated	current	is	Fourier	Transformed	(FT)	and	displayed	in	high-resolution	mass	spectra.			
The	Orbitrap	analyzer	was	first	integrated	into	a	hybrid	mass	spectrometer	in	2005.	It	was	released	
as	a	LTQ	Orbitrap	[177,	178,	180]	in	a	combination	of	a	low	resolution	but	fast	linear	ion	trap	and	a	
high	resolution	Orbitrap	analyzer.	The	Orbitrap	detects	the	MS	scans,	while	the	ion	trap	fragments	
the	peptides	by	collision	induced	dissociation	(CID)	and	scans	the	resulting	peptide	fragments	[177,	
178,	181].	 In	2009,	a	new	version	of	 the	hybrid	Orbitrap,	 the	LTQ	Orbitrap	Velos,	was	developed	
containing	a	new	inlet	system,	the	S-lens.	This	new	system	contains	apertures	to	which	RF	voltage	
is	 applied	 and	 results	 in	 a	 10-fold	 improvement	 in	 the	 transmission	 of	 ions	 compared	 to	 the	
skimmer	lens.		
In	 addition,	 a	 dual	 linear	 ion	 trap	 and	 a	 higher	 energy	 collisional	 dissociation	 (HCD)	 were	
implemented.	This	allows	for	peptide	fragmentation	and	peptide	detection	in	the	Orbitrap	detector	
[182].	 In	 the	 collision-induced	 dissociation	 (CID)	 mode	 of	 the	 LTQ	 Orbitrap	 Velos,	 the	 LTQ	 and	
Orbitrap	 operate	 as	 separate	 mass	 spectrometers,	 while	 in	 the	 HCD	mode	 the	 precursor	 ion	 is	
selected	for	fragmentation	in	the	HCD	cell.	Although	the	fragmentation	and	detection	of	peptides	is	
much	 slower	 via	 the	 HCD	 and	 Orbitrap	 detector,	 the	mass	 accuracy	 is	much	 higher	 resulting	 in	
peptides	with	significant	better	scores.	The	use	of	two	separated	mass	analyzers	 is	referred	to	as	
‘tandem	in	space’	as	 it	 is	commonly	employed	in	a	combination	of	an	ion	trap	and	Orbitrap	mass	
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analyzer	or	FT-ICR.	In	contrast,	the	sequential	use	of	the	same	analyzer	can	be	viewed	as	‘tandem	
in	time’,	like	it	is	commonly	used	in	Q	Exactive	instruments	(as	described	in	section	2.15.1.).		
	
1.6.	Aim	of	this	thesis	
Skeletal	 muscle	 fibers	 are	 highly	 differentiated	 cells	 and	 the	 development	 of	 a	 highly	 efficient	
contractile	apparatus	ensures	a	 lifelong	contraction.	 In	mammals	 the	 skeletal	muscle	 is	 the	most	
abundant	tissue	and	supports	the	whole	body	with	energy.	Thus,	the	metabolic	function	of	skeletal	
muscle	 tissue	plays	 a	 vital	 role	 for	whole	body	homeostasis.	 The	presence	of	 specific	 fiber-types	
enables	 the	 skeletal	 muscle	 to	 perform	 simultaneously	 long	 lasting	 workload	 as	 well	 as	 fast	
movements.	 Moreover,	 individual	 fiber-types	 are	 able	 to	 rapidly	 respond	 to	 external	 stimuli,	
including	loading	conditions,	nutrition	status,	and	hormonal	signals	[18,	19].	Earlier	studies	showed	
that	 not	 only	 the	 abundance	 of	 proteins	 in	 the	 cell	 is	 important	 but	 also	 the	 presence	 of	 post-
translational	modifications	(PTM),	such	as	phosphorylation,	ubiquitination	and	acetylation.	Another	
PTM,	the	methylation	of	 lysine	and	arginine	residues	is	mainly	known	as	an	essential	regulator	of	
hetero-	 and	 euchromatin,	 which	 is	 achieved	 by	 the	 formation	 of	methyl	marks	 on	 histone	 tails.	
However,	it	has	been	shown	that	protein	methylation	is	not	only	restricted	to	epigenetic	regulation	
but	also	modulates	the	activity,	stability,	and	interactions	of	many	non-histone	proteins.	According	
to	 these	 functions,	 a	 dysregulation	 of	 methyltransferases	 is	 closely	 associated	 to	 many	 human	
diseases,	such	as	cancer,	inflammation,	metabolic	syndromes	and	neurodegeneration	[183].	
The	aim	of	the	presented	thesis	is	the	functional	characterization	of	a	slow-muscle	specific	putative	
methyltransferase	annotated	as	Mettl21c	(Methyltransferase-like	21c).	To	elucidate	the	function	of	
this	enzyme	in	muscle	tissue,	a	transgenic	mouse	model	with	an	inactivated	Mettl21c	gene	should	
be	 generated.	 Besides	 the	 analysis	 of	 morphometric	 and	 physiological	 parameters,	 a	
comprehensive	 analysis	 of	 the	 transcriptome	and	proteome	 is	 aimed	 in	order	 to	understand	 the	
molecular	 consequences	 of	 the	 inactivation	 of	 Mettl21c.	 Moreover,	 protein-protein	 interaction	
studies	 based	 on	 high-resolution	 mass	 spectrometry	 should	 help	 to	 decipher	 the	 molecular	
network	and	identify	potential	substrates	for	this	enzyme.	It	will	be	central	to	investigate,	whether	
muscle	 tissue	 of	Mettl21c	 deficient	mice	 is	 able	 to	 properly	 respond	 to	 external	 stimuli	 such	 as	
atrophy	induction	to	understand	the	alterations	of	the	dynamics.	
Together,	the	goal	of	this	study	is	to	understand	how	non-histone	methyltransferases	regulate	the	
homeostasis	of	muscle	fibers	under	basal	and	disease	related	conditions.	
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2.	Materials	and	Methods	
	
2.1.	Materials	and	chemicals	for	biochemistry	methods	
	
cOmplete	protease	inhibitor	cocktail		 Roche		
Needles	and	syringes		 B.Braun		
BSA	protein	standard		 Sigma	Aldrich		
Dithiothreitol	(DTT)		 Sigma	Aldrich		
Iodacetamide		 Sigma	Aldrich		
Ammonium	bicarbonate	(ABC)		 Sigma	Aldrich		
Methanol		 AppliChem		
NuPAGE	4-12%	Bis-Tris	Gel		 Life	Technologies		
NuPAGE	LDS	sample	buffer	4x		 Life	Technologies		
NuPAGE	SDS	MOPS	running	buffer		 Life	Technologies		
InstantBlue		 Expedeon		
Ethanol		 Carl	Roth		
Acetonitrile		 Sigma	Aldrich		
Acetone		 Carl	Roth		
Trifluoroacetic	acid		 Applied	Biosystems		
Sodium	dodecyl	sulphate	(SDS)		 Carl	Roth		
Urea		 Sigma	Aldrich		
Thiourea		 Sigma	Aldrich		
HEPES		 Sigma	Aldrich		
Tris		 Carl	Roth		
Hydrochloric	acid		 AppliChem		
S-adenosylmethionine	 NEB	
Potassium	phosphate		 AppliChem		
Potassium	chloride		 Carl	Roth		
Potassium	hydrogen	phosphate		 Sigma	Aldrich		
Sodium	chloride		 AppliChem		
3M	Empore	C8	extraction	disk		 Sigma	Aldrich		
3M	Empore	C18	extraction	disk		 Sigma	Aldrich		
Sepharose	G	beads		 Life	Technologies		
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Bicine		 Sigma	Aldrich		
Bis-Tris		 AppliChem		
Tween-20		 Carl	Roth		
Whatman	(Rotilabo	blotting)	paper		 Carl	Roth		
Nitrocellulose	blotting	membrane		 GE	Healthcare	Life	Sciences		
RedAlert	western	blot	stain	10x		 EMD	Millipore		
Albumin	bovine	fraction		 Serva		
NP-40		 Fluka		
Sodium	desoxycholate		 Sigma	Aldrich		
Skim	milk	powder		 Serva		
Glass	teflon	homogenizer		 Kontes	Glass	Co.		
Ethylenediamenetetraacetic	acid	(EDTA)		 Carl	Roth		
Phenylmethanesulphonyl	fluoride	(PMSF)		 Sigma	Aldrich		
Sodium	carbonate		 Carl	Roth		
Trichloroacetic	acid		 J.T.	Baker	Chemicals		
Triton-X	100		 Carl	Roth		
Paraformaldehyde		 Sigma	Aldrich		
Mowiol	4-88	reagent		 Sigma	Aldrich		
Collagenase	P		 Sigma	
Mayers	heamalaun	 Chromo	2E038	
Eosin		 Chromo	2C140	
Xylol	 Roth	
Trichrom	Stain	(Masson)	Kit	 Sigma	Aldrich		
FITC	Lectin	 Sigma	Aldrich	
	
2.2.	Materials	and	chemicals	for	mass	spectrometry	methods	
	
Fused-silica	PicoTip	Emitter		 DNU-MS	GbR		
C18-AQ	Reprosil	Pur	beads		 Dr.	Maisch	GmbH		
Nano	electrospray	ion	source		 Proxeon		
LTQ	Velos	ESI	positive	ion	calibration	
solution		
Pierce		
Methanol		 AppliChem		
Formic	acid		 Thermo	Scientific		
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Acetonitrile		 Sigma	Aldrich		
	
2.3.	Materials	and	chemicals	for	molecular	biology	methods	
	
LB	Carl	Roth	and	agar		 Sigma	Aldrich		
Glycerol		 Sigma	Aldrich		
DMSO		 Sigma	Aldrich		
dNTP	mix		 Life	Technologies		
PfuUltra	High-Fidelity	DNA	polymerase	
AD		
Agilent	Technologies		
DpnI	restriction	enzyme		 New	England	Biolabs		
T4	DNA	ligation	buffer	10x		 Promega		
T4	DNA	ligase		 Promega		
2-propanol		 Carl	Roth		
Agarose		 Biozym		
Ethidium	bromide		 AppliChem		
TRIzol	reagent		 Life	Technologies		
Chloroform		 Merck		
Diethylpyrocarbonate	(DEPC)		 Sigma	Aldrich		
RQ1	Dnase	buffer		 Promega		
RQ1	Dnase		 Promega		
RQ1	Dnase	stop	solution		 Promega		
First	strand	buffer	5x		 Promega		
Rnase	IN		 Promega		
Rnase	H		 Promega		
Superscript	II	reverse	transcriptase		 Promega		
Calcium	chloride		 AppliChem		
Magnesium	chloride		 Carl	Roth		
Bacto-tryptone		 BD	Biosciences		
Bacto-yeast	extracts		 BD	Biosciences		
Bacto-agar		 BD	Biosciences		
Ampicillin		 Sigma	Aldrich		
Kanamycin	monosulphate		 Sigma	Aldrich		
Tris-acetate		 Sigma	Aldrich		
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Glucose		 Sigma	Aldrich		
Sodium	hydroxide		 Carl	Roth		
Potassium	acetate		 Carl	Roth		
Acetic	acid		 Carl	Roth		
1	kB	DNA	molecular	mass	standard		 Invitrogen	
	
2.4.	Materials	and	chemicals	for	cell	culture	methods	
	
DMEM	medium		 Sigma	Aldrich		
Fetal	bovine	serum	(FBS)		 Life	Technologies		
Penicillin-Streptomycin-Glutamine	100x		 Sigma	Aldrich		
PBS	tablets		 Gibco	(Life	Technologies)		
Trypsin	EDTA		 Sigma	Aldrich		
SILAC	DMEM	medium		 Silantes		
Dialyzed	fetal	bovine	serum	(dFBS)		 Silantes		
L-lysine		 Sigma	Aldrich		
L-arginine		 Sigma	Aldrich		
13C6	L-Lysine	HCl	(Lys4)	 Silantes	
4,4,5,5-D4-L-Lysine	(Lys4)	 Cambridge	Isotope	Lab	(CIL)	
13C6	15N2-L-Lysine	HCl	(Lys8)		 Silantes		
13C6	15N4-L-Arginine	HCl	(Arg10)		 Silantes		
Dimethyl	Sulphoxide	(DMSO)		 Sigma	Aldrich		
Sodium	hydrogen	phosphate		 Carl	Roth		
Calcium	chloride		 AppliChem		
TurboFect	transfection	reagent		 Thermo	Scientific		
Opti-MEM	medium		 Gibco	(Life	Technologies)		
Bafilomycin	A1	 Sigma	
Rapamycin	 Sigma	
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2.5.	Materials	and	chemicals	for	mouse	methods	
	
10%	Ketamine		 CEVA	Sante	Animale,	Düsseldorf	
2%	Xylazin		 CEVA	Sante	Animale,	Düsseldorf	
5-0	Vicryl		 Ethicon	
Tissue-Tek®	O.C.T.	PolyfreezeTM		Freezing	
media	
Miles	Inc.,	Diagnostic	Division,	Elkhart,	USA		
Running	Wheel		 TSE	Instruments		
Treadmill	 Columbus	Instruments	
	
2.6.	Enzymes	
	
Lysyl	endopeptidase	(LysC)		 Wako		
Sequencing	grade	Trypsin		 Promega		
Proteinase	K		 Sigma	Aldrich		
RNase	A		 Sigma	Aldrich		
	
2.7.	Kits	
	
DC	protein	assay	kit		 Bio-Rad		
Phusion	High-Fidelity	DNA	polymerase	
kit		
New	England	Biolabs		
QIAquick	Gel	Extraction	kit		 Qiagen		
NucleoBond	Xtra	Maxi	Kit		 Macherey	Nagel		
SuperSignal	West	femto	max.	sensitivity	
substrate	kit		
Thermo	Scientific		
PCR	clean	up	and	Gel	extraction	Kit		 Macherey-Nagel	
RNA-Seq	Kit	v2	 Thermo	Fisher	
miRNeasy	micro	Kit		 Qiagen	
Rnase	free	Dnase	Set	 Qiagen	
Ribo	Minus	Kit		 Thermo	Fisher	
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2.8.	Antibodies	
2.8.1.	Primary	antibodies	
	
Antibody		 Company		 Catalog	number		 Application		
Flag		 Sigma	Aldrich		 #F1804		 IF		
Anti-Flag	M2	affinity	
gel		
Sigma	Aldrich		 #A2220		 IP		
Flag	M2	peroxidase	
HRP		
Sigma	Aldrich		 #A8592		 WB		
GFP		 Evrogen		 #AB121		 IP		
Pan-actin		 Cell	Signaling	
Technology		
#4968		 WB		
Sequestosome	(p62)	 abcam	 #ab91526	 IP,	WB	
Valosine-containing-
protein	(p97)	
abcam	 #ab11433	 IP,	WB	
Microtubule-
associated	proteins	
1A	and	1B	(Map1lc3)	
Cell	Signaling	
Technology	
#2775	 WB	
a-Actinin	2	 Sigma	 #A7811	 	
Myomesin	clone	B-4	 Kind	gift	from		Dr.	
H.M.	Eppenberger,	
Switzerland		
	 	
	
2.8.2.	Secondary	antibodies	
	
Antibody		 Company		 Catalog	number		 Application		
Anti-mouse	IgG-
peroxidase		
Sigma	Aldrich		 #A5278		 WB		
Anti-rabbit	IgG-
peroxidase		
Sigma	Aldrich		 #A9169		 WB		
Cy2TM	 Dianova	GmbH		 #715-225-151	(mouse)	
#711-225-152	(rabbit)	
IF	
Cy3TM	 Dianova	GmbH	 #715-165-151	(mouse)	 IF	
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#711-165-152	(rabbit)	
2.9.	Buffers	and	solutions	
	
SDS	lysis	buffer		 4%	SDS		
0.1M	Tris/HCl	pH	7.6		
RIPA	lysis	buffer		 100mM	Tris/HCl	pH	7.5		
300mM	NaCl		
2%	NP-40		
2mM	EDTA		
0.2%	Sodium	deoxycholate		
Urea	(UA)	buffer		 6M	Urea		
2M	Thiourea		
0.1M	HEPES	pH	7.4		
Buffer	A		 0.1%	formic	acid		
Buffer	B		 80%	acetonitrile		
0.1%	formic	acid		
Buffer	C		 5%	Acetonitrile		
1%	Trifluoroacetic	acid		
KCM	buffer	5x		 500	mM	KCl		
150	mM	CaCl2		
250	mM	MgCl2	
LB	(Luria-Bertani)	medium	per	litre		 10g	Bacto-tryptone		
5g	Bacto-yeast	extracts		
5g	NaCl		
950	ml	deionized	water	added	and	dissolved,	
pH	adjusted	to	7.0	with	5N	NaOH,		
filled	up	to	1l	with	deionized	water,		
sterilized	by	autoclaving		
LB-Agar	plate	per	litre		 10g	Bacto-tryptone		
5g	Bacto-yeast	extracts		
5g	NaCl		
7g	Bacto-agar		
Sterilized	by	autoclaving,	
cooled	to	50-60°C	and	antibiotic	added		
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Antibiotics	(1000x	stocks)		 Ampicillin	50mg/ml	in	H2O		
Kanamycin	monosulphate	10mg/ml	in	H2O		
Tris-EDTA	(TE)	buffer	10x		 100	mM	Tris/HCl	pH	7.6		
10mM	EDTA	pH	8.0		
TAE	buffer		 40mM	Tris-acetate		
1mM	EDTA		
Mini	prep	solution	A		 25mM	Tris	pH	8.0		
10mM	EDTA		
50mM	Glucose		
10μg/ml	RNase	A		
Mini	prep	solution	B		 0.2N	NaOH		
1%	SDS		
Mini	prep	solution	C		 3M	Potassium	acetate		
8.9%	Acetic	acid		
HBS	(HEPES	Buffered	Saline)	2x		 50	mM	HEPES		
280	mM	NaCl		
1.5	mM	Na2HPO4		
pH	7.0	adjusted	using	HCl	and		
filter	sterilized		
Western	blot	transfer	buffer	20x		 500	mM	Bicine		
500	mM	Bis-Tris		
20	mM	EDTA		
TBS-T		 50	mM	Tris/HCl	pH	7.6		
150	mM	NaCl		
0.1%	Tween-20		
Methyltransferase-Buffer	 100	mM	Tris	pH	8.5		
10	mM	MgCl	
8	mM	DTT	
Sodiumposphate	buffer	 77,4	ml	1	M	NaHPO	
22,6	ml	1	M	NaHPO	
in	1	l	MilliQ-H2O,	pH	7,4		
X-Gal	fixation	solution		 Sodiumphosphate	buffer	pH	7.4	
0.2%	GDA	
2	mM	MgCl2	
5	mM	EGTA	pH	7.5	
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X-Gal	washing	solution	 2	mM	MgCl2		
0.01%	Na-Desoxycholat	
0.02%	NP-40		
Sodiumphosphate	buffer	pH	7.4	
5%	X-Gal		 50	mg/ml	X-Gal	in	Dimethylformamide	
X-Gal	staining	solution		 5	mM	K3FeCN6		
5	mM	K4FeCN6	
0.1%	X-Gal		
in	X-Gal	washing	solution	
Blocking	solution		 2%	BSA		
0.5%	NP40	
3%	Horse	Serum		
in	PBS	
Mowiol	4-88	 2.4	g	Mowiol	4-88	
6	g	Glycerin	
6	ml	MilliQ-H2O	
12	ml	Tris-HCl	pH	8.5	
2x	HBS	 50	mM	HEPES	
280	mM	NaCl	
1.5	mM	na2HPO4	x	2H2O,	pH	7.05	
4%	PFA/PBS	 40	mg/ml	Paraformaldehyd	(PFA)		
in	PBS,	pH	7.4	
1x	TE	 10	mM	Tris-HCl	
1	mM	EDTA	
pH	8	
TENS	Lysis	buffer	 50	mM	Tris-HCl,	pH	8	
100	mM	EDTA	
100	mM	NaCl	
1%	SDS	
200	µg/ml	Proteinase	K	(freshly	added)		
PBT	 0.1%	Tween20	in	PBS	
0.2%	collagenase	solution		 0.2%	Collagenase	P	in	DMEM	
10x	TBS	 2	M	Tris-HCl	pH	6.7	
1.4	M	NaCl	
in	MilliQ-H2O	
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1x	MOPS-SDS	Running	Buffer	 dilution	of	20x	MOPS-SDS	Concentrate		
(Invitrogen)	in	ddH2O	
1x	TAE	 1:50	50x	TAE,	in	ddH2O	
	
2.10.	Devices	used	
	
FLUOstar	galaxy	spectrophotometer		 BMG	Labtech	
SpeedVac	concentrator	plus		 Eppendorf		
MilliQ	water	purification	system		 Merck	Millipore		
Thermomixer		 Eppendorf		
ÄKTA	purifier		 GE	Healthcare	Life	Sciences		
Easy	nLC	1000	UHPLC		 Thermo	Scientific		
QExactive	mass	spectrometer		 Thermo	Scientific		
PCR	labcycler		 Sensquest		
NanoDrop	2000c	spectrophotometer		 Peqlab		
ChemiDoc	MP	imaging	system		 Bio-Rad		
Ion	Torrent	Proton	sequencing	platform		 Thermo	Fisher	
LSM700	confocal	microscope		 Carl	Zeiss		
Transmission	electron	microscope	 Philips	CM	10	
Zeiss	Axioimager	Z1	 Carl	Zeiss	
Leica	with	DFC	420C	camera	 Leica	
Cryostat	Leica	CM3050	 Leica	
Running	Wheel	 TSE	Instruments		
Treadmill	 Columbus	Instruments	
Bead	mill		 Retsch,	MM301	
Bioanalyzer	2100		 Agilent	
Ion	OneTouch2	instrument		 Thermo	Fisher	
	
2.11.	Cell	lines	
	
Cell	line	 Company		 description	
C2C12	 ATCC	CRL-1772™	 Murine	myoblast	cell	line			
HEK293T	 ATCC	CRL-11268™	 Human	embryonal	
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kidney	cell	line		
U-2	OS	 ATCC®	HTB-96™	 Homo	sapiens	bone	
cells	
	
2.12.	Primer	
2.12.1.	Primers	for	genotyping	
Wild	type	and	Mettl21c-/-	fw:	CTGTGAAACTAGCTCCTTGG			
Wild	type:	GATTGACCGTAATGGGATAG	
Mettl21c-/-	rev:	TTCTTATGGCTGAGAAATGC	
2.12.2.	Primers	for	Phusion	PCR	amplification	
NdeI-	Mettl21c	fw	5’-GGG	AAA	GGG	CAT	ATG	GAT	CAG	CAT	CTC	CAC	ATA	GCC	CAG	CAG	CCC	CT-3’	
BamHI-	Mettl21c	fw	5’-GGG	AAA	GGG	GGA	TCC	ATG	GAT	CAG	CAT	CTC	CAC	ATA	GCC	CAG	CAG	CCC	
CT-3’	
Mettl21c	 -nostop-SlaI	 rev	5’-CCC	TTT	CCC	CTC	GAG	CTC	CCA	CTT	TAA	TAT	CCC	TTT	AAA	CAG	CTT	
GAC	AG-3’	
NdeI-	Mettl21e	fw	5’-GGG	AAA	GGG	CAT	ATG	GAC	CTC	ACA	GTA	ACT	CAC	ATT	ACT	CAC	AAA	GA-3’	
BamHI-	Mettl21e	fw	5’-GGG	AAA	GGG	GGA	TCC	ATG	GAC	CTC	ACA	GTA	ACT	CAC	ATT	ACT	CAC	AAA	
GA-3’	
Mettl21e	 -nostop-SlaI	 rev	5’-CCC	TTT	CCC	CTC	GAG	GGC	ACT	CCT	CCG	ATT	TTT	CTT	CAT	AGC	TTT	
GTA	CA-3’	
2.12.3.	Primers	for	methyltransferase	domain	mutation	
Mettl21c-GGG/AAA	fw	5’-GCT	AAA	ATA	CTT	GAA	ATT	GCT	GCT	GCA	GCA	GCC	CTT	GTT	TCC-3’	
Mettl21c	-GGG/AAA	rev	5’-	GGA	AAC	AAG	GGC	TGC	TGC	AGC	AGC	AAT	TTC	AAG	TAT	TTT	AGC-3’	
Mettl21e	-GGG/AAA	fw	5’-AAT	GTG	ATT	GAA	ATT	GCA	GCT	GCG	ACA	GCG	CTT	GTC	TCC-3’	
Mettl21e-GGG-AAA	rev	5’-	GGA	GAC	AAG	CGC	TGT	CGC	AGC	TGC	AAT	TTC	AAT	CAC	ATT-3’	
	 	
Chapter	2	|	Material	and	Methods	
36	
	
2.12.4.	Empty	plasmids	used	in	this	study	
pGemTeasy	(Promega)	
pcDNA5/TO	(life	technologies)	
pcDNA5/TO	EGFP	(provided	by	MPI	collection,	Marten	Szibor)	
pcDNA5/TO	Flag-stop	(provided	by	MPI	collection,	Natalie	Al-Furoukh)	
pcDNA5/TO	HA-stop	(provided	by	MPI	collection,	Natalie	Al-Furoukh)	
pcDNA5/TO	Myc-stop	(provided	by	MPI	collection,	Natalie	Al-Furoukh)	
	
2.12.5.	Plasmids	generated	during	this	thesis	
Mettl21c:	
pGemTeasy-Nde1-Mettl21c-Sla1	
pcDNA5/TO-Mettl21c-Flag	
pcDNA5/TO-Mettl21c-HA	
pcDNA5/TO-Mettl21c-Myc	
pcDNA5/TO-Mettl21c-EGFP	
pGemTeasy	Nde1-Mettl21c(GGG/AAA)-Sla1	
pcDNA5/TO-Mettl21c(GGG/AAA)-Flag	
pcDNA5/TO-Mettl21c(GGG/AAA)-HA	
pcDNA5/TO-Mettl21c(GGG/AAA)-Myc	
pcDNA5/TO-Mettl21c(GGG/AAA)-EGFP	
pET26b-Mettl21c	
pET26b-Mettl21c(GGG/AAA)	
	
Mettl21e:	
pGemTeasy-Nde1-Mettl21e-Sla1	
pcDNA5/TO-Mettl21e-Flag	
pcDNA5/TO-Mettl21e-HA	
pcDNA5/TO-Mettl21e-Myc	
pcDNA5/TO-Mettl21e-EGFP	
pGemTeasy	Nde1-Mettl21e(GGG/AAA)-Sla1	
pcDNA5/TO-Mettl21e(GGG/AAA)-Flag	
pcDNA5/TO-Mettl21e(GGG/AAA)-HA	
pcDNA5/TO-Mettl21e(GGG/AAA)-Myc	
pcDNA5/TO-Mettl21e(GGG/AAA)-EGFP	
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pET26b-Mettl21e	
pET26b-Mettl21e(GGG/AAA)	
	
2.13.	Working	with	the	model	organism	Mus	musculus	
2.13.1.	Transgenic	mouse	line	Mettl21c	
The	 construct	 for	 the	 targeting	 vector	 replacing	 Mettl21c	 gene	 with	 a	 LacZ	 cassette	 was	
commercially	 obtained	 from	 VELOCIGENE	 (http://www.velocigene.com/komp/detail/15237).	 For	
inactivation	 of	 Mettl21c,	 the	 ZEN-UB1	 velocigene	 cassette	 was	 used	 that	 contains	 the	 beta-
galactosidase	 coding	 sequence	 from	E.coli	 (LacZ	Gene)	 and	 a	 polyadenylation	 signal.	 In	 addition,	
the	promoter	of	human	ubiquitin	C	genes	together	with	the	neomycin	phosphotransferase	and	a	
polyadenylation	signal	flanked	by	loxP	sites	were	used	for	positive	selection.	The	generation	of	the	
knockout	 mouse	 was	 performed	 the	 in-house	 service	 of	 the	 MPI	 mouse	 facility.	 The	 targeting	
vector	was	 linearized	and	used	to	electroporate	pluripotent	embryonal	mouse	ES	cells	 (F1	hybrid	
Bl6/129).	Transformed	ES	 cells	were	cultured	 for	8-10	days	with	G418	antibiotics.	G418	 resistant	
clones	were	isolated	and	expanded.	ES	cells	with	homologous	recombination	into	the	correct	locus	
were	 injected	 into	 C57Bl6	 mouse	 blastocytes.	 These	 blastocysts	 were	 transplanted	 into	
pseudopregnant	 C57Bl6	mice.	 Resulting	 chimera	mice	were	mated	with	 cre-deleter	mice,	 which	
express	the	Cre-Recombinase	in	the	germ	line,	to	cut	out	the	neomycin-resistance	cassette	at	the	
loxP	 sites.	 The	 Cre-Recombinase	 expression	 is	 driven	 by	 a	 beta-actin	 enhancer	 element	 and	 a	
human	 cytomegalovirus	 promotor	 (CMV)	 followed	by	 a	 rabbit	 beta-globin	polyadenylation	 signal	
[185].	 For	 seven	 generation	 back	 crossing	 C57BL6/J	 was	 used.	 The	 official	 authorization	 for	 the	
genetic	manipulation	was	given	by	the	Regierungspräsidium	in	Gießen	(B2-250).		
	
2.13.2.	Maintaining	of	transgene	mouse	colony	
The	transgene	mouse	line	Mettl21c-/-	was	housed	in	the	animal	facility	of	the	Max-Planck-Institute	
for	Heart	and	Lung	Research	in	Bad	Nauheim	under	regular	conditions	with	ambient	temperature	
of	20-22°C	and	in	a	12	hour	light-dark	cycle.	They	were	provided	with	food	and	water	ad	libitum.		
	
2.13.3.	 Genotyping	 -	 isolation	 of	 genomic	 DNA	 from	murine	 tail	
biopsy	
Murine	 tail	 biopsies	 (0.5	 cm)	were	 digested	with	 Proteinase	 K	 (200	 µg/ml)	 in	 500	 µl	 lysis	 buffer	
overnight	 at	 56°C	 shaking.	 After	 precipitation	 with	 500	 µl	 Isopropanol	 and	 washing	 with	 70%	
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Ethanol	the	genomic	DNA	was	diluted	in	300	µl	MilliQ	H2O.	For	the	following	genotyping	2	µl	were	
used.	
	
2.13.4.	Isolation	of	mouse	muscles	tissue	
All	animal	procedures	were	performed	in	accordance	with	institutional	guidelines.	For	the	isolation	
of	mouse	muscle	tissue	the	animals	were	sacrificed	by	cervical	dislocation.	For	muscle	isolation	the	
skin	 at	 the	 leg	was	opened	and	 the	 fascia	was	 carefully	 removed.	 Several	muscles,	 including	 the	
tibialis	 anterior,	 extensor	 digitorum	 longus,	 soleus	 muscle,	 gastrocnemius	 muscle,	 gluteus	
maximus,	and	the	diaphragm	were	isolated	for	biochemical	and	histological	analysis.		
	
2.13.5.	Sciatic	nerve	transection	
The	 sciatic	 nerve	 transection	 is	 a	 validated	 and	 reproducible	 model	 for	 denervation-induced	
skeletal	muscle	atrophy	 in	 rodents.	 It	was	performed	on	Mettl21c-/-	 and	 littermate	control	males	
ages	 8-12	 weeks.	 Animals	 were	 anesthetized	 with	 an	 intraperitoneal	 injection	 of	 100	 mg/kg	
ketamine	and	10	mg/kg	xylazine.	Mice	were	denervated	by	 surgical	 removal	of	approx.	5	mm	of	
sciatic	 nerve	 from	 the	 left	 hindlimb.	 The	 right	 hindlimb	 served	 as	 the	 control	 leg.	Wounds	were	
closed	by	suturing	with	5-0	Vicryl.	The	operative	 limb	was	check	daily	 for	 infections.	After	7	days	
the	animals	were	euthanized	and	skeletal	muscles	were	dissected,	flash-frozen	in	liquid	nitrogen	or	
imbedded	in	optimal	cutting	temperature	(OCT)	compound	(Tissue-Tek)	for	cryostat	sectioning.	The	
official	 authorization	 for	 the	 sciatic	 nerve	 transection	 was	 given	 by	 the	 Regierungspräsidium	 in	
Darmstadt	(B2-1082).	
	
2.13.6.	Running	Wheel		
To	 study	 the	 physiological	 ability	 and	 the	 spontaneous	 motion	 behavior	 of	 mice	 deficient	 for	
Mettl21c,	voluntary	running	experiments	were	performed.	Each	mouse	was	given	access	to	a	cage	
that	was	equipped	with	a	running	wheel	(drum	diameter	115	mm,	drum	width	40	mm,	rod	distance	
8.9	mm)	and	with	ad	libitum	access	to	food	and	water	in	a	12-hour	light/dark	cycle.	After	an	initial	
one	day	acclimation	period	the	running	performance	was	recorded	by	the	PhenoMaster	Software	
for	 three	 days.	 The	 official	 authorization	 for	 the	 running	 wheel	 experiment	 was	 given	 by	 the	
Regierungspräsidium	in	Darmstadt	(B2-1083).	
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2.13.7.	Treadmill	
To	study	the	physiological	ability	and	the	time	to	exhaustion	of	mice	with	a	deletion	of	Mettl21c	
forced	 running	 experiments	 were	 performed.	 The	 official	 authorization	 for	 the	 treadmill	
experiment	was	 given	 by	 the	 Regierungspräsidium	 in	 Darmstadt	 (B2-1083).	 The	 treadmill	model	
from	 Columbus	 Instruments	 allows	 low-intensity	 electric	 shock	 to	 the	 mouse’s	 paws	 when	 the	
mouse	stops.	Mice	are	trained	in	acclimation	runs	on	two	consecutive	days,	during	which	animals	
become	 familiar	with	 the	 apparatus.	 The	 duration	 of	 the	 acclimation	 run	 is	 12	minutes	 and	 the	
speed	increases	from	0	to	12	m/min.	This	is	done	by	starting	the	treadmill	at	5	m/min	and	slowly	
(once	 per	minute)	 adding	 1	meter	 per	minute,	 until	 the	 speed	 reading	 is	 12	m/min	 (7	minutes	
time),	and	the	speed	of	12	meters	per	minute	is	continued	for	an	additional	3	minutes.	The	mouse	
is	then	removed	from	the	treadmill,	placed	back	in	its	home	cage	and	returned	to	the	mouse	room	
by	 free	access	 to	water	and	 food.	On	the	third	day	mice	were	 fasted	 for	4	hours	 (from	~9	am	-1	
pm).	 The	exercise	protocol	 consists	of	 a	60	minutes	 run	beginning	with	a	5	min	warm-up	period	
from	which	the	mice	progress	from	0	to	12	m/min	(0.2	m/sec).	To	do	this,	the	treadmill	is	started	at	
5	m/min	 and	 increased	 by	 1	m/min	 every	 20	 seconds.	 Following	 the	warm-up	 stage,	mice	were	
then	exercised	at	12	m/min	for	the	remainder	of	the	60	min	protocol.		
The	exercise	session	is	terminated	at	any	point	at	which	a	mouse	meets	either	of	these	exhaustion	
criteria:	
1. Spending	 greater	 than	 5	 consecutive	 seconds	 on	 the	 shock	 grid	 without	
attempting	to	reengage	the	treadmill.		
2. Spending	 greater	 than	 50%	 of	 its	 time	 on	 the	 shock	 grid	 (in	 other	 words,	 it	
continues	to	go	back	to	the	shock	grid	repeatedly).	
3. The	third	time	a	mouse	is	willing	to	sustain	2	seconds	or	more	of	shock	without	
attempting	to	reengage	the	treadmill.		
Following	 the	60	minutes	 run,	mice	were	 returned	 to	 their	home	cage,	given	access	 to	 food	and	
water.	
	
2.14.	Sample	preparation	methods	for	mass	spectrometry	
2.14.1.	Protein	extraction	–	tissue	homogenization	and	cell	lysis	
Frozen	tissue	was	cryogenically	grinded	with	mortar	and	pestle	and	then	suspended	in	lysis	buffer	
(4%	 SDS	 in	 0.1	M	 Tris/HCl	 pH	 7.6)	 completed	 with	 protease	 inhibitor	 cocktail	 (Roche	 cOmplete	
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tablets	1	tablet	per	100	mL	buffer)	using	a	1:10	(w/v)	sample	to	buffer	ratio.	For	complete	cell	lysis	
samples	were	heated	for	10	minutes	at	95°C.	The	homogenate	was	spun	centrifuged	at	16000	g	for	
10	 minutes	 at	 room	 temperature.	 For	 immunoprecipitation	 experiments	 or	 complex	 muscle	
samples,	the	tissue	was	lysed	using	modified	RIPA	buffer	completed	with	protease	inhibitor	cocktail	
(Roche	cOmplete	tablets	1	tablet	per	100	mL	buffer)	using	a	1:15	(w/v)	sample	to	buffer	ratio.	The	
lysates	were	homogenized	on	a	rotating	wheel	at	4°C	for	30	minutes.	Crude	extracts	were	clarified	
by	centrifugation	at	15000	rpm	at	4°C	for	10	minutes.	The	lysis	procedure	was	similar	for	SDS-PAGE	
or	western	blot.	
	
2.14.2.	Myofiber	isolation	
For	the	purpose	of	this	experiment	8-12	weeks	old	Mettl21c-/-	and	littermate	controls	were	used.	
Different	muscles	were	isolated	very	carefully	and	placed	in	0.2%	collagenase	solution	(Collagenase	
P	 in	 DMEM)	 and	 incubated	 at	 37°C.	 The	 incubation	 time	 was	 adjusted	 depending	 on	 the	
collagenase	activity	and	on	the	size,	age	and	muscle	condition.	To	avoid	over-digestion	the	muscle	
was	 checked	 regularly.	 To	 stop	 the	digest,	 the	muscles	were	 carefully	 transferred	 to	 a	Petri	 dish	
with	prewarmed	DMEM.	To	release	the	myofibers,	the	muscle	was	carefully	pipetted	using	a	large	
glass	pipette.	The	fibers	were	washed	with	PBS	and	after	a	while	of	settling	the	supernatant	was	
removed.	 After	 three	 repetitions	 the	 single	 fibers	 can	 be	 collected	 under	 a	 stereo	 microscope	
(Leica).		
	
2.14.3.	Determination	of	protein	concentration	
The	determination	of	protein	concentration	was	determined	with	the	DC	Protein	assay	according	
to	the	manufacturer’s	 instructions	using	a	FLUOstar	galaxy	spectrophotometer.	 It	 is	based	on	the	
Lowry	method	 [186]	and	 is	based	on	 the	principle	of	 complex	 formation	of	proteins	with	copper	
ions	 at	 an	 alkaline	 pH.	 After	 this	 the	 aromatic	 amino	 acids	 in	 the	 sample	 reduce	 the	
phosphomolybdate	 phosphotungstic	 acid	 present	 in	 Folin	 Reagent.	 The	 amount	 of	 proteins	 can	
then	be	estimated	via	reading	the	absorbance	at	750	nm	from	the	end	product	of	the	Folin	reaction	
against	a	standard	curve	of	a	Bovine	Serum	Albumin	(BSA)	solution.	
	
2.14.4.	In-solution	digestion	
Proteins	 in	 lysis	buffer	 (SDS	or	RIPA	 lysis	buffer)	were	precipitated	 for	1	hour	using	4	volumes	of	
ice-cold	 acetone	 at	 -20°C.	 Centrifugation	 at	 15,000	 rpm	 at	 4°C	 for	 10	 minutes	 precipitated	 the	
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proteins.	 The	 protein	 pellet	 was	 washed	 with	 90%	 ice-cold	 acetone	 and	 again	 centrifuged.	 The	
resulting	protein	pellet	was	dissolved	in	6	M	urea,	2	M	thiourea,	10	mM	HEPES,	pH	8	and	subjected	
to	 digestion	 in	 solution.	 Next,	 protein	 disulfide	 bonds	 were	 reduced	 with	 10	 mM	 dithiothreitol	
(DTT)	for	30	minutes.	This	is	followed	by	alkylation	of	free	sulfhydryl	groups	of	the	cysteins	with	55	
mM	iodoacetamide	for	20	minutes	in	the	dark.	For	the	first	digestion	step	LysC	(Wako)	(protein	to	
LysC	 ratio	 =	 100:1)	 was	 added	 for	 3	 hours,	 which	 cuts	 after	 lysine,	 which	 is	 used	 for	 samples	
containing	 Lys6	 labeled	 proteins	 (from	 SILAC	mouse).	 For	 any	 other	 samples,	 proteins	were	 first	
digested	with	LysC	under	denaturing	conditions.	Then,	the	samples	were	diluted	to	2	M	urea	with	
50	mM	ammonium	bicarbonate	(ABC),	and	sequencing-grade	trypsin	(Promega,	Madison,	WI)	was	
added	 to	 the	 samples	 (protein	 to	 trypsin	 ratio	 =	 100:1)	 overnight.	 For	 both	 digestion	 conditions	
proteolysis	 were	 carried	 out	 at	 room	 temperature.	 Digestions	 were	 quenched	 by	 acidification	
(Buffer	 C)	 and	 desalted	with	 stop	 and	 go	 extraction	 tips	 (Stage	 Tips).	 Stage	 Tips	 were	made	 in-
house	 by	 stacking	 two	 layers	 of	 C18	material	 in	 pipette	 tips.	 Before	 loading	 the	 samples	 on	 the	
Stage	Tips,	they	were	activated	with	20	µl	100%	methanol,	washed	with	Buffer	B	to	elute	any	dirt	
from	the	C18	material	and	twice	with	Buffer	A	to	remove	any	remaining	acetonitrile	from	Buffer	B.	
The	digested	peptides	were	 then	 loaded	onto	 the	 equilibrated	C18	material.	 Centrifugation	 is	 at	
2600	 rpm	 for	2	 (equilibration)	 and	4	 (sample	 loading)	minutes,	 respectively.	Due	 to	hydrophobic	
interaction,	peptides	bind	to	the	C18	material.	Finally,	the	Stage	Tips	were	washed	with	20	μl	Buffer	
A	 and	dried	using	 a	 syringe.	 Stage	 Tips	were	 stored	 at	 4°C	 until	 elution	 for	measurement	 at	 the	
mass	spectrometer.		
	
2.14.5.	In-gel	digestion	
Protein	mixtures	were	separated	according	their	molecular	weight	by	subjecting	them	to	SDS-PAGE	
(4-12%	NuPage	BisTris	Gel,	Invitrogen)	followed	by	Instant	Blue	Staining	for	15	minutes	on	a	shaker.	
After	this	the	gel	was	washed	twice	with	distilled	water.	Gel	lanes	were	cut	into	equal	pieces	and	
digested	 in	gel	as	described	by	Shevchenko	et	al.	[187].	At	first,	the	gel	pieces	were	destained	by	
incubating	them	twice	with	100	µl	50	mM	ABC	solution	for	20	minutes.	Dehydration	took	place	by	
incubating	twice	with	100	µl	ethanol	for	10	minutes,	followed	by	drying	using	the	SpeedVac	for	5	
minutes	 at	 30°C.	 Proteins	were	 reduced	with	10	mM	dithiothreitol	 (DTT)	 at	 56°C	 for	 45	minutes	
with	shaking	at	600	rpm	in	a	Thermomixer.	The	free	sulfhydryl	groups	were	alkylated	with	55	mM	
iodoacetamide	 (IAA)	 in	 the	dark	 for	30	minutes.	 Following	 this,	 the	gel	pieces	were	washed	with	
100	μl	50	mM	ABC	for	15	min,	dehydrated	with	100	μl	ethanol	for	15	min,	again	washed	with	100	
μl	50	mM	ABC	for	15	min	and	dehydrated	twice	with	100	μl	ethanol	for	15	min.	The	dehydrated	gel	
pieces	were	dried	using	SpeedVac	for	5	min	at	30°C.	Then	50	μl	12ng/μl	LysC	or	trypsin	was	added	
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to	the	gel	pieces,	which	were	incubated	on	ice	for	15	min	for	swelling.	Then	80	μl	50	mM	ABC	was	
added	and	the	gel	pieces	were	incubated	at	37°C	overnight.	On	the	next	day,	generated	peptides	
were	extracted	using	an	increasing	acetonitrile	(ACN)	concentration.	At	first,	to	stop	the	enzymatic	
digestion	the	gel	pieces	were	incubated	with	100	µl	30%	ACN	/	3%	trifluoroacetic	acid	(TFA)	for	20	
minutes.	This	is	followed	by	twice	with	100	μl	70%	ACN	for	20	min	and	then	twice	with	100	μl	100%	
ACN	for	20	min.	Collected	peptide	mixtures	were	concentrated	by	using	a	SpeedVac	to	~80	µl	and	
mixed	with	 80	 µl	 Buffer	 C.	 Finally	 they	were	 desalted	 using	 the	 stop	 and	 go	 extraction	 (STAGE)	
technique	as	described	earlier.		
	
2.15.	 Liquid	 Chromatography	 –	 Tandem	 Mass	 Spectrometry	 (LC-
MS/MS)	
2.15.1.	The	Q	Exactive	series	mass	spectrometers	
The	 combination	 of	 a	 quadrupole	 mass	 filter	 with	 an	 Orbitrap	 analyzer	 called	 Q	 Exactive	 was	
introduced	 in	 2011	 [188].	 Its	 ability	 to	 perform	multiplexed	 operation	 at	MS	 and	MS/MS	modes	
makes	 the	 Q	 Exactive	 to	 a	 highly	 efficient	 and	 fast	 mass	 spectrometer	 for	 complex	 proteomic	
analyses.	 Due	 to	 its	 fast	 switching	 times	 the	 Q	 Exactive	 is	 able	 to	 select	 the	 ions	 almost	
instantaneously,	resulting	from	the	fact	that	ions	within	a	specified	m/z	(mass/charge)	range	have	
stable	trajectories.	The	ions	are	fragmented	in	the	HCD	cell	on	a	similar	time	scale.		
The	Q	 Exactive	 instrument	 is	 coupled	 to	 a	 nano	 electrospray	 ion	 source,	where	 ions	 are	 formed	
under	atmospheric	pressure	and	transferred	through	a	capillary	into	the	S-lens.	The	ions	pass	the	S-
lens	through	an	injection	flatapole	 into	a	bent	flatapole.	The	2	mm	gaps	between	the	rods	of	the	
bent	 flatapole	 allow	 for	 clusters	 and	 droplets	 to	 fly	 unimpeded	 out	 of	 the	 flatapole.	 After	 the	
transmission	 through	 a	 lens	 they	 are	 brought	 into	 a	 hyperbolic	 quadrupole	 mass	 filter,	 which	
separates	the	 ions	of	 interest.	On	their	way	to	the	C-trap	the	 ions	pass	through	the	quadrupole’s	
exit	 lens	and	a	split	 lens,	which	target	the	 ion	beam	through	an	octapole	directly	 into	the	C-trap,	
the	 ion	storage	device.	The	gas-filled	HCD	cell	 fragments	multiple	precursor	 ions	by	adjusting	the	
offsets	 of	 the	 RF	 rods	 and	 the	 axial	 field	 resulting	 in	 collision	 energy.	 The	 ion	 population	 is	
transferred	back	into	the	C-trap	and	finally	injected	into	the	Orbitrap	mass	analyzer	where	they	are	
detected.	The	ions	are	filled	into	the	HCD	cell	and	in	parallel	the	ions	from	the	previous	detection	
cycle	are	being	analyzed	in	the	Orbitrap	mass	analyzer	resulting	in	enhanced	speed	and	quality	of	
the	spectra	(Figure	7).	Thereby,	the	cycle	time	in	the	Q	Exactive	instrument	is	achieved	at	the	rate	
of	1	s	for	a	top	10	HCD	method.	A	doubling	of	the	resolution	of	the	spectra	was	obtained	from	the	
enhanced	 Fourier	 Transformation	 (eFT)	 algorithm	 [189].	 All	 these	 advances	 in	 instrumentation	
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resulted	 in	 a	 compact,	 high	 performance	 quadrupole	 Orbitrap	 instrument	 with	 great	 analytical	
properties.	
	
Figure	 7.	 Construction	 of	 the	 Q	 Exactive.	 The	 ions	 are	 directed	 towards	 the	 S-lens,	 the	 bent	
flatapole,	the	mass	selective	quadrupole,	the	C-trap	for	ion	storage,	the	HCD	cell	for	fragmentation	
to	 the	 Orbitrap	 mass	 analyzer	 (the	 schematic	 representation	 was	 adapted	 from	
www.planetorbitrap.com).	
Recently,	the	Q	Exactive	and	the	Q	Exactive	High	Field	(HF)	mass	spectrometers	have	emerged.	The	
Q	Exactive	features	an	ultra-high-field	Orbitrap	analyser,	resulting	in	a	doubling	of	the	spectra.	It	is	
built	on	the	proven	performance	of	the	Q	Exactive	Plus	series	which	features	a	low	resolution	mass	
filter	incorporated	within	the	injection	flatapole	so	that	unwanted	ions	do	not	enter	deep	into	the	
instrument.	 Furthermore,	 they	 contain	 a	 segmented	 quadrupole	 resulting	 in	 enhanced	 isolation	
efficiency	with	a	2-fold	improvement	at	narrow	isolation	windows	and	it	uses	a	cycle	time	of	1	s	for	
a	 top	 15	 to	 top	 20	 HCD	 method.	 These	 features	 make	 the	 Q	 Exactive	 Plus	 and	 Q	 Exactive	 HF	
instruments	very	stable	systems	with	exceptional	analytical	performance	for	single-shot	analysis	of	
complex	biological	samples	and	post-translationally	modified	peptides	[190].		
Data	 dependent	 analysis	 on	 the	 quadrupole-Orbitrap	 and	 linear	 iontrap-Orbitrap	 mass	
spectrometers	 have	 proven	 to	 be	 leading	 in	 the	 field	 of	MS-based	 proteomics,	 still	 most	 of	 the	
eluting	peptides	are	not	selected	for	fragmentation.	Therefore,	increasing	sequencing	speed	would	
improve	 identification	 and	 quantification.	 The	 ultra-high-field	 Orbitrap	 analyzer	 doubles	 the	
sequencing	speed	at	the	same	resolution	like	the	Q	Exactive	Plus,	resulting	from	a	size	reduction	of	
the	Orbitrap	mass	analyzer	and	thus	leading	to	increased	field	strength	[190].		
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2.15.2.	Reversed	phase	liquid	chromatography	(LC)	
For	elution	of	the	peptides	from	the	Stage	Tips	30	µl	Buffer	B	was	pipetted	on	the	C18	material	and	
incubated	for	20	minutes.	Following,	the	elution	by	pushing	it	through	with	a	syringe	into	a	96-well	
plate	and	evaporating	the	acetonitrile	by	using	a	SpeedVac.	The	concentrated	peptides	(~2	µl)	were	
resuspended	in	10	µl	Buffer	A.		A	binary	buffer	system	consisting	of	buffer	A	(0.1%	formic	acid)	and	
buffer	B	(80%	Acetonitrile,	0.1%	formic	acid)	was	used	for	peptide	separation	on	an	Easy	nano-flow	
UHPLC	 system	 (Thermo	 Fisher	 Scientific).	 This	 system	 was	 coupled	 via	 a	 nano	 electrospray	
ionization	source	to	the	Q	Exactive	or	Q	Exactive	Plus	mass	spectrometer.	Peptide	elution	from	the	
in-house	packed	20/50	cm	(1.8	µm	Reprosil	Pur	Beads,	75	µm	ID,	Dr.	Maisch	Germany)	column	was	
achieved	by	increasing	the	relative	amount	of	B	from	7%	to	38%	in	a	linear	gradient	within	150	min	
or	 240	min	 at	 a	 column	 temperature	 of	 40°C.	 Followed	 by	 5	min	 at	 95%	 B	 and	 gradients	 were	
completed	by	re-equilibration	time	of	5	min	to	5%	B.	
	
2.15.3.	Tandem	Mass	Spectrometry	(MS/MS)	
Tandem	 Mass	 Spectrometry	 contains	 multiple	 stages	 of	 mass	 analysis,	 with	 some	 form	 of	
fragmentation	 occurring	 between	 the	 stages.	 Peptides	 are	 eluted	 via	 an	 increasing	 acetonitrile	
gradient	 from	 the	C18	 column	and	are	 then	 ionized	by	electrospray	under	atmospheric	pressure	
(electrospray	 ionization,	 ESI).	 The	 nano-electrospray	 ion	 source	 sprays	 the	 peptides	 onto	 the	
transfer	 capillary	 of	 the	 Q	 Exactive	mass	 spectrometer.	 The	 Q	 Exactive	was	 operated	 in	 a	 data-
dependent	mode,	where	full	MS	scans	(300-1750	m/z)	were	acquired	by	the	Orbitrap.	MS	Spectra	
were	recorded	at	70,000	resolution	(200	m/z,	3E6	ions	as	AGC	target)	within	a	maximum	injection	
time	of	20	ms.	Acquisition	of	MS/MS	spectra	in	a	data-dependent	mode	after	high	collision	induced	
dissociation	 (HCD)	 fragmentation	 (Top10)	 was	 carried	 out	 at	 17,500	 (200	 m/z)	 in	 the	 highly	
accurate	Orbitrap	mass	analyser	using	1E6	as	the	AGC	target	and	60	ms	for	maximal	injection	time.	
Separation	width	was	set	to	1.7	m/z.	A	spray	voltage	of	1.8	kV	and	capillary	temperature	of	280°C	
were	 among	 the	 general	 settings	 applied.	 For	 mass	 accuracy	 the	 Q	 Exactive	 instrument	 was	
calibrated	once	in	three	days	using	LTQ	Velos	ESI	positive	ion	calibration	solution.		
	
2.15.4.	Data	processing	with	MaxQuant	
All	 acquired	 raw	 file	were	processed	using	 the	MaxQuant	 software	 versions	1.3.7.4	 to	1.5.2.8	 as	
well	as	the	implemented	Andromeda	search	engine.	For	protein	identification	HCD	MS/MS	Spectra	
were	 correlated	 and	 compared	 to	 the	 latest	 Uniprot	 mouse	 (Mus	 musculus)	 data	 set	 involving	
74,265	protein	sequence	entries.	An	additional	list	of	common	contaminants	was	used,	addressing	
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the	 filtering	 of	 those	 proteins.	 Searches	were	 performed	with	 tryptic	 or	 LysC	 specificity	 allowing	
two	miscleavages	and	a	mass	range	window	of	4.5	ppm	for	MS	spectra.	For	first	MS/MS	searches	I	
allowed	 a	 mass	 range	 of	 7	 ppm	 and	 for	 main	 searches	 4	 ppm.	 Carbamidomethyl	 at	 cysteine	
residues	was	set	as	a	 fixed	modification.	Oxidation	at	methionine,	acetylation	at	 the	N-	 terminus	
and	lysine	residues	were	considered	as	variable	modifications.	PSM	(peptide	spectrum	match)	and	
protein	 FDR	 (False	Discovery	 Rate)	were	 set	 to	 0.01	 and	 the	minimal	 peptide	 length	 to	 7	 amino	
acids.	For	SILAC	quantification	the	minimal	ratio	count	was	set	to	2.		
Perseus	 (version	1.4.1.3)	and	R	package	was	used	 for	 following	data	analysis	and	visualization	as	
well	as	the	statistical	environment	R.	Distance	matrix	for	hierarchical	clustering	was	computed	by	
Pearson	correlation	and	for	clustering	the	average	linkage	method	was	used.		
	
2.16.	Molecular	Biology	
2.16.1.	Concentration	measurement	of	DNA	and	RNA	
Determination	 of	 the	 concentration	 of	 nucleic	 acids	 was	 performed	 with	 the	 NanoDrop2000	
photometer	 (Peqlab).	 Parameters:	 OD260=1=50	 µg/ml	 dsDNA,	 OD260=1=40	 µg/ml	 ssRNA.	 Sample	
solvent	was	used	to	calibrate	the	photometer.		
	
2.16.2.	Polymerase	chain	reaction,	PCR	
Polymerase	chain	reaction	(PCR)	was	used	for	the	amplification	of	double	stranded	DNA	fragments	
with	 specific	 primers.	 The	 reaction	 always	 contains	 the	 following	 steps:	 denaturing	 of	 double	
stranded	 DNA,	 primer	 annealing,	 extension	 and	 final	 extension.	 For	 genotyping	 the	 following	
protocol	was	used.	A	25	µl	reaction	with	2.5	µl	PCR	buffer,	1	µL	2	mM	MgCl2,	1µL	10	mM	dNTP	mix,	
0.2	µl	forward	primers	and	0.2	µl	reverse	primers,	0.2	µl	0.2	U	Taq	DNA	polymerase,	2	µl	DNA	and	
MilliQ	 H2O	 was	 performed	 in	 a	 thermocycler.	 The	 initial	 denaturating	 step	 (3	 min,	 95°C)	 was	
followed	by	34	cycles	with	30	s	at	95°C	 (denaturing),	30	s	55°C	 (oligonucleotide	annealing)	and	1	
min/kb,	72°C	(extension).	After	the	last	cycle	there	was	a	final	extension	period	for	5	min	at	72°C.	
The	reaction	was	then	 loaded	on	to	an	agarose	gel	where	the	separation	of	the	DNA	is	based	on	
size.	A	1	kB	DNA	molecular	mass	standard	(Invitrogen)	was	used	as	a	reference.	
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2.16.3.	Agarose	gel	electrophoresis		
Agarose	gel	electrophoresis	 is	used	to	separate	DNA	molecules	by	size	when	a	current	 is	applied.	
Based	 on	 the	 fact	 that	 the	 phosphate	 backbone	 of	 the	 DNA	 is	 negatively	 charged,	 the	 DNA	
fragments	will	migrate	to	the	positively	charged	anode.	According	to	the	size	of	the	DNA	molecules,	
1-2%	agarose	gels	were	prepared	by	melting	the	agarose	powder	in	1xTAE	buffer	in	the	microwave.	
By	adding	5-10	µl	ethidium	bromide	to	the	agarose	solution	DNA	can	be	visualized	under	UV	light.	
After	the	gel	was	polymerized	in	the	gel	chamber,	the	PCR	reaction	mixed	with	loading	buffer	was	
loaded	on	the	gel	and	run	for	30-40	minutes	at	160	V.	Finally	the	separated	and	ethidium	bromide	
incorporated	DNA	 fragments	were	 visualized	using	 an	UV	 trans-illuminator.	 These	 fragments	 are	
either	 documented	 or	 excised	 with	 a	 scalpel	 and	 purified	 using	 the	 QIAquick	 Gel	 Extraction	 Kit	
(QIAGEN)	following	the	manufacturer’s	instructions.	The	DNA	was	eluted	with	sterile	water	and	the	
concentration	was	measured.	
	
2.16.4.	 Amplification	 of	 the	 coding	 sequences	 of	 Mettl21c	 and	
Mettl21e	from	mouse	cDNA	using	Phusion	polymerase	
RNA	was	isolated	from	mouse	myoblasts	(C2C12	cells)	with	the	Trizol	reagent	and	generated	cDNA	
using	the	Superscript	 II	Reverse	Transcriptase	according	to	the	manufacturer’s	recommendations.	
The	resulting	cDNA	was	used	as	a	template	for	Phusion	amplification	of	the	Mettl21	genes.	
To	 facilitate	 subcloning	 of	 the	 Mettl21	 genes	 from	 the	 pGemTeasy	 plasmid	 into	 the	 different	
expression	plasmids,	specific	enzymatic	restriction	sites	were	introduced	at	the	5’	and	3’	end	of	the	
amplification	product	by	primer	design.	For	subcloning	 into	the	pcDNA5/TO	and	related	plasmids	
BamH1	 was	 used	 as	 a	 5’	 restriction	 site,	 while	 Nde1	 was	 chosen	 for	 targeting	 the	 pET26b(+)	
plasmid.	 For	 all	 constructs	 a	 Sla1	 site	was	 introduced	 at	 the	 3’	 end.	 The	 coding	 sequences	were	
amplified	without	 stop	 codon.	 Phusion	 PCR	 (Finnzymes)	 amplification	was	 performed	 in	 a	 20	 µl	
volume	according	to	the	manufacturer’s	recommendations	using	3%	DMSO	and	the	following	PCR	
protocol:	 1-98°C-30sec,	 2-98°C-10sec,	 3-68°C-20sec,	 4-72°C-30sec,	 5-72°C-5min,	 repeat	 from	 2-4	
for	25	cycles.	
	
2.16.5.	Gel	elution	and	A-tailing	
The	Phusion	PCR	product	was	mixed	with	6x	DNA	loading	dye	and	run	on	a	1%	TAE	agarose	gel	with	
ethidiumbromide	(10	µg/ml)	at	150	V.	Then	the	size	of	the	amplified	band	was	checked	using	a	UV	
table	and	then	the	band	was	excised	with	a	scalpel	and	the	DNA	was	eluted	from	the	gel	using	the	
PCR	clean	up	and	Gel	extraction	Kit	(Macherey-Nagel)	according	to	the	standard	protocol.	The	PCR	
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product	 was	 eluted	 with	 20-50	 µl	 MilliQ	 H2O	 and	 the	 concentration	 was	 determined	 using	 the	
Nanodrop	photometer	(Thermo	Scientific).	
For	 subcloning	 into	 the	 pGemTeasy	 plasmid	 a	 3:1	 ratio	 (plasmid:insert)	was	 used.	 Since	 Phusion	
polymerase	results	in	the	amplification	of	blunt	end	fragments	the	corresponding	amount	of	eluted	
PCR	product	was	subjected	to	A-tailing	prior	to	ligation.	For	A-tailing	the	gel	purified	PCR	product	
was	mixed	with	 3	 µl	 of	 10x	 Taq	 Polymerase	 buffer	with	MgCl2,	 1	 µl	 1	mM	 dATP,	 1	 µl	 Taq	 DNA	
Polymerase	(5PRIME)	and	MilliQ	H2O	was	added	to	a	final	volume	of	30	µl.	The	A-tailing	mix	was	
incubated	for	30	minutes	at	70°C	and	then	cooled	on	ice.	
	
2.16.6.	Ligation	in	pGemTeasy	and	transformation	in	XL1Blue	E.coli	
For	ligation	of	the	Mettl21	genes	into	the	pGemTeasy	plasmid	the	30	µl	A-tailing	mixture	containing	
the	gel	eluted	PCR	products	was	mixed	with	1	µl	pGemTeasy	plasmid	(50	ng/µl),	5	µl	10x	T4	DNA	
Ligation	buffer,	2	µl	T4	DNA	Ligase	and	water	to	a	final	volume	of	50	µl.	The	ligation	was	performed	
overnight	in	a	temperature	controlled	heating	block	at	16°C.	
The	 next	 day	 5	 µl	 of	 the	 ligation	mixture	was	 added	 to	 35	 µl	MilliQ	H2O	 and	 10	 µl	 5x	 KCM	and	
cooled	on	 ice.	50	µl	competent	XL1Blue	E.coli	were	added	and	then	 incubated	for	10	minutes	on	
ice,	 for	 20	 minutes	 at	 room	 temperature	 and	 then	 1	 ml	 of	 LB-0	 medium	 was	 added	 and	 the	
transformations	were	incubated	for	1	hour	at	37°C	under	shaking	(650	rpm).	Then	the	medium	was	
removed	(1000	g,	1	min,	room	temperature)	and	the	transformed	bacteria	were	plated	on	LB-agar	
plates	 containing	 the	 corresponding	 antibiotics	 (Ampicillin	 for	 pGemTeasy	 and	 pcDNA5/TO,	
Kanamycin	 for	 pET26b).	 The	 plate	 was	 incubated	 overnight	 at	 37°C	 and	 transformants	 were	
analyzed	 by	 mini-DNA	 preparation	 and	 sequencing	 using	 the	 T7	 sequencing	 primer	 for	 the	
pGemTeasy	plasmids.	
	
2.16.7.	Subcloning	the	Mettl21	genes	from	pGemTeasy	in	the	final	
expression	plasmids	
To	 generate	 tagged	 versions	 of	 the	 Mettl21	 genes	 for	 the	 expression	 in	 mammalian	 cells,	 the	
following	plasmids	were	used:	pcDNA5/TO-Flag,	pcDNA5/TO-HA,	pcDNA5/TO-Myc	plasmids.	These	
plasmids	 contain	 a	 Flag-tag	 (amino	 acid	 sequence:	 DYKDDDDK),	 HA-tag	 (amino	 acid	
sequenceYPYDVPDYA)	or	Myc-tag	(amino	acid	sequence:	EQKLISEEDL)	followed	by	a	stop	codon	(5’-
TGA).	 The	 tag-stop	 sequences	were	 cloned	 into	 the	pcDNA5/TO	plasmid	using	 the	Xho1	 (5’)	 and	
Xba1	 (3’)	 restriction	 sites	 downstream	 of	 the	multiple	 cloning	 site.	 This	 insertion	 results	 in	 a	 C-
terminal	 tagging	of	 the	protein	of	 choice.	For	bacterial	expression	of	Mettl21	 the	pET	expression	
system	and	the	pET-26b(+)	plasmid	(Novagen)	was	used.	
Chapter	2	|	Material	and	Methods	
48	
	
The	subloning	was	done	by	enzymatic	digestion	of	the	pGemTeasy	plasmids	containing	the	Mettl21	
genes	with	either	BamH1/Sla1	or	Nde1/Sla1	flanking	restriction	sites	and	the	corresponding	target	
plasmids.	In	general	1	µg	of	plasmid	was	digested	with	1	µl	enzyme	1,	1	µl	enzyme	2	and	5	µl	of	the	
corresponding	10x	buffer	in	a	total	volume	of	50	µl	for	4	hours	at	37°C.	
	
2.16.8.	 Mutation	 of	 the	 methyltransferase	 domains	 of	 Mettl21c	
and	Mettl21e	
Coding	sequences	of	the	Mettl21	genes:	
Mettl21c	coding	sequence	(NM_001013799):	747	bp	length	
ATGGATCAGCATCTCCACATAGCCCAGCAGCCCCTACTCTCGGGGACTCCACAGGAAGATGGTTTTGCAGGA
CCCTCAGTAGAGTTCGACAGGATAGAATCATCTCTTCGTAGCATCCAGAAATTTGTTCCTACAGACTATGCCA
GCTACACACAAGAGCATTATCAGTTCGCAGGCAAGAAGATCATCATTCAAGAATCCATTGAGAACTATGGCA
CAGTGGTGTGGCCAGGGGCTACAGCTCTGTGTCAATATTTAGAAGACCATACAGAGGAATTAAATCTCCAAG
ATGCTAAAATACTTGAAATTGGTGCTGGAGCAGGCCTTGTTTCCATTGTATCCAGTCTTTTAGGAGCTCAAG
TCACAGCAACAGACCTGCCTGATGTTCTAGGAAATCTTCAATACAATATTTTAAAAAACACACTAGAATGCAC
AGCTCATCTACCTGAAGTGAGAGAACTGGTATGGGGGGAAGACCTGGAGCAGAGCTTCCCTAAGTCAACCT
GTTGTTATGACTACGTGCTGGCCTCTGATGTTGTCTACCACCACTACTTCCTGGACAAGCTGCTCGCTACCAT
GGTGTACCTTTCCCAGCCAGGCACTGTGGTGCTGTGGGCAAACAAATTCAGATTTAGTGCTGACTATGAATT
TTTAGGTAAGTTTAAGCAAGCCTTTGATACCACTCTCTTGGCTGAATATTCAGAATCATCTGTCAAGCTGTTTA
AAGGGATATTAAAGTGGGAGTGA	
	
Mettl21e	coding	sequence	(NM_207281):	735	bp	length	
ATGGACCTCACAGTAACTCACATTACTCACAAAGAGACCTACAAAGAGCCCAGAGACGATGATGATGACAA
GCAGGTGGTCGCAGAGATCATGGCAAGAAGTTTTATCCCAACTCTGATAACGACTATTCCTTGGGAAGGCTT
TCACTTTGCTGGTCATGAGATTCAGATTACTGAAGGCAAAGATTGCTATGGTGCATTTGTCTGGCCATCGGCC
CTTGTTCTATGCTATTTTCTGGAAACACATGCCAAGCAATATAACATGGTTGATAAAAATGTGATTGAAATTG
GAGCTGGGACAGGGCTTGTCTCCATTGTGGCAAGCTTACTTGGTGCTCGTGTGATTGCTACAGACTTACCTG
AATTACTTGGAAACCTGCAATATAATATTTCCAGAAACACCAAAATGAAATGCAAGCATCTGCCTCAGGTCA
AAGAACTATCCTGGGGAGTAGCATTAGACAGGAATTTCCCCAGGTCTTCCAATAACTTTGACTACATCCTGGC
AGCAGATGTTGTCTATGCCCATCCGTTCCTGGAGGAGCTTCTCATGACCTTTGACCATCTCTGCAAAGAAACT
ACCATTATACTCTGGGCTATGAGATTCAGGCTGGAGAAAGAAAATAAATTTGTAGATAAATTTAAGGAACTG
TTTGACCTGGAAGAAATTTCTAGTTTCCCTAGCCTGAATATTAAGTTGTACAAAGCTATGAAGAAAAATCGGA
GGAGTGCCTAG	
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Enzymes	 that	are	not	cutting	 in	 this	 sequence	and	 therefore	can	be	used	 for	 the	cloning	process	
were	determined	with	the	“NEBcutter“-software:	BamH1,	XhoI/SlaI,	and	Nde1.	
	
2.16.9.	 Methyltransferase	 domain	 mutation	 with	 site-directed	
mutagenesis	
A	 methyltransferase	 domain	 (conserved	 in	 Motif	 1)	 has	 the	 following	 consensus	 motif	 1:	
(oEoGoGoG).	Since	the	mutation	of	glycins	in	this	domain	is	known	to	impair/abolish	SAM	binding,	I	
mutated	 the	 three	 glycins	 into	 alanins	 using	 site-directed	 mutatgenesis	 PCR.	 First,	 Clustal	 W	
alignment	 showed	 that	 the	 glycin	 residues	 of	 the	 putative	 methyltransferase	 domains	 of	 both,	
Mettl21c	and	Mettl21e,	are	highly	conserved.		
	
Q8BLU2	Mettl21c	248	amino	acids	
MDQHLHIAQQPLLSGTPQEDGFAGPSVEFDRIESSLRSIQKFVPTDYASYTQEHYQFAGKKIIIQESIENYGTVVWP
GATALCQYLEDHTEELNLQDAKILEIGAGAGLVSIVSSLLGAQVTATDLPDVLGNLQYNILKNTLECTAHLPEVREL
VWGEDLEQSFPKSTCCYDYVLASDVVYHHYFLDKLLATMVYLSQPGTVVLWANKFRFSADYEFLGKFKQAFDTTL
LAEYSESSVKLFKGILKWE		
	
Q8CDZ2	Mettl21e	244	amino	acids	
MDLTVTHITHKETYKEPRDDDDDKQVVAEIMARSFIPTLITTIPWEGFHFAGHEIQITEGKDCYGAFVWPSALVLC
YFLETHAKQYNMVDKNVIEIGAGTGLVSIVASLLGARVIATDLPELLGNLQYNISRNTKMKCKHLPQVKELSWGV
ALDRNFPRSSNNFDYILAADVVYAHPFLEELLMTFDHLCKETTIILWAMRFRLEKENKFVDKFKELFDLEEISSFPSL
NIKLYKAMKKNRRSA		
	
For	site-directed	mutagenesis	of	 the	methyltransferase	domains	 in	Mettl21c	and	Mettl21e	 I	used	
the	oligonucleotides,	which	have	alanine	codons	instead	of	the	three	central	glycine	codons.	
For	the	mutagenesis	reaction	the	Agilent	Pfu	Polymerase	AD	was	used	with	the	following	reaction	
mixture:	Primer	fw	(10	pmol/µl)	0.64	µl,	Primer	rev	(10	pmol/µl)	0.64	µl,	10x	Buffer	2.5	µl,	dNTPs	
(10	mM)	0.5	µl,	Pfu	AD	Polymerase	0.5	µl,	plasmid	template	(10	ng/µl	of	the	pGemTeasy	Mettl21c	
or	Mettl21e	plasmids,	respectively)	1	µl.	The	PCR	was	run	with	the	following	PCR	program:	1-95°C-
1min,	 2-95°C-30sec,	 3-annealing	 Tm-5°C-30sec,	 4-72°C-1min	 per	 kilobase,	 5-72°C-10min,	 repeat	
from	2-4	for	20	cycles.	
5	µl	of	the	mutagenesis	PCR	mixture	was	analyzed	on	a	1%	TAE	agarose	gel.	The	residual	20	µl	were	
precipitated	 with	 80	 µl	 MilliQ	 H2O,	 100	 µl	 4M	 NH4Acetate	 and	 400	 µl	 Isopropanol	 (15	 min	
incubation	 at	 room	 temperature	 and	 15	min	 precipitation	 at	max	 speed	 in	 the	 centrifuge).	 The	
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pellet	 was	 washed	 with	 70%	 ethanol	 and	 precipitated	 again	 for	 5	 min	 at	 maximum	 speed.	 The	
pellet	was	dissolved	in	13	µl	water	and	1.5	µl	Jena	Buffer	B2	was	added	with	0.5	µl	Dpn1	enzyme.	
The	 template	 DNA	 plasmid	 was	 digested	 for	 4	 hours	 at	 37°C.	 Then	 5	 µl	 of	 this	 mixture	 was	
subjected	to	 transformation	 (+	35µl	MilliQ	H2O,	10	µl	5x	KCM)	 in	E.coli	XL1	blue	and	analyzed	by	
miniprep	and	sequencing.		
	
2.16.10.	Chemical	competent	bacteria	
After	growing	10	μl	of	an	E.coli	Xl1Blue	cryostock	 in	1	ml	LB	medium	for	1	hour	at	37°C	with	700	
rpm	shaking,	the	cells	were	plated	on	a	LB	agar	plate	without	antibiotics	(LB-0)	and	incubated	over	
night	at	37°C.	On	the	next	day	5	ml	LB-0	medium	was	inoculated	with	a	single	bacteria	clone	and	
incubated	over	night	at	37°C	shaking	with	200	rpm.	Next	morning,	5	ml	of	the	culture	is	transferred	
to	100	ml	LB-0	and	incubated	for	1	hour	at	37°C	until	the	OD600	reached	a	value	of	0.5-0.6,	which	
resembles	 the	 logarithmic	 phase.	 Subsequently,	 the	 bacteria	 are	 harvested	 by	 centrifugation	 at	
2500	 g	 at	 4°C	 for	 15	minutes	 and	 then	 resuspended	 in	 7.5	ml	 TSB	 buffer.	 This	 suspension	 was	
incubated	on	ice	for	1	hour.	Afterwards	aliquots	of	110	µl	bacterial	suspension	were	snap	frozen	in	
liquid	 nitrogen	 and	 stored	 at	 -80°C.	 Test	 transformations	 were	 performed	 to	 test	 the	 chemical	
competence.	
	
2.16.11.	Plasmid	DNA	isolation	
For	 analytical	 plasmid	 isolation	 (Mini-prep)	 a	 small-scale	 mini	 preparation	 (from	 5	 ml	 bacterial	
culture)	 and	 for	 preparative	 plasmids	 isolation	 (Maxi-prep)	 a	 large-scale	 preparation	 (200	 ml	
bacterial	 culture)	was	used.	 LB-medium	containing	100	µg/µl	 selective	antibiotics	was	 inoculated	
with	 a	 bacteria	 clone	 from	 an	 agar	 plate	 and	 incubated	 overnight	 (14-16	 hours)	 at	 37°C	 with	
shaking	at	200	rpm.		
For	 the	Mini-prep	 the	bacteria	overnight	 culture	was	pelleted	by	 centrifugation	 for	 5	minutes	 at	
14000	 g.	 Optional	 a	 glycerol	 stock	 was	 kept	 by	 mixing	 225	 µl	 glycerol/1xTE	 and	 500	 µl	 of	 the	
overnight	culture	which	can	then	be	stored	at	-80°C.	To	break	the	cells	the	pellet	was	resuspended	
with	 150	 µl	 Miniprep	 Solution	 A	 containing	 RNase	 and	 incubated	 for	 10	 minutes	 at	 room	
temperature.				
Induction	of	alkaline	lyses	of	the	genomic	DNA	resulted	from	the	addition	of	200	µl	Solution	B	for	
10	 minutes.	 Then	 175	 µl	 Solution	 C	 was	 added	 for	 neutralization	 and	 incubated	 on	 ice	 for	 10	
minutes.	After	centrifugation	at	14000	g	for	10	minutes	at	4°C	the	supernatant	was	transferred	into	
a	 new	 tube	 containing	 500	 µl	 isopropanol.	 This	 is	 followed	 by	 precipitation	 of	 the	 DNA	 by	
centrifugation	for	20	minutes	at	20000	g	at	4°C.	By	using	500	µl	70%	ethanol	the	DNA	pellet	was	
Chapter	2	|	Material	and	Methods	
51	
	
washed,	 subsequently	 air	 dried	 and	 resuspended	 in	 sterile	 water.	 The	 plasmid	 concentration	 as	
well	as	the	quality	was	determined	using	Nanodrop2000	Spectrophotometer.		
For	 the	 Maxi-prep	 of	 plasmid	 DNA	 NucleoBond	 Xtra	 Maxi	 Kit	 was	 used	 following	 the	
manufacturer’s	instructions.		
	
2.16.12.	Sequencing	of	DNA	
Sequencing	of	plasmids	is	based	on	the	chain	termination	method	by	Sanger	and	was	performed	by	
the	company	Seqlab	in	Göttingen.	A	mixture	of	7	µl	of	DNA	solution	with	a	concentration	of	~200	
µg/ml	with	1	µl	sequencing	primer	(10	pmol/µl)	was	submitted	for	sequencing.	
	
2.17.	Morphological	and	immunostaining	methods	
2.17.1.	Immunofluorescence	
C2C12	 cells	 were	 cultured	 on	 coverslips	 and	 transfected	 with	 Flag-tagged	Mettl21c	 and	 control	
plasmid	(empty	vector	with	Flag-tag)	for	24	hours,	fixed	with	4%	paraformaldehyde	for	10	minutes,	
permeabilized	 with	 0.1%	 Triton	 X-100	 in	 Phosphate-buffered	 saline	 (PBS)	 for	 10	 minutes	 and	
stained	 with	 anti-Flag	 antibody	 for	 1-2	 hours	 at	 RT.	 Alexa	 dye	 conjugated	 secondary	 antibodies	
were	 purchased	 from	 Life	 Technologies.	 Nuclear	 counterstaining	 was	 done	 with	 DAPI	 (4’,6-
diamidino-2-phenylindole),	which	emits	blue	fluorescence	upon	binding	to	AT	regions	of	DNA.	The	
coverslips	were	mounted	in	Mowiol	4-88	Reagent.	Imaging	was	performed	with	a	Zeiss	Axioimager	
Z1.		
	
2.17.2.	Immunohistochemical	stainings	
All	 muscle	 immunolabeling	 experiments	 started	 with	 embedding	 the	 muscle	 tissue	 in	 Optimal	
Cutting	 Temperature	 compound	 (OCT,	 Tissue-Tek®	 O.C.T.Polyfreeze™)	 media	 prior	 to	 frozen	
sectioning.	The	muscle	was	positioned	in	liquid	OCT	avoiding	any	air	bubbles	and	then	immersed	in	
isopentane	(2-methyl-butan),	which	was	cooled	down	by	liquid	nitrogen.	Frozen	tissue	was	stored	
in	the	-80°C	freezer.		
The	muscles	were	 then	 cut	 into	 10-20	 µm	 thick	 sections	 on	 a	 cryostat	 (-25°C)	 and	mounted	 on	
lysine	 coated	 slides	 (Superfrost).	 The	 slides	 were	 air	 dried	 for	 1	 hour	 before	 freezing	 (-20°C)	 or	
staining	the	slides.		
On	the	day	of	immunostaining	the	slides	were	allowed	to	reach	room	temperature	for	30	minutes	
before	 4%	 paraformaldehyde/Desoxycholate/NP40	 fixation	 for	 5	 minutes.	 This	 is	 followed	 by	
proteolytic	digestion	with	0.02%	pepsin	 in	0.2	N	HCl	for	about	1.5	minutes.	After	several	washing	
Chapter	2	|	Material	and	Methods	
52	
	
steps	 in	 PBS,	 pH	 7.4	 the	 slides	 were	 incubated	 with	 blocking	 solution	 (2%	 BSA,	 0.5%	 NP40,	 3%	
Horse	Serum)	for	45	minutes.	Followed	by	primary	antibody	 incubation	overnight	at	4°C	 in	a	wet	
chamber.	
When	 performing	 serial	 sectioning	 one	 slide	 per	 sample	 was	 incubated	 with	 anti-MyHC	 slow	
antibody	 (1:450	 dilution)	 and	 the	 other	 one	was	 incubated	with	 anti-MyHC	 fast	 antibody	 (1:900	
dilution).	A	third	serial	section	slide	was	stained	for	X-Gal	to	detect	the	LacZ	activity.	
The	 following	 day,	 sections	 were	 rinsed	 three	 times	 with	 PBS	 and	 incubated	 with	 biotinylated	
second	 antibody	 in	 blocking	 solution	 for	 1	 hour	 at	 room	 temperature.	 Slides	 were	 again	 rinsed	
three	times	with	PBS.	After	this	it	was	incubated	with	the	VECTASTAIN®	Elite	ABC	Staining	solution	
for	1	hour,	which	functions	with	an	advanced	avidin/biotin	technology	and	allows	sensitive	binding	
to	biotinylated	targets.	The	avidin-peroxidase	complex	is	formed	by	mixing	2	droplets	of	Reagent	A	
(Avidin	 DH)	 and	 Reagent	 B	 (biotinylated	 peroxidase	 H)	 in	 PBS	 with	 0.1%	 Tween20	 (PBT).	 For	
detection	 of	 the	 antibody-stained	 sections	DAB	 (3,	 3’-diaminobenzidine)	 as	 a	 HRP	 substrate	was	
used	and	incubated	for	about	2-5	minutes	at	room	temperature	under	constant	supervision	under	
the	microscope.	One	tablet	DAB	(10	mg)	was	diluted	in	17	ml	PBT	und	activated	with	1	µl	30%	H2O2	
in	1	ml	PBT.	DAB	produces	a	dark	brown	reaction	product.	 Finally,	 the	 stainings	are	 rinsed	 three	
times	with	PBT	and	then	mounted	in	Mowiol	4-88	reagent.	
	
2.17.3.	X-Gal	staining	of	mouse	tissues	
Mettl21c	 deletion	 mutants	 (8	 weeks)	 were	 euthanized	 by	 cervical	 dislocation.	 Skeletal	 muscles	
were	 isolated,	 washed	 with	 PBS	 and	 then	 placed	 in	 X-Gal	 fixation	 solution	 (Sodiumphosphate	
buffer	pH	7.4,	25%	GDA,	1M	MgCl,	EGTA	pH	7.5)	for	5	minutes.	After	rinsing	several	times	with	X-
Gal	washing	 solution	 (Sodiumphosphate	buffer	pH	7.4,	2%	NP40,	1M	MgCl,	1%	Na-desoxycholat)	
for	10	minutes,	the	pups	were	incubated	in	the	X-Gal	staining	solution	(X-Gal	washing	solution,	0.5	
M	K3FeCN6,	0.5	M	K4FeCN6,	0.1%	X-Gal)	overnight	protected	from	light	with	gentle	shaking.	The	
next	day,	the	skeletal	muscles	were	washed	three	times	and	stored	at	4°C	until	the	clearing.	
	
2.17.4.	Clearing	of	stained	muscle	tissues	
The	 X-Gal	 stained	 skeletal	muscles	were	 cleared	 in	 Cedar	Wood	Oil.	 First	 they	were	 dehydrated	
through	 graded	ethanol	 steps	 up	 to	 100%	and	 then	placed	 in	 Xylene-Ethanol	 (1:1)	mixture	 for	 1	
hour	up	to	1	day.	Finally,	the	skeletal	muscles	were	transferred	to	high	quality	cedar	wood	oil	and	
gently	rocked	until	the	desired	clearance	was	achieved.	The	cedar	wood	oil	was	replaced	once.	The	
imaging	of	the	whole	mount	mouse	skeletal	muscles	was	carried	out	using	a	6	cm	dish	with	a	0.5%	
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agarose	layer	and	a	stereomicroscope.	The	skeletal	muscles	were	placed	onto	the	dish	and	covered	
with	1xPBS	and	imaged	using	the	AxioVision3.1	software.				
	
2.17.5.	X-Gal	staining	on	cryosections	
The	beta-galactosidase	activity	on	cryosections	of	postnatal	and	adult	tissues	was	detected	using	X-
Gal	staining.	The	cryosections	of	OCT	embedded	tissues	were	placed	in	a	glass	cuvette	with	X-Gal	
fixation	solution	for	5	minutes	and	then	immediately	treated	with	washing	solution	three	times	for	
5	 minutes.	 Staining	 was	 then	 carried	 out	 for	 1	 up	 to	 12	 hours	 in	 the	 X-Gal	 staining	 solution.	
Thereafter,	the	sections	were	washed	again	3	times	for	5	minutes,	then	mounted	in	Mowiol	4-88	
Reagent	and	stored	at	4°C	until	imaging	at	a	Zeiss	Axioimager	Z1.	
	
2.17.6.	Haematoxylin/Eosin	(H&E)	staining	
H&E	staining	is	a	widely	used	histological	method	that	allows	visualizing	different	tissue	structures.	
It	 contains	 the	 two	 dyes	 haematoxylin	 and	 eosin.	 Eosin	 is	 an	 acidic	 dye,	 which	 stains	 basic	 or	
acidophilic	structures	like	cytoplasmic	structures	and	connective	tissue	red	or	pink.	Haematoxylin	is	
considered	 a	 basic	 dye,	 which	 stains	 acidic	 or	 basophilic	 structures	 such	 as	 DNA	 and	 RNA	 in	 a	
purplish	blue.			
The	cryosections	were	treated	with	hematoxylin	(Mayers	heamalaun)	for	10	minute	and	after	that	
with	tap	water.	Subsequently,	samples	were	treated	with	eosin	for	6	minute	and	after	that	with	tap	
water.	 Then	 they	were	dehydrated	 in	 95%	and	100%	ethanol	 series	 for	 2	minutes,	 each.	 Finally,	
they	were	washed	in	xylol	for	2	times	5	minutes	and	mounted	in	Mowiol	4-88	reagent.	
	
2.17.7.	Masson's	Trichrome	Staining		
Masson’s	 Trichrome	 staining	 consists	 of	 Weigert’s	 iron	 hematoxylin,	 which	 stains	 the	 nuclei	 in	
black,	 Biebrich	 scarlet-acid	 fuchsin,	 which	 stains	 cytoplasm	 and	 muscle	 fibers	 in	 red	 and	 after	
treatment	with	phosphotungstic	and	phosphomolybdic	acid,	collagen	is	stained	in	blue	with	aniline	
blue.	Briefly,	slides	are	fixated	with	4%	PFA	at	room	temperature	for	15	minutes.	Slides	are	placed	
in	Weigert’s	 iron	 hematoxylin	 for	 10	minutes,	 rinsed	 in	 running	water	 for	 10	minutes,	 placed	 in	
Beibrich	 scarlet-acid	 fuchsin	 solution	 for	 15	minutes,	 and	 rinsed	 until	 clear.	 Then	 the	 slides	 are	
placed	in	phosphomolybdic-phosphotungstic	acid	solution	for	15	minutes,	followed	by	aniline	blue	
solution	for	20	minutes,	rinsed,	and	then	placed	in	1%	acetic	water	for	5	minutes.	Finally,	the	slides	
are	dehydrated	and	protected	with	cover	slips,	mounted	using	Mowiol	4-88	reagent.		
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2.17.8.	Lectin	staining	
After	fixation	with	4%	PFA	at	room	temperature	for	15	minutes	and	washing	with	PBS	3	times	for	5	
minutes,	 the	 slide	 were	 incubated	 for	 1	 hour	 in	 moist	 chambers	 in	 the	 dark	 with	 the	 FITC-
conjugated	lectins	diluted	to	0.05	mg/ml	in	PBS.	The	slides	were	then	washed	in	PBS	and	mounted	
in	Mowiol	4-88	reagent	and	photographed	in	a	fluorescence	microscope.		
	
2.18.	Biochemistry	methods	
2.18.1.	SDS	Polyacrylamide	Gel	Electrophoresis	(SDS-PAGE)	
For	electrophoretic	separation	by	means	of	their	molecular	size	protein	samples	were	diluted	with	
lysis	 buffer	 and	 1xLDS	 protein	 sample	 loading	 buffer.	 The	 samples	 were	 heated	 at	 70°C	 for	 10	
minutes	to	denature	the	proteins	for	SDS	binding.	The	samples	were	loaded	on	4-12%	Bis-Tris	Gels	
and	run	with	MOPS	buffer	at	180	V	for	50	minutes.	
	
2.18.2.	Immunoprecipitation	
Cells	 or	 tissues	were	 lysed	 in	RIPA	buffer	 supplemented	with	protease	 inhibitors	 (1:100	 v/v)	 and	
incubated	on	a	rotating	wheel	for	30	min	at	4°C.	The	crude	lysates	were	cleared	by	centrifugation	
at	maximum	speed	 for	10	min	at	4°C.	Protein	concentration	was	measured	using	 the	Bio-Rad	DC	
protein	 assay	 and	 typically	 500	 µg	 lysate	was	 used	 for	 immunoprecipitation.	 A	 pre-clearing	 step	
with	 30	µl	 Sepharose	G	 beads	was	 performed	 for	 30	min.	 Beads	with	 unspecific	 protein	 binding	
were	removed	by	centrifugation	at	2000g	for	2	min	at	4°C	and	the	supernatant	was	incubated	with	
5-10	µg	antibody	(for	analysis	with	mass	spectrometry)	or	2	µg	(for	analysis	with	western	blot)	on	a	
rotating	wheel	 for	 30	min	 at	 4°C.	 Subsequently,	 fresh	30	µl	 Sepharose	G	beads	were	 added	and	
incubated	overnight	on	a	 rotating	wheel.	While	using	antibody	coupled	to	beads,	 this	was	added	
directly	after	the	pre-clearing	step.	On	the	next	day,	beads	with	bound	proteins	were	washed	3-4	
times	with	RIPA	buffer	by	 centrifuging	at	2000	g	 for	2	min	at	4°C	each	 time.	Proteins	were	 then	
eluted	from	the	beads	by	heating	with	1.5x	Laemmli	buffer	and	40	mM	DTT	for	10	min	at	70°C.	
	
2.18.3.	Western	blotting	
Proteins	eluted	from	immunoprecipitated	beads	or	otherwise	20-40	µg	proteins	(heated	with	1.5x	
Laemmli	 buffer	 and	 40	 mM	 DTT	 for	 10	 min	 at	 70°C)	 were	 loaded	 on	 a	 4-12%	 Bis-Tris	 gel	 and	
separated	 using	 SDS-PAGE,	 which	 was	 run	 using	 MOPS	 buffer	 at	 180	 V	 for	 50	 minutes.	
Subsequently,	 proteins	were	 transferred	 from	 the	 gel	 to	 a	 nitrocellulose	membrane	 sandwiched	
between	two	Whatmann	papers	at	35	V	for	2	hours.	Transfer	buffer	was	used	in	the	inner	chamber	
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and	water	with	ice	in	the	outer	chamber	to	maintain	the	system	at	low	temperature.	Following	the	
transfer,	the	membrane	was	stained	using	Red	Alert	for	5	min	on	a	shaker	and	the	excess	stain	was	
then	washed	with	MilliQ	water	 to	 visualize	 the	 protein	 bands.	 The	membrane	was	washed	with	
TBS-T	buffer	on	a	shaker	 for	complete	removal	of	 the	stain	and	then	blocked	with	5%	BSA	or	5%	
non-fat	 dry	 milk	 in	 TBS-T	 for	 1	 h	 at	 room	 temperature	 on	 a	 shaker.	 Following	 blocking,	 the	
membrane	was	 incubated	with	primary	antibody	diluted	 in	blocking	buffer	at	4°C	overnight	with	
gentle	 shaking.	On	 the	 next	 day,	 the	membrane	was	washed	 5	 times	 for	 5	min	with	 TBS-T	with	
rigorous	shaking	to	remove	any	unbound	primary	antibody.	The	washed	membrane	was	incubated	
with	horseradish	peroxidase-coupled	secondary	antibody	diluted	in	blocking	buffer	for	1	h	at	room	
temperature	 with	 gentle	 shaking.	 The	membrane	 was	 washed	 5	 times	 with	 rigorous	 shaking	 to	
remove	any	unspecific	binding	of	secondary	antibody.	Antibody-bound	proteins	were	detected	on	
a	 VersaDoc	 using	 enhanced	 chemiluminiscence	 method	 with	 an	 equal	 proportion	 of	 peroxide	
solution	and	luminol	enhancer.	
	
2.18.4.	In	vitro	methylation	assay	
In	 vitro	methylation	 assays	 are	 used	 to	 determine	 the	 specificity	 of	 PKMT	 and	 to	 discover	 new	
PKMT	 substrates.	 The	 analysis	 of	 protein	 methylation	 was	 performed	 in	 vitro	 using	 an	
immunoprecipitated	Mettl21c	in	the	presence	of	selected	substrates.	
The	 methyltransferase	 Mettl21c,	 its	 family	 member	 Mettl21e	 and	 the	 substrates	 Valosine-
containing	 protein	 (VCP,	 p97),	 Sequestosome	 (Sqstm1,	 p62)	 are	 immunoprecipitated	 from	
overexpressed	 HEK	 293T	 cells	 or	 C2C12	 cells.	 In	 a	 1.5	 ml	 Eppendorf	 tube	 the	 beads	 with	 the	
immunoprecipitated	 substrate,	 2	 mM	 S-adenosylmethionine	 (stock	 solution	 32	 mM),	 25	 µl	
Methyltransferase	buffer	and	H2O	up	to	50	µl	are	mixed.	The	methylation	reaction	is	initiated	with	
beads	 that	 carry	 the	 immunoprecipitated	Mettl21c-Flag.	 The	 reaction	 is	mixed	 gently	 by	 tapping	
and	 then	 incubated	 at	 37°C	 for	 30	minutes.	 To	 stop	 the	 reaction	 1xLDS	 protein	 sample	 loading	
buffer	was	added	and	heated	at	70°C	for	10	minutes.	The	sample	was	run	on	a	4-12%	SDS-PAGE	gel	
at	180	V	for	50	minutes	using	MOPS	running	buffer.	The	separated	samples	are	then	subjected	to	
in-gel	digest	and	the	peptides	are	measured	on	the	Q	Exactive	mass	spectrometer.	
	
2.19.	Cell	culture	methods	
2.19.1.	Maintenance	of	cell	lines	
Human	 embryonic	 kidney	 (HEK)	 293T	 cells	 and	 C2C12	 cells	 were	 cultured	 in	 high	 glucose	
Dulbecco’s	 Modified	 Eagle’s	 Medium	 (DMEM)	 containing	 4.5	 g/L	 glucose.	 The	 medium	 was	
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supplemented	 with	 10%	 Fetal	 Bovine	 Serum	 (FBS)	 and	 1%	 Penicillin-Streptavidin-L-Glutamine	
(PSG).	 The	 incubator	was	maintained	at	 37°C	 and	with	10%	CO2.	 Confluent	 cells	 in	 10	 cm	dishes	
were	washed	 once	with	 5	ml	 PBS	 and	 treated	with	 1	ml	 trypsin-EDTA	 for	 about	 2	min	 to	 allow	
detachment	of	cells.	Standard	cell	culture	medium	containing	FBS	was	added	to	stop	the	activity	of	
trypsin.	Cells	were	split	1:3	or	1:6	for	HEK	or	C2C12	respectively,	for	experiments	on	the	next	day.	
	
2.19.2.	SILAC	labeling	
Cells	 were	 labeled	 by	 culturing	 in	 SILAC	 DMEM	medium	 containing	 high	 glucose	 of	 4.5	 g/L	 and	
supplemented	with	10%	dialyzed	FBS	and	1%	PSG.	Additionally,	L-lysine	(Lys0)	and	L-arginine	(Arg0)	
were	 supplied	 to	 the	 ‘light’	medium,	 4,4,5,5-D4-L-Lysine	 (Lys4)	 and	 13C6-labeled	 L-arginine	 (Arg6)	
were	supplied	to	the	‘middle’	medium,	and	13C6	15N2-labeled	L-lysine	(Lys8)	and	13C6	15N4-labeled	L-
arginine	 (Arg10)	were	 supplied	 to	 the	 ‘heavy’	medium.	The	concentrations	of	 lysine	and	arginine	
used	were	84	g/L	and	147	g/L	respectively.	Cells	were	cultured	for	5	passages	to	ensure	complete	
labeling.	
	
2.19.3.	Cell	storage	
Cells	were	washed	with	PBS,	trypsinized	and	pelleted	by	centrifugation	at	1500	rpm	for	5	min.	The	
cell	pellet	was	frozen	in	90%	FBS	and	10%	DMSO.	Cells	obtained	from	a	confluent	10	cm	dish	were	
frozen	as	two	aliquots	and	stored	at	-80°C	over	the	first	night.	On	the	next	day,	frozen	cell	stocks	
were	 transferred	 to	 a	 liquid	 nitrogen	 tank	maintained	 at	 -180°C	 for	 longer	 storage.	 Frozen	 cells	
were	 recovered	 by	 thawing,	 resuspending	 in	 the	 culture	 medium	 and	 centrifuging	 to	 remove	
DMSO.		
	
2.19.4.	Calcium	phosphate	transfection	
Calcium	phosphate	transfection	method	was	used	for	HEK	293T	cells.	For	transfection	of	a	10	cm	
dish,	10	µg	plasmid	was	precipitated	 in	61	µl	2M	CaCl2	and	 filled	up	to	500	µl	with	sterile	water.	
This	mixture	was	added	to	500	µl	2x	HEPES	buffered	saline	(HBS)	and	mixed.	The	1	ml	transfection	
reagent	 was	 added	 as	 drops	 onto	 the	 cells	 carefully.	 Cells	 were	 maintained	 in	 the	 transfection	
medium	for	24	hours.	
	
2.19.5.	Transfection	with	TurboFect	
TurboFect	transfection	reagent	was	used	for	transfection	of	C2C12	myoblasts.	To	transfect	a	10	cm	
dish,	 10	 µg	 plasmid	 was	 diluted	 in	 1	 ml	 reduced	 serum	 Opti-MEM	 medium	 after	 which	 20	 µl	
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TurboFect	transfection	reagent	was	added	and	vortexed	thoroughly.	This	mixture	was	incubated	at	
room	temperature	for	20	min	and	carefully	added	to	the	cells	as	drops.	Cells	were	maintained	 in	
the	transfection	medium	for	24-36	hours.	
	
2.19.6.	Induction	of	autophagy	in	cell	culture	
C2C12	 and	 HEK	 293T	 cells	 were	 cultured	 on	 6	 well	 plates	 and	 transfected	 for	 24	 hours	 with	
Mettl21c-Flag	 plasmid	 or	 control	 plasmid	 (empty	 plasmid	 with	 Flag-tag),	 respectively.	 For	 the	
induction	of	autophagy	Rapamycin	 (through	 inhibition	of	TORC1)	was	used.	Cells	were	 incubated	
for	5	hours	with	1	µM	Rapamycin	and	in	the	 last	hour	100	nM	Bafilomycin	A1,	which	 inhibits	the	
lysosomal	Na+H+	ATPase,	thereby	preventing	the	activity	of	lysosomal	acid	proteases.	This	leads	to	
accumulation	of	autophagosomes	and	the	autophagic	flux	can	be	measured.			
	
2.20.	Deep	Sequencing	
Differences	in	the	transcript	levels	were	analyzed	by	deep	sequencing,	which	was	done	by	the	in-
house	 core	 facility.	 Next	 generation	 sequencing	 was	 performed	 on	 the	 Ion	 Torrent	 Proton	
sequencing	 platform	 (Thermo	 Fisher)	 using	 the	 Ion	 Total	 RNA-Seq	 Kit	 v2	 (Thermo	 Fisher)	 with	
minor	modifications.	 Total	 RNA	 for	 transcriptome	 analysis	was	 isolated	with	miRNeasy	micro	 Kit	
(Qiagen)	from	individual	soleus	muscles	with	on	column	DNAse	treatment	(RNase	free	DNase	Set,	
Qiagen).	 Homogenization	 of	 samples	 before	 lysis	was	 done	 on	 bead	mill	 (Retsch,	MM301)	 for	 4	
minutes	at	room	temperature.	Integrity	of	RNA	was	checked	on	Bioanalyzer	2100	(Agilent)	and	2	µg	
of	RNA	with	RIN	>8.7	was	used	for	ribosomal	depletion	using	the	Ribo	Minus	Kit	(Thermo	Fisher).	
Following	modifications	 to	 the	 standard	 RNA-seq	 Library	 protocol	 were	 performed:	 Fragmented	
RNA	was	concentrated	to	3	µl	with	SpeedVac	(Eppendorf)	for	10-15	minutes	and	all	3	µl	were	used	
for	further	steps.	Numbers	of	amplification	cycles	were	reduced	to	10-12	cycles	resulting	in	lower	
PCR	duplication	 levels	without	 any	 influence	 to	quality/contribution	of	 obtained	 reads.	Obtained	
RNA	 libraries	 were	 diluted	 to	 100	 pM	 and	 used	 in	 a	 final	 concentration	 of	 9	 pM	 for	 template	
preparation	 on	 Ion	OneTouch2	 instrument	 (Thermo	 Fisher).	 For	 each	 run	 on	 the	 V2	 Ion	 Torrent	
Chip	2	RNA	libraries	were	pooled	in	equimolar	ratios	to	obtain	between	27-52M	reads	per	sample.		
	
2.21.	Electron	microscopy	of	muscles	
Electron	microscopy	analysis	of	mouse	muscles	was	performed	 in	collaboration	with	PD	Dr.	Sawa	
Kostin,	Max-Planck-Institute	for	Heart	and	Lung	Research	in	Bad	Nauheim.	After	pre-fixation	of	the	
whole	mouse	by	perfusion	with	3%	glutaraldehyde	buffer,	the	soleus	muscles	were	prepared	and	
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fixed	directly	after	preparation	in	3%	glutaraldehyde	buffer	at	room	temperature.	The	fixative	was	
removed	by	6	times	washing	in	0.1	M	sodium	cacodylate	buffer.	Then	the	tissues	were	incubated	
for	1	hour	with	1%	osmium	tetroxid/0.1	M	cacodylate	buffer,	washed	3	times	10	minutes	in	water,	
dehydrated	for	30	minutes	in	serial	ethanol	dilution	10%,	30%,	50%	with	following	incubation	in	1%	
uranyl	 acetate/70%	 ethanol	 for	 1	 hour.	 Uranil	 acetate	was	 removed	 by	washing	 in	 70%	 ethanol	
overnight.	Further	dehydration	of	sections	was	performed	in	70%,	90%	and	twice	in	100%	ethanol	
for	30	minutes	 in	each	solution.	After	dehydration	the	samples	were	 infiltrated	with	epoxy	resin,	
ethanol:SPURR=3:1	for	3	hours;	epoxy	resin,	EtOH:SPURR	=	1:1	for	4	hours,	overnight	with	epoxy	
resin;	 EtOH:SPURR	=	1:3	 and	 twice	8	hours	 in	pure	 SPURR,	which	polymerizes	 finally.	 The	blocks	
were	 sectioned	with	 an	 ultramicrotome.	 The	 sections	were	 placed	 on	 copper	 grids.	Muscle	 cells	
were	visualized	using	a	transmission	electron	microscope	(Philips	CM	10	electron	microscope).	
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3.	Results	
	
3.1.	 Bioinformatics	 and	 structural	 analysis	 of	 Mettl21c	 identifies	
conserved	SAM	binding	domains	and	a	methyltransferase	domain	
The	 putative	 Class	 I	 MTase	 Mettl21c	 (Methyltransferase-like	 21c)	 was	 originally	 identified	 in	 a	
previous	 study	 by	 Drexler	 et	 al.,	 which	 examined	 the	 distribution	 of	 proteins	 in	 fast	 and	 slow	
muscles.	 Sequence	 alignment	 on	 protein	 level	 revealed	 for	Mettl21c	 a	 similarity	 of	 20-40%	 to	 a	
small	 group	 of	 methyltransferases	 namely	 Mettl21a-e.	 This	 protein	 group	 represents	 a	 small	
subfamily	of	the	ten	human	Methyltransferase	16	(MTF16)	enzymes	and	belongs	to	the	class-I-like	
SAM	 binding	 methyltransferase	 superfamily,	 which	 utilize	 the	 ubiquitous	 methyl	 donor	 S-
adenosylmethionine	 (SAM).	 The	 Mettl21	 family	 is	 structurally	 highly	 conserved	 and	 consists	 of	
central	 seven	beta-strands,	 five	 alpha	helices	 and	 four	distinct	motifs	 for	 SAM	binding.	 The	 SAM	
binding	site	is	conserved	in	the	primary	sequences	of	four	short	signature	motifs	designated	Motif	
1,	Motif	Post	1,	Motif	2	and	Motif	3	[3].	Spacings	in	the	primary	sequence	between	the	motifs	are	
variable,	but	often	conserved.	Structurally,	 the	motifs	can	be	classified:	Motif	1	contains	 the	 first	
conserved	beta-strand	(β1)	and	the	following	loop,	Motif	Post	1	consists	of	the	second	beta-strand	
(β2),	Motif	 2	 corresponds	 the	 fourth	beta-strand	 (β4),	 and	Motif	 3	 includes	 the	 fifth	beta-strand	
(β5)	 and	 the	alpha-helix	preceding	 it	 [191].	Of	note,	 a	hallmark	of	 the	MTF16	protein	 family	 is	 a	
distinct	DXXY	motif	[(D/E)-X-X-(Y/F)]	located	after	Motif	2,	probably	important	for	the	positioning	of	
the	methyl	group	donated	by	SAM	in	the	methylation	reaction	[149].	The	first	motif	GxGxG	at	the	
end	 of	 the	 first	 beta-strand	 is	 a	 characteristic	 of	 a	 nucleotide-binding	 site	 and	 hence	 binds	 the	
cofactor	SAM.	Mettl21c	contains	248	amino	acids	and	the	methyltransferase	domain	ranges	from	
amino	acid	52	to	232.	Besides	the	presence	of	a	nuclear	localization	sequence	with	a	score	of	5	on	
Mettl21c	(http://nls-mapper.iab.keio.ac.jp/cgi-bin/NLS_Mapper_form.cgi;	Score:	5	indicates	that	it	
may	 be	 possibly	 located	 in	 both	 the	 nucleus	 and	 the	 cytoplasm),	 the	 mass	 spectrometric	
measurements	revealed	newly	 identified	mono-	and	dimethylation	sites	 that	were	not	previously	
indicated	on	phosphosite.org	(Figure	8).		
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Figure	8.	Sequence	 landscape	of	Mettl21c	consisting	of	248	amino	acids,	displaying	 four	distinct	
motifs	 (Motif	1,	Motif	Post	1,	Motif	2	and	Motif	3)	and	 indicating	 the	methyltransferase	domain,	
the	nuclear	 localization	 signal	 (cNSL	 score:	 5)	 and	 the	newly	 identified	mono-	 and	dimethylation	
sites	(not	previously	indicated	on	phosphosite.org).	
In	order	to	identify	orthologues	of	Mettl21c	a	BLAST	search	was	performed	resulting	in	the	
identification	of	several	Mettl21c	orthologues	in	different	species	such	as	insects,	plants	and	fungi.	
The	four	highly	conserved	motifs	are	highlighted	in	the	sequence	alignment	(	
Figure	9)	and	also	the	characteristic	DXXY	motif	can	be	found	in	all	species.	
	
	
	
Figure	9.	Sequence	alignment	of	Mettl21c	(Q8BLU2)	shown	for	the	closest	homologues	in	human	
(Q5VZV1),	 yeast	 (Q9P7L6),	 zebrafish	 (B7ZVT8),	 bovine	 (A6QP81),	 xenopus	 (A4IGU3)	 and	 showed	
the	four	highly	conserved	methyltransferase	motifs	(Motif	1,	Motif	Post	1,	Motif	2	and	Motif	3).	
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This	initial	bioinformatic	analysis	reveals	that	Mettl21c	belongs	to	the	seven	beta-strand	MTase	
family	and	is	present	in	a	wide	range	of	multicellular	eukaryotes.	
	
3.2.	Characterization	of	the	Mettl21c-/-	mouse	
To	characterize	the	function	of	the	mammalian	Mettl21c	more	in	detail,	we	inactivated	Mettl21c	by	
homologous	 recombination	 in	mice.	The	mouse	Mettl21c	gene	 is	 located	on	Chromosome	1	and	
spans	five	exons	over	a	genomic	region	of	10.6	kb.	The	resulting	mRNA	transcript	has	1086	bp	and	
the	ATG	start	codon	is	localized	at	the	beginning	of	exon	2.	For	inactivation	of	Mettl21c,	the	ZEN-
UB1	velocigene	cassette	was	used.	It	contains	the	beta-galactosidase	coding	sequence	from	E.coli	
(LacZ	Gene)	 and	 a	 polyadenylation	 signal.	 In	 addition,	 the	promoter	 of	 human	ubiquitin	 C	 genes	
together	with	the	neomycin	phosphotransferase	and	a	polyadenylation	signal	flanked	by	loxP	sites	
were	 used	 for	 positive	 selection	 (Figure	 10).	 The	 vector	 was	 purchased	 from	 velocigene	
(http://www.velocigene.com/komp/detail/15237).	 The	 construct	was	 inserted	 by	 electroporation	
into	 ES	 cells	 and	 successful	 homologous	 recombination	 into	 the	 Mettl21c	 locus	 was	 tested	 by	
Taqman	 PCR	 to	 detect	 the	 mutation.	 Next,	 positive	 ES	 cell	 clones	 were	 used	 for	 injection	 into	
blastocysts	to	generate	chimeric	animals.	The	generation	of	ES	cells	and	the	transgenic	mice	were	
performed	by	the	laboratory	of	Professor	Braun	and	the	central	animal	facility	of	the	Max-Planck-
Institute	in	Bad	Nauheim.	Chimeric	mice	were	mated	with	cre-deleter	mice,	which	express	the	cre-
Recombinase	in	the	germ	line	to	eliminate	the	neomycin-resistance	cassette.		
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Figure	 10.	 Schematic	 representation	 of	 the	 Mettl21c	 gene	 and	 the	 gene	 ablating	 deletion	 by	
homologous	 recombination.	 (A)	 The	wild	 type	 and	 the	 targeting	 allele	 are	 displayed	 in	 5’	 to	 3’	
orientation.	The	five	exons	of	Mettl21c	are	represented	as	grey	rectangles	and	are	stretching	over	
1086	 base	 pairs.	 The	 coding	 sequence	 from	 exon	 2	 to	 exon	 5	 is	mainly	 deleted	 by	 homologous	
recombination	and	the	insertion	of	a	LacZ	cassette.	The	size	of	the	gene	ablating	deletion	is	7.628	
kb.	(B)	Displaying	the	targeted	allele	with	the	 inserted	LacZ	cassette	and	the	neomycin-resistance	
cassette	 as	well	 as	 the	 binding	 sites	 of	 the	 sequencing	 primers.	 The	 binding	 site	 for	 the	 reverse	
primer	for	the	wild	type	is	located	in	intron	2.	(C)	The	deletion	of	the	neomycin-resistance	cassette	
resulted	by	cre-mediated	recombination	at	the	loxP	sites	(red	triangles).	
For	genotyping	offspring	were	tested	by	PCR	to	distinguish	between	wild	type,	heterozygous,	and	
knockout	animals	and	the	excision	of	the	neomycin	cassette.	The	PCR	strategy	was	based	on	three	
primers	 to	 simultaneously	detect	wild	 type,	and	deletion	alleles.	One	primer	 (forward	primer	 for	
wild	type	and	knockout	detection)	is	located	in	intron	1,	the	reverse	wild	type	primer	is	located	in	
intron	2	and	the	deletion	primer	is	placed	in	the	LacZ	cassette.	The	wild	type	allele	was	identified	
by	PCR	fragment	of	245	base	pairs.	Whereas	the	knockout	allele	created	a	456	base	pair	fragment	
(Figure	11A).	
Since	there	is	no	working	mouse	antibody	available,	the	in	vivo	SILAC	spike-in	approach	was	used	
to	confirm	the	absence	of	any	translated	Mettl21c	protein	in	Mettl21c-/-	animals.	The	soleus	muscle	
from	wild	type	and	knockout	animals	were	mixed	with	the	soleus	muscle	from	the	fully	labeled	13C6	
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Lysine	(Lys6)	SILAC-mouse	in	a	1:1	ratio,	respectively.	The	protein	mixture	was	in-solution	digested	
with	LysC	and	measured	by	LC-MS/MS.	Peptides	were	now	measured	as	SILAC	pairs	with	a	distance	
of	6	Da	and	the	relative	peak	intensity	was	used	for	relative	protein	quantification.	The	analysis	of	
wild	 type	animals	 revealed	several	Mettl21c	SILAC	peptide	pairs	with	a	1:1	 ratio.	 In	contrast,	 the	
absence	 of	 any	 light	 peptide	 for	Mettl21c	 in	 the	 knockout	mouse	 confirmed	 the	 absence	 of	 the	
Mettl21c	protein	in	homozygous	animals	(Figure	11B).	
	
	
Figure	11.	PCR	and	mass	spectrometry	confirmation	of	Mettl21c	knockout.	(A)	The	PCR	fragment	
for	 a	 wild	 type	 is	 245	 bp	 and	 for	 a	 knockout	mouse	 456	 bp.	 A	 100	 bp	 ladder	 was	 used	 as	 the	
marker.	 (B)	Mass	spectrometry	measurement	confirmed	the	knockout,	due	to	the	absence	of	the	
light	peptide	(in	our	example	for	42FVPTDYASYTQEHYQFAGK60,	Q8BLU2)	of	Mettl21c	at	a	m/z	ratio	
of	751.35	(charge	3+).	White	circle	represents	the	non-labeled	Mettl21c	peptide,	whereas	the	black	
circle	 labeled	 the	 Lys6	 containing	 peptide.	 The	 arrow	 in	 B	 (right	 MS	 spectrum)	 highlights	 the	
absence	of	the	corresponding	non-labeled	peak	at	751.35	m/z.	
		
3.2.1.	 Mettl21c	 is	 expressed	 in	 Z-disk	 structures	 of	 slow	 muscle	
fibers		
The	 function	of	 skeletal	muscle	 cells	 is	 the	 coordinated	contraction	and	elongation	of	millions	of	
sarcomeres	 that	 are	 mainly	 composed	 of	 actin	 and	 myosin	 filaments.	 Several	 sarcomeres	 are	
arranged	 consecutively	 and	 are	 separated	 via	 Z-disks	 to	 form	 a	myofibril.	 The	 organization	 of	 a	
sarcomere	is	a	key	feature	of	the	sliding	filament	model.	Muscle	activity	is	related	to	the	enzymatic	
and	physical	properties	of	 actin,	myosin,	 and	 the	accessory	proteins	 that	 constitute	 the	 thin	and	
thick	filaments.		
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The	 availability	 of	 a	 human	 Mettl21c	 antibody	 made	 it	 feasible	 to	 visualize	 the	 endogenous	
localization	of	Mettl21c	within	human	skeletal	muscle	 fibers.	 Longitudinal	human	skeletal	muscle	
sections	 were	 immunostained	 with	 antibodies	 against	 human	 Mettl21c,	 the	 M-line	 protein	
Myomesin	 and	 the	 Z-disk	 marker	 alpha-Actinin	 2.	 Confocal	 laser	 scanning	 microscopy	 enabled	
analyzing	 the	 structure	 of	 sarcomeres	 showing	 that	 the	 majority	 of	 Mettl21c	 co-localizes	 with	
alpha-Actinin	 2,	 which	 serves	 as	 an	 actin	 filament	 cross-linker	 within	 the	 sarcomere.	 Double	
staining	with	Mettl21c	and	Myomesin	showed	clearly	a	distinct	expression	pattern	(Figure	12).		
	
Figure	12.	Mettl21c	 localizes	 to	 the	 Z-disk	of	 striated	muscle.	 Immunohistochemical	 analysis	 on	
longitudinal	 human	 skeletal	 muscle	 sections	 with	 (C,	 E,	 G)	 anti-Mettl21c	 (green),	 (B,	 D)	 anti-
Myomesin	(red,	marker	for	M-line)	and	(F)	anti-alpha-Actinin	2	(red,	marker	for	Z-disk)	antibodies.	
The	counterstaining	of	the	nucleus	was	done	with	DAPI.	(A)	Counterstaining	with	DAPI.	Scale	bars	=	
10	µm.		
Next,	the	LacZ	enzyme	activity	was	used	to	analyze	the	expression	pattern	of	Mettl21c	in	different	
muscle	types,	in	order	to	evaluate	unique	anatomical	structures	expressing	Mettl21c.	The	Mettl21c	
knockout	 mutant	 line	 carries	 an	 allele	 with	 the	 promotor	 of	 the	 Mettl21c	 gene	 driving	 a	 LacZ	
(bacterial	 beta-galactosidase)	 reporter.	 Comparing	 Mettl21c	 homozygous	 and	 heterozygous	
deletion	 mutants	 will	 depict,	 that	 homozygous	 animals	 have	 twice	 as	 much	 of	 bacterial	 beta-
galactosidase	resulting	in	different	staining	intensities.		
The	 expression	 and	 localization	 of	 beta-galactosidase	 in	Mettl21c	 hetero-	 and	 homozygous	mice	
were	 followed	 by	 whole	 mount	 stainings	 and	 cryosections	 (20	 µm	 slice	 thickness).	 The	 LacZ	
expression	profiling	 revealed	 the	highest	X-Gal	 staining	 in	 the	 soleus	muscle,	with	approximately	
50%	of	all	soleus	fibers	being	Mettl21c/LacZ	positive	(Figure	13A,	E).	Similarly,	the	gluteus	maximus	
(Figure	13B,	F),	which	is	a	mixed	fiber	muscle	[192]	also	showed	a	mosaic	pattern,	but	with	lower	
intensity	compared	to	the	soleus	muscle.	Analysis	of	the	extensor	digitorum	longus	(Figure	13C,	G)	
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and	the	diaphragma	(Figure	13D,	H)	muscles	with	predominately	fast-twitch	fibers	[18],	displayed	
only	a	weak	staining	for	a	minor	fraction	of	~1%	of	fibers	with	significant	smaller	diameter.		
	
Figure	13.	LacZ/Mettl21c	positive	cells	 show	a	mosaic	pattern	 in	different	muscle	 types.	Whole	
mount	and	corresponding	transversal	cryosections	(20	µm	slice	thickness)	of	(A,	E)	soleus	muscle;	
gluteus	maximus	 (B,	 F),	 extensor	digitorum	 longus	 (C,	G)	 and	diaphragma	 (D,	H)	muscles	 stained	
with	 X-Gal	 revealed	 the	 expression	 pattern	 of	Mettl21c.	 The	 inlet	 in	 (C)	 and	 (D)	 shows	 a	 higher	
magnification	of	LacZ	positive	fibers.	
Taken	together,	the	systematic	analysis	of	LacZ	positive	cells	showed	that	Mettl21c	was	expressed	
in	a	specific	subset	of	muscle	fibers	in	different	muscles.	The	number	of	LacZ	positive	cells	reflected	
the	proportion	of	 slow	and	 fast	 fibers	within	 those	muscles.	Moreover,	 the	 soleus	muscle	as	 the	
slowest	 muscle	 showed	 the	 highest	 LacZ	 staining	 intensity	 suggesting	 that	 Mettl21c	 is	
predominantly	expressed	in	slow	fibers,	which	confirms	a	previous	report	[19].	
To	 validate	 that	 Mettl21c	 is	 expressed	 in	 a	 specific	 subset	 of	 fiber-types	 immunohistochemical	
stainings	with	 antibodies	 directed	 against	 slow	myosin	 heavy	 chain	 I	 (MyHC	 I,	 slow,	 gene	 name	
Myh7)	and	against	the	fast	MyHC	IIa	(MyHC	IIa,	fast,	gene	Name	Myh2)	in	combination	with	LacZ	
stainings	 were	 performed.	 The	 expression	 pattern	 of	 Mettl21c/LacZ	 was	 assessed	 on	 serial	
cryosections	 (20	 µm	 slice	 thickness)	 from	 soleus	 muscle	 of	 wild	 type	 controls,	 Mettl21c+/-,	 and	
Mettl21c-/-	littermates.		
The	 overlap	 of	 those	 sections	 clearly	 revealed	 that	 Mettl21c/LacZ	 signals	 were	 exclusively	
expressed	in	slow-twitch	muscle	fibers	(Figure	14A,	B)	since	only	MyHC	I	positive	fibers	were	also	
Mettl21c/LacZ	positive	and	MyHC	II	positive	fibers	were	negative	for	Mettl21c/LacZ.		
To	clarify	whether	the	inactivation	of	Mettl21c	influence	fiber-type	specification,	I	counted	MyHC	II	
and	MyHC	 I	 positive	 cells	 in	 adjacent	 sections	 after	 immunostainings	 with	 slow	 and	 fast	 MyHC	
Chapter	3	|	Results	
66	
	
antibodies.	 In	 total,	 ~100	 fibers	 for	 each	genotype	were	 counted	and	 I	 observed	~50%	MyHC	 IIa	
and	 45%	 MyHC	 I	 positive	 fibers	 in	 wild-type	 animals.	 This	 ratio	 reflects	 exactly	 the	 fiber-type	
distribution	 in	 the	 soleus	 muscle	 as	 reported	 in	 previous	 studies	 [18,	 193].	 The	 analysis	 of	
Mettl21c+/-	 and	 Mettl21c-/-	 revealed	 a	 similar	 proportion	 compared	 to	 the	 wild	 type	 soleus,	
indicating	that	the	inactivation	of	Mettl21c	has	no	effect	on	the	fiber-type	composition	in	the	slow	
soleus	muscle.	Each	genotype	was	analyzed	in	biological	triplicates.	
	
Figure	 14.	 Mettl21c	 is	 exclusively	 expressed	 in	 slow-twitch	 muscle	 fibers.	 (A)	
Immunohistochemical	stainings	for	myosin	heavy	chain	monoclonal	I	antibody	(MyHC	I,	slow)	and	II	
(MyHC	 II,	 fast)	 as	 well	 as	 LacZ	 stainings	 for	 serial	 sections	 (20	 µm	 slice	 thickness)	 from	 soleus	
muscle	of	wild	type,	Mettl21c+/-,	and	Mettl21c-/-	 littermates.	(B)	Higher	magnification	of	panel	(A).	
The	 cross	 indicates	 a	Mettl21c/LacZ	 expressing	 cell	 and	 correlates	 it	 to	 the	MyHC	 I	 and	MyHC	 II	
staining.	(C)	Analysis	of	the	fiber-type	composition	of	the	soleus	muscle	from	wild	type,	Mettl21c+/-,	
and	Mettl21c-/-	littermates.	This	was	correlated	to	the	total	number	of	fibers	(~100)	in	each	section.	
All	stainings	and	quantitative	measurements	were	performed	in	biological	triplicates.	
Next,	 to	decipher	the	general	morphology	and	architecture	of	Mettl21c	deficient	soleus	muscle	a	
haematoxylin	 and	 eosin	 staining	 (H&E)	 was	 performed	 to	 visualize	 eosinophilic	 structures	 and	
nuclei	 of	 cells	 (Figure	 15A).	 To	 monitor	 the	 carbohydrate	 composition	 of	 glycoproteins	 and	
proteoglycans	a	Lectin	staining	was	utilized	(Figure	15B).	Moreover,	staining	for	cytoplasmic,	nuclei,	
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collagen	 and	 mucosa	 substances	 were	 achieved	 by	 the	 Trichrom	 method	 (Figure	 15C).	 The	
comprehensive	 analysis	 of	 cellular	 and	 extracellular	 matrix	 structures	 by	 different	 staining	
procedures	 revealed	 no	 morphological	 changes	 between	 wild	 type	 and	 homozygous	 animals	
(Figure	15).		
	
Figure	 15.	 Mettl21c	 deficiency	 does	 not	 influence	 muscle	 morphology	 and	 fiber	 integrity.	
Representative	image	of	(A)	Haematoxylin	and	Eosin	(H&E),	(B)	Lectin	and	(C)	Trichrom	staining	for	
Mettl21c-/-	and	wild	type	littermate	controls.	
To	gain	a	view	on	the	intracellular	localization	of	Mettl21c,	I	used	U2OS	and	C2C12	cells	transiently	
transfected	with	Flag-tagged	Mettl21c	 for	24	hours.	After	 fixation	and	permeabilization,	 the	cells	
were	stained	with	Flag	antibody	and	counterstained	with	DAPI	to	visualize	the	nucleus	structures.	
Figure	 16	 shows	 that	 Mettl21c	 is	 homogenously	 expressed	 in	 transiently	 transfected	 U2OS	 and	
C2C12	cells.		
	
Figure	 16.	 Mettl21c	 does	 not	 localize	 in	 a	 specific	 cellular	 compartment.	 Immunofluorescence	
microscopy	 of	 U2OS	 cells	 and	 C2C12	 myoblasts	 showed	 that	 Mettl21c-Flag	 is	 expressed	 in	
cytoplasmic	 and	nuclear	 structures.	 Localization	of	 the	 Flag-tagged	methyltransferase	 is	 revealed	
by	immunofluorescence	with	a	Cy2-labeled	antibody.	Counterstaining	of	the	nucleus	was	done	with	
DAPI.	
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Collectively,	the	methyltransferase	Mettl21c	is	highly	enriched	in	Z-disk	structures	and	is	expressed	
exclusively	in	slow-twitch	muscle	fibers.	The	deletion	of	the	Mettl21c	gene	did	not	alter	the	general	
morphology	 and	 architecture	 of	 the	 soleus	 muscle.	 Localization	 of	 Mettl21c	 in	 transiently	
transfected	cell	lines	revealed	that	Mettl21c	is	homogenously	expressed	within	the	nucleus	and	the	
cytoplasm.	
	
3.2.2.	Deletion	of	Mettl21c	leads	to	reduced	voluntary	and	forced	
running	capabilities	
Forced	 and	 voluntary	 running	 performance	 tests	were	 chosen	 as	 a	mean	 to	 characterize	muscle	
performance	in	control	and	mutated	mice.	To	exclude	any	effects	based	on	body	mass,	weight	and	
length	of	muscles	each	morphometric	parameter	from	all	experimental	animals	participating	in	the	
physiological	 tests	 was	 determined.	 Notably,	 the	 analysis	 revealed	 no	 significant	 differences	 in	
body	weight	 and	muscle	 size	within	 the	 experimental	 groups	 and	between	different	 phenotypes	
(Figure	17A).		
A	voluntary	running	assay	is	based	on	a	running	wheel	that	is	localized	directly	in	the	mouse	cage	
and	the	mouse	can	enter	the	device	at	any	time	during	day	and	night.	Each	rotation	is	counted	by	
an	 online	 computer	 system	 and	 the	 number	 of	 rotations	 per	 day/night	 is	 a	 proxy	 of	 the	
physiological	 activity	 and	 muscle	 performance	 of	 the	 animal.	 Day	 and	 night	 rotations	 were	
recorded	after	one	day	of	acclimation	time.	The	running	profile	of	wild	type	control	group	clearly	
confirmed	higher	running	activity	during	the	night	since	mice	are	nocturnal	animals	(Figure	17B).		
The	 comparison	 to	Mettl21c	 deficient	 animals	 showed	 a	 clear	 reduction	 in	 the	 running	 distance	
during	 night	 (Figure	 17C,	 -53%,	 n=22,	 p	 <	 0.05).	 Similarly,	 Mettl21c+/-	 animals	 showed	 also	 a	
reduced	 running	 performance	 (-15%;	 n=16),	 indicating	 a	 dose-dependent	 effect	 (Figure	 17C)	 of	
Mettl21c	on	voluntary	running	performance.	
The	forced	running	test	is	an	intensive	test	on	a	treadmill	to	monitor	acute	muscle	endurance	and	
to	determine	the	time	of	exhaustion.	These	running	experiments	were	conducted	after	a	two	day	
training	period	and	the	test	was	scheduled	for	60	minutes	at	a	speed	of	12	m/min	(0.6	km/h).	Each	
exercise	session	was	terminated	at	any	point	at	which	a	mouse	meets	one	out	of	three	exhaustion	
criteria,	including	the	willingness	of	the	mouse	to	spend	greater	than	5	consecutive	seconds	on	the	
shock	grid	without	attempting	to	reengage	the	treadmill	or	the	mouse	spending	greater	than	50%	
of	its	time	on	the	shock	grid	or	if	a	mouse	is	spending	three	times	two	seconds	on	the	shock	grid.	
Consistently,	 Mettl21c-/-	 animals	 showed	 significant	 reduced	 ability	 to	 sustain	 a	 forced	 running	
activity	(-64%,	n=15,	p	<	0.05).	Controls	were	able	to	run	constantly	for	at	least	one	hour,	whereas	
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Mettl21c-/-	 animals	 were	 exhausted	 after	 20	 ±	 5minutes.	 Of	 note,	 heterozygous	 animals	 also	
showed	 a	 dose-dependent	 effect	 as	 indicated	 by	 a	 slight	 reduction	 of	 running	 capability	 (Figure	
17D).	
	
	
Figure	17.	Deletion	of	Mettl21c	 results	 in	 significant	decrease	of	 forced	and	voluntary	exercise	
performance.	 (A)	Determination	of	mouse	weight	 [g],	 soleus	 length	 [cm]	and	soleus	weight	 [mg]	
for	wild	 type	 littermates,	Mettl21c+/-,	and	Mettl21c-/-	mice	participating	 in	 the	physiological	 tests.	
(B)	Voluntary	wheel	 running	performance	 for	Mettl21c-/-	 and	wild	 type	 littermates	monitored	 for	
two	 days	 and	 nights.	 (C)	 Mettl21c-/-	 demonstrated	 significantly	 reduced	 running	 durations	
compared	to	wild	type	littermates	(p	<	0.05).	(D)	Treadmill	exercise	performance	was	recorded	for	
a	60	minutes	treadmill	run	at	12	m/min.	The	exercise	session	was	terminated	at	any	point	at	which	
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a	mouse	meets	one	of	the	three	exhaustion	criteria.	For	this	test	Mettl21c-/-	animals	demonstrated	
a	significantly	reduced	forced	running	performance	(p	<	0.05).	
	
3.2.3.	Proteomic	and	transcriptomic	profiling	of	Mettl21c	deletion	
mutants	
In	order	to	investigate	the	observed	phenotype	of	reduced	muscle	performance	on	the	molecular	
level,	 a	 global	 transcript	 and	 protein	 expression	 profiling	 was	 performed.	 To	 achieve	 the	 best	
correlation	between	 transcriptomic	and	proteomic	data,	 the	soleus	muscle	 from	male	Mettl21c-/-	
and	 wild	 type	 control	 littermates	 was	 divided	 into	 two	 samples.	 One	 piece	 of	 the	 soleus	 was	
subjected	 to	 quantitative	 mass	 spectrometry	 analysis	 and	 the	 other	 half	 was	 used	 for	
transcriptome	analysis	using	a	deep	sequencing	approach.	
For	the	mass	spectrometric	analysis	20	µg	of	SDS-extracted	protein	 lysate	was	separated	by	one-
dimensional	SDS-PAGE	gel	electrophoresis.	Each	gel	 lane	was	cut	 into	10	slices	and	then	proteins	
were	 in-gel	digested	with	the	endopeptidase	Trypsin.	The	resulting	peptides	were	then	extracted	
from	the	gel	and	the	peptide	mixture	was	cleaned	and	concentrated	by	stop	and	go	extraction	tips	
(STAGE	tips).	Subsequently	samples	were	analyzed	by	high-resolution	liquid	chromatography	mass	
spectrometry	 (LC-MS/MS)	 using	 150	 min	 LC-gradients	 (Figure	 18A).	 In	 total,	 60	 samples	 were	
measured	resulting	in	a	MS	measurement	time	of	7	days.	For	accurate	protein	quantification	label-
free	 protein	 quantification	 methods	 was	 used.	 To	 achieve	 statistically	 relevant	 datasets	 each	
experiment	(Mettl21c-/-	versus	wild	type)	were	performed	in	biological	triplicates.	To	visualize	the	
dataset,	 volcano	 plots	 were	 generated,	 which	 plot	 the	 log2	 fold	 change	 between	wild	 type	 and	
mutant	 animals	 and	 the	 -log10	 p-values.	 The	 p-value	 was	 obtained	 by	 a	 t-test	 modified	 with	 a	
fudge	factor	of	0.1.	The	fudge	factor	ascertains	that	the	variance	of	the	relative	difference	between	
the	 experimental	 groups	 is	 independent	 of	 the	 mean	 of	 the	 protein	 expression.	 To	 control	 for	
multiple	 testing	 a	 permutation-based	 false	 discovery	 (FDR)	 in	 Perseus	 [194]	 was	 used.	 The	 FDR	
guarantees	 that	 the	 probability	 of	 observing	 a	 false	 positive	 but	 significant	 protein	 is	 below	 a	
certain	threshold.		
Alterations	on	the	mRNA	transcription	 level	were	analyzed	by	a	deep	sequencing	approach	using	
an	 Ion	 Torrent	 Proton	 (Thermo	 Fisher).	 The	 experiments	 were	 performed	 by	 the	 in-house	 core	
facility	of	the	Max-Planck-Institute	for	Heart	and	Lung	research.	Isolated	RNA	from	the	soleus	was	
first	 fragmented	and	 then	 ligated	 to	adapters	 (library).	The	resulting	 library	 fragments	were	 then	
bound	 to	 beads	 and	 amplified	 by	 PCR.	 Gene	 transcript	 levels	 were	 then	 analyzed	 by	 massively	
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parallel	 sequencing	 of	 cDNA	 tags	 as	 shown	 in	 Figure	 18B	 and	 then	 aligned	 to	 the	 reference	
transcriptome	of	the	mouse	[195].	
	
Figure	 18.	 Generic	 workflow	 of	 quantitative	 LC-MS/MS	 proteomics	 and	 deep	 sequencing	
transcriptome	 analysis	 of	Mettl21c-/-	 and	wild	 type	 control	 animals.	 After	 the	 extraction	 of	 the	
soleus	muscle	one	part	was	subjected	to	mass	spectrometry	and	the	other	part	to	deep	sequencing	
analysis.	(A)	In-depth	proteome	analysis	was	carried	out	by	in-gel	digestion.	The	resulting	peptides	
were	then	analyzed	by	high-resolution	LC-MS/MS.	The	label-free	protein	quantification	was	based	
on	the	LFQ	algorithm	of	MaxQuant	[169].	(B)	The	RNA	was	initially	fragmented	and	then	ligated	to	
adapters	 (library).	 The	 library	 fragments	 were	 then	 bound	 to	 beads	 and	 amplified	 by	 PCR	
(emulsions	 PCR).	 The	 global	 gene	 transcript	 levels	 were	 then	 analyzed	 by	 massively	 parallel	
sequencing	of	cDNA	tags	with	the	Ion	Torrent	Proton.	
The	proteomic	analysis	resulted	in	the	recording	of	5576997	MS/MS	fragment	spectra	which	were	
used	 for	 the	 Andromeda	 search	 algorithm	 (MaxQuant,	 Version	 1.5.2.8).	 To	 estimate	 the	 rate	 of	
false	 positive	 identified	 peptides	 and	 proteins	 the	 database	 consists	 of	 a	 concatenated	 reverse	
database	 and	 the	 false	 discovery	 rate	 was	 set	 to	 1%	 on	 peptide	 and	 protein	 level.	 The	 search	
against	 the	 mouse	 Uniprot	 database	 (from	 2015,	 a	 data	 set	 involving	 74,265	 protein	 sequence	
entries)	 resulted	 in	 the	 identification	 of	 109772	 peptides	 and	 merging	 this	 peptides	 to	 protein	
groups	resulted	in	7379	proteins.	Since	statistical	analysis	can	only	be	performed	for	cases	where	at	
least	 two	 out	 of	 three	 conditions	 were	 detected	 with	 protein	 intensity,	 missing	 values	 were	
replaced	by	random	numbers	that	are	taken	from	the	normal	distribution.	The	default	values	are	
chosen	to	mimic	low	abundant	protein	intensities.	The	width	parameter	of	this	normal	distribution	
was	 chosen	 as	 0.3	 of	 the	 standard	 deviation	 of	 all	measured	 values	 and	 the	 center	was	 shifted	
towards	 low	 abundance	 by	 1.8	 times	 of	 the	 standard	 deviation.	 This	 procedure	 increases	 the	
number	of	quantified	proteins	 for	32	%	(Figure	19A)	and	using	this	approach	6414	proteins	were	
quantified.	Notably,	a	minor	fraction	of	54	up	and	66	down	regulated	proteins	(absolute	log2	fold	
change	 >	 0.58	 and	 -log10	 p	 value	 >	 1.3)	 could	 be	 identified.	 In	 addition,	 the	 high	 Pearson	
correlation	of	>	0.90	among	all	replicates	reflected	the	accurate	and	robust	protein	quantification.	
Chapter	3	|	Results	
72	
	
To	verify	differences	between	wild	type	and	Mettl21c-/-	animals	and	to	gain	a	more	systematic	view	
on	potential	protein	changes	a	principle	component	analysis	among	all	phenotypes	and	replicates	
was	performed.	Principle	component	analysis	helps	to	reduce	the	high-dimensionality	of	the	data	
while	 retaining	most	 of	 the	 variation	 in	 the	 data	 set.	 This	 analysis	 identifies	 directions	 that	 are	
called	principle	 components,	which	 can	be	plotted.	 Thereby	 similarities	 and	differences	between	
different	 phenotypes	 and	 replicates	 can	 be	 easily	 observed	 [196].	 Clearly,	 two	 principle	
components	 revealed	 a	 separation	 between	 wild	 type	 and	 Mettl21c-/-	 animals,	 which	 made	 up	
63.5%	 of	 the	 total	 variation.	 It	 presents	 a	 high	 clustering	 among	 the	 wild	 type	 triplicates	 but	 a	
heterogeneous	distribution	for	Mettl21c-/-	in	the	two-dimensional	graph	(Figure	19B).	
The	mRNA	study	 revealed	30-50	Million	 raw	reads	of	which	90%	were	of	high	quality	 reads.	The	
data	analysis	resulted	in	>80%	possible	mapped	reads	using	the	software	program	“Star”	[197].	In	
total	the	analysis	resulted	in	24448	transcripts	with	more	than	one	read	per	gene.	I	detected	a	high	
Spearman	correlation	among	the	two	biological	replicates	ranging	from	0.92	to	0.95.	Differentially	
expressed	genes	were	assessed	with	DeSeq	[198]	and	similar	to	the	proteomics	data	59	statistically	
significantly	 regulated	 genes	were	observed	 (absolute	 log2	 fold	 change	>	 1	 and	 -log10	p	 value	 >	
1.3).	To	accomplish	a	proteomic-transcriptomic	integrative	analysis	protein	Uniprot	identifiers	were	
overlapped	with	the	Ensemble	Identifiers	of	the	transcript	dataset.	A	total	number	of	2534	proteins	
were	 correlated	 which	 resulted	 in	 a	 Pearson	 correlation	 of	 0.29	 (Figure	 19D).	 Both	 omics	
approaches	proved	the	inactivation	of	Mettl21c	as	shown	in	Figure	19A	and	C.		
The	 comparison	 between	 the	 quantitative	 global	 soleus	 proteome	 and	 transcriptome	 analysis,	
studying	differences	of	Mettl21c-/-	and	wild	type	littermates	under	basal	conditions,	revealed	only	a	
weak	correlation	between	the	respective	abundances	of	these	two	classes	of	biological	molecules.		
Previous	 studies	 showed	 that	 the	mouse	 soleus	muscle	 contains	equal	number	of	 slow	and	 fast-
twitch	 fibers	 [18,	 193].	 Since	Mettl21c	 is	 exclusively	 expressed	 in	 slow-twitch	muscle	 fibers,	 it	 is	
possible	that	a	potential	protein	alteration	is	covered	by	non-affected	fast	fibers.	Thus,	to	obtain	a	
more	detailed	view	on	the	slow	fibers	with	inactivated	Mettl21c,	single	fibers	were	isolated	which	
were	 positive	 for	 the	 Mettl21c/LacZ	 staining.	 Thus,	 using	 fibers	 that	 are	 positive	 for	 the	
Mettl21c/LacZ	 expression	 marker	 enables	 a	 more	 focused	 view	 of	 the	 slow	 muscle	 proteome	
alterations.		
Isolated	 soleus	 muscle	 was	 incubated	 with	 collagenase	 to	 disaggregate	 single	 fibers	 and	
heterozygous	 and	homozygous	 fibers	were	 incubated	with	 the	X-Gal	 staining	 solution.	Only	 blue	
fibers	were	selected	 for	subsequent	MS	analysis	 (Figure	14A+B,	Figure	20A).	For	 the	experiments	
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~30	fibers	from	heterozygous	and	homozygous	soleus	muscle	were	isolated,	respectively.	The	pool	
of	slow	muscle	fibers	was	lysed	and	in-gel	digested	using	SDS-PAGE	gel	electrophoresis.	
	
Figure	19.	Proteomic	and	transcriptomic	profiling	of	Mettl21c	deletion	mutants.	(A)	Volcano	plot	
depicting	significantly	regulated	proteins	of	Mettl21c-/-	mutants	in	respect	to	wild	type	controls.	In	
the	proteome	experiment	6414	proteins	were	quantified.	Significant	regulated	proteins	are	colored	
in	blue	(absolute	log2	fold	change	>	0.58	and	-log10	p	value	>	1.3).	(B)	Principal	component	analysis	
showing	high	similarity	among	the	wild	type	triplicates	(blue)	but	a	heterogeneous	distribution	for	
Mettl21c-/-	(green).	(C)	Volcano	plot	depicting	significant	regulated	mRNAs	of	Mettl21c-/-	compared	
to	 wild	 type	 littermates.	 Significant	 regulated	 proteins	 are	 colored	 in	 blue	 (absolute	 log2	 fold	
change	 >	 1	 and	 -log10	 p	 value	 >	 1.3).	 (D)	 Scatter	 plots	 visualizing	 the	 correlation	 of	 large-scale	
quantitative	proteome	and	mRNA	transcriptome	analysis	of	Mettl21c	deletion	mutants.		
The	 mass	 spectrometric	 analysis	 revealed	 1564	 quantified	 proteins	 and	 the	 biological	 samples	
showed	 a	 Pearson	 correlation	 between	 0.97	 and	 0.98	 (Figure	 20B).	 The	 Principal	 component	
analysis	 revealed	 a	 high	 similarity	 among	 the	 biological	 replicates	 of	 Mettl21c-/-	 (green)	 and	
Mettl21c+/-	 (blue)	mice	 (Figure	 20C)	 and	 a	 clear	 separation	 between	 both	 groups.	 The	 label-free	
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protein	quantification	resulted	 in	37	statistically	significantly	 regulated	candidate	genes	 (absolute	
log2	fold	change	>	0.58	and	-log10	p	value	>	1.3)	(Figure	21A)	
	
Figure	20.	Characterization	of	the	proteome	of	slow-twitch	muscle	fibers	from	soleus	muscle	of	
Mettl21c-/-	 and	 Mettl21c+/-	 mice.	 (A)	 Experimental	 workflow	 for	 30	 X-Gal	 positive/	 slow-twitch	
fibers	 isolated	 from	soleus	muscle	of	Mettl21c-/-	 and	Mettl21c+/-	mice.	 Slow-twitch	 fiber	 isolation	
performed	by	collagenase	digest	and	X-Gal	staining	was	followed	by	a	quantitative	LC-MS/MS	mass	
spectrometry	 approach	 (Q	 Exactive).	 (B)	 Pearson	 correlation	 of	 the	 soleus	 samples	 ranged	 from	
0.97	 to	 0.98,	 representing	 a	 high	 correlation.	 (C)	 Principal	 component	 analysis	 showing	 high	
similarity	among	the	biological	replicates	of	Mettl21c-/-	(green)	and	Mettl21c+/-	(blue)	mice.		
Notably,	the	proteomic	approach	of	single	soleus	fibers	and	a	gene	ontology	term	analysis	provided	
evidence	that	 the	 loss	of	Mettl21c	alters	 the	expression	of	many	autophagy-related	proteins	and	
these	 candidates	were	not	 significantly	 changed	 in	 the	whole	 soleus	muscle	 analysis.	 Autophagy	
related	proteins	are	summarized	in	Figure	21B.	For	example,	the	Ca2+/Calmodulin	Kinase	II	(Camk2g	
and	 Camk2b)	 is	 activated	 by	 Ca2+/Calmodulin	 and	 can	 thereby	 regulate	 the	 autophagic	 process	
[199].	Gain-and-loss-of-function	studies	on	Bnip3,	a	BH3-only	protein,	proved	that	Bnip3	modulates	
autophagy	 by	 FoxO-dependent	 regulation	 [28].	 In	muscle,	 several	 tissue-specific	 E3	 ligases	 have	
been	 identified	 as	 atrophy-related	 genes,	 the	 F-box	 protein	 atrogin-1/MAFbx,	 and	 the	 MURF	
muscle-specific	RING-finger	proteins	among	that	Trim54/Murf3	[200].	For	Lamin	A/C	(Lmna)	it	was	
shown,	that	it	modulates	the	mTorc1	signaling	and	leads	to	impaired	autophagy	[201].	Ulbricht	et	
al.	revealed	that	chaperone-assisted	selective	autophagy	(CASA)	is	as	a	tension-induced	autophagy	
pathway,	which	plays	an	important	role	for	mechanotransduction	in	muscle.	For	the	formation	of	
autophagosomes	 during	 CASA	 the	 interaction	 of	 BAG3	 with	 synaptopodin-2	 (Synpo2)	 is	 of	
importance	 [202].	Here,	 cytoplasmic	 dynein	 1	 intermediate	 chain	 2	was	detected	with	 increased	
levels	 in	Mettl21c	 deficient	mice	 and	 the	 clearance	 of	 aggregate-prone	 proteins	 is	 regulated	 by	
dynein,	 probably	 by	 modulating	 autophagosome-lysosome	 fusion	 [203].	 In	 a	 global	 shRNA	
screening	using	the	accumulation	of	the	autophagy	marker	p62,	Strohecker	et	al.	identified,	among	
many	other	candidates,	Phosphorylase	kinase	alpha	1	 (Phka1)	as	a	potential	autophagy	regulator	
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[204].	 In	 addition,	 it	 was	 also	 shown,	 that	 defective	 autophagy	 is	 the	 result	 of	 collagen	 VI	
deficiencies	(Col6aI-III)	in	the	ECM	leading	to	muscular	dystrophies	[8].		
Taken	 together,	 our	 analysis	 of	 the	 slow-twitch	 soleus	 fiber	 proteome	 revealed	 an	 alteration	 on	
many	 known	autophagy-related	proteins	 in	Mettl21c	mutants	 and	 this	 effect	 is	 only	 visible	 after	
separation	of	slow	and	fast	muscle	fibers.		
	
Figure	21.	Loss	of	Mettl21c	alters	the	expression	of	many	know	autophagy-related	proteins.	 (A)	
Volcano	 plot	 depicting	 significantly	 regulated	 proteins	 of	 Mettl21c-/-	 mutants	 in	 respect	 to	
Mettl21c+/-	 controls.	 In	 the	 sub-proteome	 experiment	 of	 single	 slow-twitch	 soleus	 fibers	 1564	
proteins	were	 quantified.	 Significant	 differently	 regulated	 proteins	 are	 colored	 in	 blue	 (absolute	
log2	 fold	change	>	0.58	and	 -log10	p	value	>	1.3).	 (B)	The	expression	of	many	autophagy-related	
proteins	is	altered	in	slow-twitch	muscle	fibers	due	to	the	Mettl21c	deletion.	
	
3.3.	 Mettl21c	 interacts	 with	 autophagic	 regulator	 proteins	 –	
Valosin-containing	protein	(p97)	and	Sequestosome-1	(p62)	
In	 order	 to	 elucidate	 the	molecular	 interplay	 between	Mettl21c	 and	 autophagy	 related	 proteins	
several	protein-protein	interaction	studies	were	performed.	As	mentioned	in	section	3.2.,	until	now	
there	is	no	working	mouse	antibody	available.	Hence,	SILAC	based	affinity	purification	experiments	
using	Mettl21c	with	different	tags	were	performed.	Mettl21c	was	transfected	in	mammalian	cells	
such	as	human	embryonic	kidney	cells	(HEK	293T)	and	mouse	myoblast	cells	(C2C12).	After	affinity	
purification	with	specific	tag	antibodies,	enriched	proteins	were	analyzed	by	the	quantitative	mass	
spectrometric	 workflow.	 Flag-tagged	 and	 GFP-tagged	 Mettl21c	 were	 generated	 by	 cloning	 the	
mouse	Mettl21c	coding	sequence	into	the	pcDNA5/TO	vector	containing	either	a	C-terminal	Flag-	
or	GFP-tag.	SILAC	labeled	cells	were	transfected	with	Flag-	and/or	GFP-tagged	Mettl21c	(under	the	
control	 of	 the	 CMV	 promotor)	 as	 well	 as	 empty	 expression	 plasmid	 (TO5-Flag	 or	 TO5-GFP)	 for	
control	 experiments.	 One	 day	 post	 transfection,	 cells	 were	 harvested,	 lysed	 with	 modified	 RIPA	
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buffer,	 and	 immunoprecipitated	using	 Flag	and	GFP	antibodies	 in	 combination	with	 Sepharose	G	
beads.	 In	 the	 case	 of	 a	 SILAC	 experiment	 non-labeled	 (light)	 and	 labeled	 (heavy)	 samples,	 cell	
lysates	were	washed	and	mixed	before	elution.	Eluted	proteins	were	separated	using	SDS-PAGE,	in-
gel	digested	and	subjected	to	LC-MS/MS	analysis.		
Although	 the	 overexpression	 of	 expression	 vectors	 in	 cell	 culture	 cells	 is	 a	 valuable	 method	 to	
screen	for	protein-protein	interactions,	this	approach	is	often	hampered	by	the	missing	expression	
of	 tissue	 specific	 proteins.	 To	 cope	 with	 these	 shortcomings	 a	 more	 physiological	 protein	
interaction	 screen	was	 conducted.	 Here	 Flag-tagged	Mettl21c	 derived	 from	HEK	 293T	 cells	were	
incubated	 with	 mouse	 soleus	 lysate	 to	 enrich	 interaction	 partners	 from	 differentiated	 muscle	
tissue.	 For	 an	 appropriate	 control,	 beads	 were	 incubated	 with	 the	 tissue	 lysate.	 Control	 and	
Mettl21c	samples	were	again	analyzed	by	the	LC-MS/MS	approach.		
Since	each	 immunoprecipitation	contains	a	 large	number	of	background	binders	resulting	 in	false	
positive	 interactors	 each	 experiment	 was	 performed	 in	 duplicates	 and	 the	 overlap	 of	 the	 most	
common	 hits	 revealed	 that	 Mettl21c	 interacts	 predominately	 with	 co-chaperones,	 Heat-Shock-
Proteins,	autophagosomal	and	proteasomal	proteins	(Figure	22).	
	
Figure	 22.	 Mettl21c	 interacts	 predominately	 with	 co-chaperones,	 Heat-Shock-Proteins,	
autophagosomal	 and	 proteasomal	 proteins.	 Three	 different	 interaction	 partner	 screens	 were	
performed	in	duplicates.	Flag-	and	GFP-tagged	Mettl21c	was	overexpressed	in	SILAC-labeled	C2C12	
myoblasts	and	HEK	293T	cells,	 immunoprecipitated,	analyzed	using	LC-MS/MS	and	normalized	 to	
the	 controls.	 In	 addition,	 the	 Flag-tagged	 Mettl21c	 was	 overexpressed	 in	 HEK	 293T	 cells,	
immunoprecipitated,	incubated	with	mouse	soleus	lysate	and	analyzed	using	LC-MS/MS.	
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Notably,	 the	 Valosin-containing	 protein	 (Vcp,	 p97),	 and	 Sequestosome-1	 (Sqstm1,	 p62),	 two	
autophagic	 adapter	 proteins,	 raised	 my	 particular	 attention.	 The	 two	 proteins	 are	 involved	 in	
transport	 of	 degradation	 cargo	 and	 are	 important	 regulators	 of	 these	 degradation	 pathways.	 As	
shown	 in	 Figure	 23A	 the	MS	 spectra	 revealed	 that	 the	 bait,	 GFP-tagged	Mettl21c,	was	 enriched	
with	the	highest	intensity.	The	SILAC	MS	spectra	for	Vcp	and	Sqstm1	also	proved	that	GFP-tagged	
Mettl21c	serves	as	an	interactor	for	these	autophagic	adapter	proteins.	The	SILAC	proteomics	data	
were	 validated	 by	 western	 blotting	 (Figure	 23B).	 To	 verify	 the	 Mettl21c-Vcp,	 and	 Mettl21c-
Sqstm1/p62	 interaction	 reverse	 immunoprecipitations	with	 Vcp	 and	 Sqstm1/p62	 from	HEK	 293T	
were	performed	corroborating	the	interaction	of	Mettl21c	with	Vcp	and	Sqstm1/p62	(Figure	23B).	
	
Figure	23.	Mettl21c	interacts	with	two	autophagic	regulator	proteins,	Valosin-containing	protein	
(Vcp/p97)	and	Sequestosome-1	(Sqstm1/p62).	(A)	MS	spectra	from	a	triple	SILAC	experiment	and	
(B)	 western	 blot	 analysis	 proofing	 the	 interaction	 of	 Mettl21c	 with	 Vcp	 and	 Sqstm1.	 Reverse	
immunoprecipitations	with	endogenous	VCP	and	SQSTM1	 from	HEK	293T	cells	 corroborating	 the	
interaction	with	Mettl21c.	
In	 addition,	 the	 results	 also	 revealed	 an	 interaction	 between	 Mettl21c	 and	 its	 family	 member	
Mettl21e,	even	 though	 it	was	not	observed	 in	every	 type	of	experiment,	probably	depending	on	
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the	 expression	 level	 in	 the	 cells	 (Figure	 22,	 Figure	 24).	 Therefore,	 the	 Mettl21c-Mettl21e	
interaction	was	confirmed	by	overexpressing	Flag-tagged	Mett21c	and	HA-tagged	Mettl21e	as	well	
as	HA-tagged	Mett21c	and	Flag-tagged	Mettl21e,	 respectively.	 Immunoprecipitation	and	western	
blotting	confirmed	this	interaction	(Figure	24).	
	
	
Figure	24.	Mettl21c	interacts	with	its	family	member	Mettl21e.	(A)	Scatter	plot	and	(B)	MS	spectra	
of	 immunoprecipitated	 GFP-tagged	 Mettl21c	 overexpressed	 in	 HEK	 293T	 cells	 depicting	 the	
interaction	of	Mettl21c	with	endogenous	METTL21E.	 (B)	Western	blot	 confirming	 the	 interaction	
between	Mettl21e	 and	Mettl21c	 by	 immunoprecipitating	with	 Flag-antibody	overexpressed	 Flag-
tagged	Mettl21c	and	HA-tagged	Mettl21e	as	well	as	HA-tagged	Mettl21c	and	Flag-tagged	Mettl21e,	
respectively.	
Together,	 these	 results	 suggest	 that	Mettl21c	plays	 a	 pivotal	 role	 in	 the	 autophagy	process	 as	 it	
interacts	with	important	regulators	like	Vcp	and	p62.		
	
3.4.	Mettl21c	trimethylates	Valosin-containing	protein	in	vitro	and	
in	vivo	
Since	Mettl21c	 is	 annotated	 as	 a	 potential	 methyltransferase	 it	 would	 be	 important	 to	 identify	
potential	 substrates,	 which	 are	 methylated	 in	 the	 presence	 of	 Mettl21c.	 In	 order	 to	 identify	
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whether	Mettl21c	 is	 able	 to	methylate	Vcp,	 Sqstm1	and	Mettl21e,	 an	 in	 vitro	methyltransferase	
assay	was	developed.	Of	note,	previous	studies	have	shown	that	the	family	member	METTL21D	is	
able	to	methylate	VCP	at	position	lysine-315	[3].	
Both,	 the	 substrate	 and	 enzyme	 were	 overexpressed	 in	 HEK	 293T	 cells	 and	 enriched	 by	
immunoprecipitation.	 This	 procedure	 ensures	 the	 presence	 of	 important	 cofactors	 for	 the	
enzymatic	 reaction,	which	might	 be	 absent	 in	 in	 vitro	 assays.	 The	 immunoprecipitated	 potential	
substrates	are	incubated	with	the	methyl	donor	S-adenosylmethionine	(SAM)	and	the	methylation	
reaction	 is	 initiated	 with	 the	 immunoprecipitated	 Mettl21c	 (Figure	 25A).	 To	 identify	 the	
methylation	site(s)	induced	by	Mettl21c	activity,	all	reactions	were	analyzed	by	mass	spectrometry.	
All	 peptide	 intensities	 were	 compared	 to	 the	 empty	 bead	 controls	 (without	 Mettl21c).	 As	
mentioned	 previously	 the	 consensus	 sequence	 at	 amino	 acid	 position	 101	 with	 the	 sequence	
“LEIGAGAG”	is	important	for	the	catalytic	activity	of	Mettl21c.	Thus,	a	potential	mutant	variant	of	
Mettl21c	was	generated	by	replacing	the	consensus	sequence	by	“LEIAAAAA”	resulting	in	impaired	
SAM	binding	[205]	(Figure	25B).		
	
Figure	25.	Experimental	design	for	the	MTase	assay	with	Mettl21c	and	the	potential	substrates.	
(A)	 In	 vitro	 methylation	 assay	 using	 endogenous	 Flag-tagged	 Mettl21c	 and	 different	 potential	
substrates	(Vcp,	Sqstm1	and	Mettl21e).	The	potential	substrates	bound	to	Sepharose	G	beads	are	
incubated	 with	 the	 methyl	 donor	 S-adenosylmethionine	 (SAM)	 and	 the	 methylation	 reaction	 is	
initiated	with	beads	that	carry	the	immunoprecipitated	Mettl21c-Flag.	(B)	The	reaction	of	Mettl21c	
with	the	potential	substrate	could	induce	mono-,	di-	and	trimethylation,	which	was	analyzed	by	LC-
MS/MS.		
All	components	were	mixed	as	described	in	the	method	section	2.18.4.	and	incubated	for	one	hour	
at	room	temperature.	Then	the	reactions	were	stopped	by	adding	1xLDS	buffer	and	prepared	for	
in-gel	digestion	and	LC-MS/MS	analysis.	For	the	reaction	of	Mettl21c	with	Sqstm1	and	Mettl21e	no	
detectable	methylation	sites	were	observed.	One	reason	for	a	missing	methylation	might	be	that	
these	proteins	are	only	interaction	partners	and	no	substrates.	Alternatively,	it	is	possible	that	the	
methylated	peptides	are	not	accessible	for	MS	analysis	since	their	 length	is	too	short	or	too	long.		
In	 contrast,	 the	 incubation	of	Mettl21c	and	Vcp	generated	 several	methylated	 lysine	 residues.	 In	
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total	 I	observed	a	sequence	coverage	of	88%	and	found	6	mono-,	3	di-,	and	1	trimethylation	site	
(Figure	26A).	All	mono-	and	dimethylation	sites	were	equally	detected	in	all	experiments,	indicating	
a	 background	 methylation	 independent	 of	 Mettl21c.	 However,	 increased	 trimethylation	 in	 the	
presence	 of	 Mettl21c	 was	 observed	 on	 the	 lysine	 at	 position	 315	 on	 VCP	 (Figure	 26B,	 C).	 The	
MS/MS	fragmentation	spectrum	showed	an	Andromeda	score	of	160	of	the	trimethylated	peptide	
and	 Figure	 26D	 depicts	 the	 presence	 of	 high	 mass	 accuracy	 y-	 and	 b-	 ions	 based	 on	 HCD	
fragmentation	on	a	Q	Exactive	mass	spectrometer,	confirming	the	presence	of	the	trimethylation	at	
lysine-315	on	VCP.	
	
Figure	 26.	 Mettl21c	 trimethylates	 lysine-315	 of	 VCP.	 (A)	 MTase	 assay	 showed	 that	 Mettl21c	
methylates	VCP	at	distinct	lysine	residues	(B)	but	only	lysine-315	is	trimethylated	in	respect	to	the	
mutant	 control.	 (C)	 Bar	 plot	 displaying	 the	 upregulation	 of	 the	 intensity	 of	 the	 trimethylation	 of	
lysine-315	upon	incubation	with	Mettl21c	in	respect	to	the	control	reaction	and	a	mutant	form	of	
Mettl21c.	 (D)	MS/MS	spectrum	depicts	the	 identification	of	the	trimethylation	on	 lysine-315	with	
an	Andromeda	score	of	160.	
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To	 investigate	this	trimethylation	of	VCP	under	more	physiological	conditions	soleus	muscle	from	
wild	 type	 control	 and	 Mettl21c-/-	 was	 isolated	 and	 protein	 extracts	 with	 RIPA	 buffer	 were	
generated.	Next,	Vcp	was	immunoprecipitated	from	both	genotypes	and	trimethylation	was	tested	
by	western	blotting	using	an	anti-trimethyl	antibody.	The	experiment	revealed	clearly	a	reduced	tri-
methylation	 in	 Mettl21c	 deficient	 animals	 compared	 to	 the	 wild	 type	 controls	 (Figure	 27A).	
However,	 based	 on	 this	 western	 blot	 one	 cannot	 exclude	 the	 presence	 of	 other	 trimethylation	
sites,	which	are	also	less	methylated	in	Mettl21c-/-	animals.	
To	 investigate	 the	 consequences	 of	 a	 reduced	 trimethylation	 at	 position	 315	 on	 Vcp,	 a	 protein	
interaction	 study	 using	 the	 soleus	 from	wild	 type	 and	Mettl21c-/-	mutants	was	 performed.	 After	
protein	extraction	and	antibody	 incubation,	samples	were	digested	 in-gel	and	LC-MS/MS	analysis	
was	conducted.	As	described	earlier	Vcp	interacts	with	the	cofactor	Nsfl1c	also	known	as	p47.	This	
interaction	is	important	to	modulate	the	ATPase	activity	of	Vcp	[206,	207].	
The	 immunoprecipitation	 and	 LC-MS/MS	 analysis	 confirmed	 the	 Vcp-Nsfl1c	 interaction	 and	
interestingly	this	 interaction	was	clearly	reduced	 in	Mettl21c	deficient	soleus	muscle	 (Figure	27A,	
B)
	
Figure	27.	Reduced	Vcp	trimethylation	on	lysine-315	might	compromise	interaction	with	the	Vcp	
cofactor	Nsfl1c/p47.	 (A)	 Immunoprecipitation	 and	western	blot	 of	 control	 and	Mettl21c-/-	 soleus	
muscle.	 (B)	 Scatter	 plots	 showing	 the	 log2	 Ratio	 of	 Vcp-IP	 versus	 the	 Ctrl-IP	 in	 two	 quantitative	
mass	spectrometry	based	protein	interaction	studies	from	soleus	muscle	of	wild	type	(left	plot)	and	
Mettl21c-/-	mutants	(right	plot).		
Collectively,	 the	 interaction	 of	 Mettl21c	 and	 Vcp	 links	 this	 slow-muscle	 fiber	 specific	
methyltransferase	 to	 control	 mechanisms	 of	 autophagy.	 Furthermore	 SAM	 methylation	 assays	
revealed	that	it	trimethylates	mammalian	VCP	on	lysine-315	since	a	42	Da	mass	shift	was	identified	
in	 the	mass	 spectra	 in	 comparison	 to	 an	 unmethylated	 peptide.	 The	methylation	was	 abolished	
when	using	a	mutant	form	of	Mettl21c	with	impaired	SAM	binding.	For	other	interaction	partners,	
like	p62	or	Mettl21e,	I	could	not	show	any	upregulated	methylation	sites	compared	to	the	controls.		
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3.5.	 Electron	 microscopy	 reveals	 changes	 in	 ultrastructure	 of	
Mettl21c	deletion	mutants	
Electron	microscopy	is	a	powerful	approach	to	monitor	the	ultrastructure	of	cellular	compartments	
such	as	mitochondria	or	the	contractile	apparatus	of	skeletal	muscle	fibers.		
To	monitor	alterations	 in	Mettl21c	deficient	animals,	30-	and	94-week	old	wild	 type,	Mettl21c+/-,	
and	Mettl21c-/-	soleus	muscle	were	analyzed	by	a	Philips	CM	10	electron	microscope.		
Interestingly,	 I	 identified	 an	 accumulation	 of	 autophagosomes	 in	 Mettl21c	 mutants,	 which	
resemble	 structures	 found	 in	 autophagic	 vacuolar	 myopathies.	 Electron	 microscopy	 analysis	
revealed	 that	 these	 accumulated	 autophagic	 vacuoles	 are	 present	 in	 Mettl21c	 deficient	 and	
Mettl21c+/-	myofibers	but	not	in	age-matched	wild	type	controls.	From	electron	microscopy	analysis	
the	sarcoplasmic	reticulum	appear	normal	(Figure	28).	Since	the	autophagosomes	are	not	observed	
in	normal	muscle	fibers,	autophagic	vacuoles	have	been	often	considered	as	pathological	hallmarks	
of	numerous	neuromuscular	disorders.	
	
Figure	28.	Electron	micrographs	reveal	accumulation	of	vacuoles	in	Mettl21c	mutants.	Shown	in	a	
myofiber	of	 a	30-	 and	94-week-old	wild	 type	 (top),	Mettl21c+/-	 (middle)	 and	Mettl21c-/-	 (bottom)	
mouse.	 The	 images	 are	 representative	 of	 results	 obtained	 from	 three	 different	 animals	 per	
experimental	group.	Bars	=	1	µm.	
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3.6.	 Mettl21c	 is	 associated	 to	 the	 autophagic	 flux	 upon	
denervation-induced	atrophy		
The	 inactivation	 of	 Mettl21c	 under	 steady	 state	 conditions	 resulted	 in	 reduced	 muscle	
performance	 and	 increased	 levels	 of	 proteins	 associated	with	 degradation	 pathways.	Moreover,	
the	interaction	with	Vcp	and	its	cofactor	Nsfl1c	suggests	that	Mettl21c	functions	as	a	protein	that	
might	modulate	general	protein	degradation	processes.	To	investigate	how	Mettl21c	influences	the	
process	 of	 autophagy	 in	 skeletal	muscle	 tissue,	 neuronal	 denervation	 by	 unilaterally	 cutting	 the	
sciatic	nerve	of	Mettl21c	deficient	and	control	mice	for	a	time	period	of	seven	days	was	performed.	
The	contralateral	limb	served	as	a	control	(Figure	29A).	After	seven	days	of	denervation	the	soleus	
muscle	 from	the	control	and	denervated	site	of	Mettl21c-/-	 and	wild	 type	control	mice	 (n=3)	was	
isolated	and	the	muscle	weights	were	normalized	to	the	total	body	weight.	Notably,	wild	type	and	
Mettl21c-/-	 muscles,	 displayed	 a	 significant	 reduction	 of	 ~35%	 (+/-	 10%)	 upon	 denervation	
compared	to	the	control	site,	indicating	muscle	atrophy.	However,	Mettl21c	deficient	mice	showed	
a	 similar	 reduction	 of	 the	 muscle	 mass	 compared	 to	 their	 wild	 type	 littermates	 suggesting	 no	
severe	abnormalities	during	denervation-induced	muscle	atrophy	(Figure	29B).		
In	order	 to	characterize	 the	 role	of	Mettl21c-/-	on	 the	molecular	 level	upon	denervation,	a	global	
quantitative	proteome	analysis	based	on	mass	spectrometry	was	conducted.		
The	 proteomic	 expression	 profiling	 resulted	 in	 6482	 quantifiable	 proteins	 and	 the	 analysis	 of	
biological	 triplicates	 lead	 to	 the	 identification	of	134	up	and	221	down	 regulated	proteins	 in	 the	
soleus	muscle	of	wild	type	compared	to	the	control	limb	(Figure	29D	and	F).	Similarly,	121	up	and	
203	 down	 regulated	 proteins	 (absolute	 log2	 fold	 change	 >	 0.58	 and	 -log10	 p	 value	 >	 1.3)	 were	
detected	 in	 Mettl21c-/-	 mice	 (Figure	 29E,	 F).	 Since	 the	 main	 focus	 of	 this	 experiment	 was	 the	
identification	of	proteins	related	to	autophagy,	a	systematic	gene	ontology	term	(GO)	analysis	was	
conducted.	The	analysis	clearly	showed	that	GO	terms	for	mitochondrial	proteins	was	significantly	
enriched	 but	 phagosomal	 proteins	were	 not	 enriched	 in	Mettl21c-/-	mice	 compared	 to	wild	 type	
control	 mice	 (Figure	 29C,	 Figure	 30,	 Figure	 31)	 corroborating	 the	 role	 of	 Mettl21c	 in	
autophagocytosis.	
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Figure	 29.	Mettl21c	 regulates	 phagosomal	 and	mitochondrial	mechanisms	 during	 denervation-
induced	atrophy.	(A)	Experimental	design	for	denervation-induced	atrophy	in	Mettl21c-/-	and	wild	
type	control	mice.	Unilaterally	denervation	by	severing	the	sciatic	nerve	for	a	time	period	of	seven	
days,	with	the	contralateral	 limb	serving	as	a	control.	 (B)	Muscle	mass	corrected	for	body	weight	
proved	a	 reduction	 in	muscle	mass	 in	both	wild	 type	 control	 (n=3,	 30%	 reduction,	p	<	0.05)	 and	
Mettl21c-/-	 (n=3,	 34%	 reduction,	 p	 <	 0.05)	 animals.	 (C)	 Fisher	 exact	 test	 showing	 significantly	
regulated	Go-terms	for	experimental	animals.	 (D+E)	Volcano	plot	depicting	significantly	regulated	
proteins	of	denervated	wild	type	(D)	and	Mettl21c-/-	mutant	 (E)	 limbs	 in	respect	 to	control	 limbs.	
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Significant	differently	regulated	proteins	are	colored	in	blue	(absolute	log2	fold	change	>	0.58	and	-
log10	 p	 value>	 1.3).	 Phagosomal	 proteins	 are	 indicated	 as	 green	 circles.	 (F)	 Table	 showing	 the	
regulated	proteins	in	wild	type	control	and	Mettl21c-/-	mice.	
	
	
Figure	30.	Increased	mitophagy	in	Mettl21c	deletion	mutants.	(A)	Boxplot	depicting	regulation	for	
all	 (blue)	 and	 significantly	 regulated	 (green)	 mitochondrial	 proteins	 from	 quantitative	 mass	
spectrometric	 analysis.	 (B)	 Mass	 spectrometry	 analysis	 revealing	 that	 mitochondrial	 proteins	 in	
Mettl21c-/-	 mice	 are	 upregulated	 under	 steady	 state	 conditions	 but	 further	 downregulated	 post	
denervation	in	comparison	to	wild	type	control	mice.	
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Interestingly,	 comparison	of	wild	 type	and	Mettl21c	mice	under	 regular	 conditions	 revealed	 that	
mitochondrial	proteins	were	significantly	upregulated	(Figure	30).	Conversely,	upon	denervation	in	
Mettl21c	 deficient	 animals	 mitochondrial	 proteins	 showed	 the	 opposite	 effect	 and	 were	
significantly	 downregulated	 in	 comparison	 to	 denervated	 wild	 type	 control	 mice.	 Since	
mitochondria	are	highly	dynamic	organelles	mitophagy	is	a	general	process	of	atrophying	muscle	to	
prevent	 the	accumulation	of	damaged	mitochondria.	Thus,	 the	 finding	 that	Mettl21c-/-	 showed	a	
decreased	 abundance	 of	 mitochondrial	 proteins	 upon	 denervation	 indicates	 most	 likely	 an	
increased	 level	 of	mitochondrial	 clearance.	 In	 addition,	 the	 rigorous	 statistical	 analysis	 based	 on	
FDR	 calculation	 revealed	 a	 significant	 upregulation	 of	 several	 proteins	 involved	 in	
phagosomal/lysosomal	 transport	 for	 the	denervated	wild	 type	control	 (Figure	31A).	For	example,	
the	subunits	of	the	V-ATPase	are	essential	for	the	lysosomal	hydrolase	activity	and	the	autophagic	
flux.	Here,	wild	type	animals	showed	a	clear	increase	of	this	protein	family	(green	circles	in	Figure	
31C),	 whereas	 the	 denervated	 muscle	 from	 Mettl21c	 mutants	 (Figure	 31B)	 did	 not	 show	 any	
upregulation	 of	 the	 ATP6	 subunits	 leading	 to	 relative	 down	 regulation	 compared	 to	 denervated	
wild	type	animals	(Figure	31A-D).		
	
Figure	 31.	 Mettl21c	 regulates	 the	 autophagic	 flux.	 (A)	 Boxplot	 showed	 regulation	 for	 all	 (blue	
circles)	 and	 significantly	 regulated	 (green	 circles)	 phagosomal	 proteins	 from	 quantitative	 mass	
spectrometric	 analysis.	 (B,	 C)	 Volcano	 plots	 shows	 significantly	 regulated	 proteins	 of	 denervated	
Mettl21c-/-	mutants	and	wild	 type	muscles	 compared	 to	 control	muscles,	 respectively.	 Significant	
differently	 regulated	proteins	are	 colored	 in	blue	 (absolute	 log2	 fold	 change	>	0.58	and	 -log10	p	
value	 >	 1.3).	 Phagosomal	 proteins	 in	 the	 Mettl21c	 deficient	 mutants	 and	 wild	 type	 mice	 are	
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selected	and	labeled	in	green.	The	Volcano	plot	is	revealing	a	deregulation	for	phagosomal	proteins	
between	wild	type	control	and	Mettl21c-/-	animals.	(D)	Schematic	scheme	of	the	V-type	ATPase	and	
the	deregulated	subunits.	 (E)	Western	Blot	of	denervated	and	control	soleus	 lysate	of	Mettl21c-/-	
and	wild	type	littermates	depicting	increase	of	both	the	lipidated	and	unlipidated	form	of	LC3	for	
wild	type	mice.	For	Mettl21c-/-	mice	the	lipidation	of	LC3	was	blocked.	
The	 finding	 that	 lack	 of	Mettl21c	 leads	 to	dysregulation	of	 lysosomal	 proteins,	 persuaded	me	 to	
investigate	the	functional	consequences	for	autophagosomal	formation.	Lipidated	and	cleaved	LC3	
is	a	general	autophagic	marker	[48].	As	shown	in	previous	studies	the	induction	of	autophagy	leads	
to	 an	 increase	 of	 both	 the	 lipidated	 and	 unlipidated	 form	 of	 LC3.	 Strikingly,	 the	 western	 blot	
analysis	of	denervated	Mettl21c-/-	clearly	indicated	a	block	of	LC3	lipidation	(Figure	31E),	indicating	
a	dysregulation	of	the	autophagic	flux	in	Mettl21c	deficient	mutants.		
	
Figure	 32.	 Mettl21c	 increases	 autophagic	 flux.	 C2C12	 cells	 were	 transfected	 either	 with	 Flag-
tagged	 Mettl21c	 or	 empty	 vector	 control	 (Mock	 Ctrl)	 as	 well	 as	 GFP-TO5	 vector.	 To	 induce	
autophagy	1	µM	Rapamycin	was	used	and	100	nM	BafilomycinA1	to	block	autophagic	flux.	Reliable	
autophagy	 markers,	 like	 LC3	 and	 Sqstm1/p62,	 show	 upregulated	 levels,	 when	 cells	 were	
transfected	with	Mettl21c.	The	expression	of	VCP	was	not	altered.	
To	 further	 evaluate	 the	 function	 of	 Mettl21c	 cultivated	 C2C12	 myoblasts	 were	 transient	
transfected	 with	 a	 Mettl21c-Flag	 fusion	 construct.	 After	 transfection	 of	 Mettl21c	 and	 the	
corresponding	 empty	 control	 vector,	 the	 C2C12	 cells	 were	 treated	 with	 Rapamycin	 to	 induce	
autophagy.	In	addition,	Bafilomycin	was	used	to	increase	the	pH	of	the	lysosome,	thereby	blocking	
the	autophagy	flux.	All	cells	were	transfected	with	GFP	to	ensure	same	levels	of	protein	content	in	
the	 cell.	 The	 transfection	 experiments	 revealed	 that	 cells	 transfected	with	Mettl21c	 and	 treated	
with	Rapamycin	have	increased	levels	of	the	autophagy	markers	LC3	and	Sqstm1.	In	contrast,	VCP	
was	 not	 altered	 upon	 Mettl21c	 transfection	 and	 autophagy	 induction.	 Similarly,	 simultaneous	
incubation	 of	 Rapamycin	 and	 Bafilomycin	 lead	 to	 an	 upregulation	 of	 LC3	 and	 Sqstm1	 in	 the	
Chapter	3	|	Results	
88	
	
presence	 of	 Mettl21c	 (Figure	 32).	 Taken	 together,	 the	 cell	 culture	 experiments	 suggest	 that	
expression	 of	 Mettl21c	 increases	 the	 levels	 of	 LC3	 and	 Sqstm1	 and	 thereby	 regulates	 the	
autophagic	flux.		
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4.	Discussion	
	
4.1.	Protein	methylation	in	skeletal	muscle	
Reversible	 post-translational	 modifications	 (PTM)	 modulate	 several	 cellular	 processes,	 including	
cell	 proliferation,	 intracellular	 cell	 signaling,	 metabolic	 activity	 and	 even	 muscle	 contraction.	
Clearly,	the	mapping	of	global	phosphorylation	pattern	by	mass	spectrometry	helped	tremendously	
to	understand	signaling	events	under	regular	and	pathological	conditions.	Another	PTM,	which	was	
initially	 identified	 to	 be	 important	 for	 epigenetic	 regulation	 of	 histone	 molecules,	 is	 the	
methylation	 of	 arginine	 and	 lysine	 residues.	 Previous	 studies	 proved	 that	 several	 non-histone	
proteins	are	strongly	methylated.	Such	mono-,	di-	or	trimethylation	on	arginine	and	lysine	residues	
are	known	to	modulate	protein-protein	interactions	as	well	as	enzymatic	activities	[92,	116-118].		
The	 skeletal	 muscle	 is	 a	 highly	 dynamic	 organ,	 which	 can	 rapidly	 adapt	 to	 force	 demands,	
nutritional	 status	 and	 other	 environmental	 changes.	 The	 skeletal	 muscle	 is	 characterized	 by	 a	
heterogeneous	 composition	 of	 fiber-types	with	 distinct	metabolic	 activities.	Notably,	 it	 has	 been	
shown	that	not	only	the	expression	of	specific	slow	and	fast	MyHC	molecules	classify	muscle	fibers,	
but	 a	 complex	 expression	 pattern	 of	 different	 classes	 of	 proteins,	 including	metabolic	 enzymes,	
signaling	and	structural	proteins.	Recently,	 it	has	been	described	that	extensive	post-translational	
modifications	determine	the	ability	of	skeletal	muscle	fibers	to	undergo	adaptive	changes	[19,	208].	
Until	now	more	than	hundred	thousand	phosphorylation	sites	on	serine,	threonine,	and	tyrosine	on	
skeletal	 muscle	 proteins	 were	 mapped	 by	 mass	 spectrometry	 and	 there	 is	 also	 an	 increasing	
number	for	the	identification	of	ubiquitination	and	acetylation	sites.		
Although	protein	methylation	was	 identified	about	 the	time	as	phosphorylation,	 the	number	and	
understanding	 of	 methylation	 of	 non-histone	 proteins	 is	 still	 in	 its	 infancy.	 Recently,	 the	
understanding	of	enzymes	that	catalyze	the	transfer	of	methyl	groups	from	S-adenosylmethionine	
(SAM)	 to	 DNA,	 RNA,	 proteins,	 lipids	 and	 small	molecules	 has	 greatly	 expanded	 and	most	 of	 the	
knowledge	 originates	 from	 epigenetics	 studies	 [183].	 Strikingly,	 the	 development	 of	 antibodies	
directed	 against	 protein	 methylation,	 peptide	 arrays,	 and	 mass	 spectrometry	 resulted	 in	 the	
identification	of	many	“non-histone”	methylation	sites	on	arginine	and	 lysine	 residues	within	 the	
mammalian	 proteome.	 Until	 now	 ~3097	 sites	 were	 annotated	 in	 common	 databases	
(www.phosphosite.org;	December	2015)	but	this	number	of	identified	methylation	sites	most	likely	
represents	only	the	tip	of	the	iceberg	[209-213].		
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However,	the	function	and	dynamic	regulation	for	most	of	the	protein	methylation	events	is	poorly	
understood.	One	example	for	a	known	function	is	the	methylation	of	specific	lysine	residues	of	the	
tumor	suppressor	p53.	Besides	the	known	functions	of	several	phosphorylation,	ubiquitination	and	
acetylation	 sites,	 it	has	been	 shown	 that	methylation	enhances	or	 suppresses	 the	activity	of	p53	
during	tumorigenesis	[116,	117].	The	Set	and	MYND	domain	containing	protein	2	(SMYD2)	is	mainly	
responsible	 for	 p53	 methylation	 [214].	 This	 enzyme	 falls	 into	 the	 Class	 VI	 SET	 domain	
methyltransferases.	 In	 addition,	 Smyd2	 has	 an	 intriguing	 function	 in	 the	 cytoplasm	 of	 skeletal	
myocytes,	 where	 it	 methylates	 the	 chaperone	 Hsp90	 which	 promotes	 the	 interaction	 between	
Hsp90	and	the	N2A	domain	of	titin	[92].		
Another	 important	 protein	 regulating	 a	 wide	 range	 of	 physiological	 processes	 throughout	
eukaryotic	 organisms	 is	 Calmodulin,	 a	 key	 mediator	 of	 the	 calcium-dependent	 signaling,	 which	
plays	 an	 important	 role	 in	 skeletal	muscle	 excitation.	 Several	 studies	 showed	 that	 Calmodulin	 is	
modulated	by	many	 regulatory	post-translational	modifications,	 including	a	 trimethylation	of	 the	
lysine-115	residue	[102,	123,	124].	It	has	been	shown	that	the	trimethylation	of	Calmodulin	results	
in	the	regulation	of	certain	enzymes	such	as	the	NAD	kinase	[124,	215-217]	and	the	trimethylation	
of	Calmodulin	controls	the	protein	turnover	rate	via	the	ubiquitin-dependent	degradation	pathway	
[218,	219].	
In	comparison	 to	other	post-translational	modifications,	 the	 function	of	methylation	 is	not	based	
on	 a	 charge	 change	 and	 the	mono-,	 di-,	 and	 trimethylation	 causes	 only	 a	 14,	 28	 or	 42	 Da	mass	
increase	 of	 a	 protein,	 respectively.	 Nevertheless,	 methylation	 on	 arginine,	 lysine,	 and	 the	 N-
terminus	 induces	 a	 wide	 range	 of	 protein	 changes.	 For	 example,	 protein	 methylation	 is	 closely	
associated	 with	 other	 PTMs	 and	 there	 is	 an	 obvious	 crosstalk	 to	 dynamic	 ubiquitination	 and	
phosphorylation	 sites	 [209,	 220,	 221].	 Furthermore,	 protein	 methylation	 can	 create	 a	 binding	
surface	 to	 recruit	other	proteins,	 thereby	 regulating	protein	complexes	and	networks	 [222,	223].	
Thus,	“methyl	switches”	are	important	to	modulate	signals	at	neighboring	amino	acids	and	act	as	
regulators	for	DNA	binding	[88,	224].		
In	a	global	SILAC-based	quantitative	proteome	screen	comparing	differentially	 regulated	proteins	
between	slow	(soleus)	and	fast	(EDL)	muscle	types,	the	Methyltransferase-like	21c	was	identified	as	
an	 abundant	 protein	 with	 high	 expression	 in	 the	 slow-twitch	 muscle	 [19].	 This	 led	 to	 the	
assumption	 that	 this	 methyltransferase	 acts	 as	 a	 regulator	 for	 slow-twitch	 muscle	 function	 and	
identity.	The	aim	of	this	study	was	to	examine	the	role	for	Mettl21c	in	global	muscle	homeostasis	in	
living	mice.	Since	Mettl21c	is	mainly	expressed	in	slow-twitch	muscle	fibers,	where	it	interacts	with	
autophagic	 adaptor	proteins,	 this	 study	 focused	on	 the	 investigation	of	 how	Mettl21c	 associates	
muscular	 strength	 with	 vesicular	 trafficking	 and	 autophagic	 flux.	 Clearly,	 the	 proper	 balance	 of	
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autophagy	is	a	nodal	point	for	optimal	muscle	function	and	there	are	several	hints	that	changes	in	
the	autophagy	flux	are	mediators	for	severe	human	muscle	diseases.		
Taken	together,	the	aforementioned	examples	emphasize	that	methylation	of	non-histone	proteins	
is	an	important	tool	for	cells	to	modulate	protein-protein	interactions,	protein	stability,	and	activity	
under	regular	and	pathophysiological	conditions.		
	
4.2.	 Bioinformatic	 analysis	 associates	 Mettl21c	 to	 cytoplasmic	
Class	I	methyltransferases		
Mettl21c	 belongs	 to	 a	 small	 subfamily	 of	 four	 highly	 homologous	 (30-50%	 sequence	 homology)	
uncharacterized	 putative	 methyltransferases	 (MTases),	 designated	 Mettl21a	 –	 Mettl21e.	 The	
family	members	belong	to	Class	I	methyltransferases,	which	contain	a	canonical	Rossmann-fold-like	
bundle	of	seven-beta-strands	and	display	four	characteristic	conserved	sequence	motifs	denoted	as	
Motif	 1,	 Motif	 Post	 1,	 Motif	 2	 and	 3.	 The	 crystal	 structure	 of	 human	 METTL21C	 (PDB:	 4mtl)	
revealed	 that	 it	 consists	of	a	 seven-stranded	beta-sheet	adjoined	by	 five	alpha	helices.	The	small	
cofactor	 SAM	 binds	 in	 the	 deep	 cleft	 resulting	 from	 the	 beta-sheet	 which	 contains	 a	 central	
topology	 switch	 point.	 All	 SAM-dependent	 methyltransferases	 show	 a	 structurally	 conserved	
binding	domain	consisting	of	 two	conserved	 regions.	First,	 the	conserved	Motif	1,	which	displays	
the	sequence	GxGxG	(in	Mettl21c	GAGAG)	localized	at	the	end	of	the	first	beta	strand,	proved	to	be	
important	 for	 binding	 of	 the	 carboxypropyl	 part	 of	 SAM	 [191].	 Mutation	 of	 the	 glycines	 (G104,	
G106,	 G108)	 into	 alanines	 results	 in	 impaired	 SAM	 binding	 and	 hence	 inactivates	 the	 enzyme.	
However,	 until	 now	 the	 methyltransferase	 activity	 of	 Mettl21c	 was	 only	 shown	 by	 lysine-
automethylation	[3].	In	addition,	all	Mettl21c	orthologues	contain	a	conserved	DXXY	motif	located	
C-terminal	 to	Motif	 2.	 The	 conserved	acidic	 residue	aspartate	 forms	one	hydrogen	bond	 to	each	
hydroxyl	of	the	SAM	ribose	part	[225]	and	a	mutation	in	these	regions	would	lead	to	a	catalytically	
inactive	enzyme.	Although	the	Mettl21c	protein	structure	suggests	a	potential	 lysine	and	arginine	
methylation	activity,	the	physiological	function	and	protein	targets	for	most	of	the	Mettl21	family	
members	are	completely	unknown.		
Identification	 of	 specific	 substrates	 and	 the	 structural	 analysis	 of	 the	 complex	 with	 the	 specific	
methyltransferase	 will	 reveal	 the	 requirements	 for	 methyl	 transfer	 and	 explain	 substrate	
specificity.	Many	of	the	amino	acids	directly	involved	in	substrate	binding	are	conserved	within	the	
Mettl21	 family.	However,	 the	 analysis	 of	 alterations	 in	 the	 amino	acid	 composition	of	 the	 active	
site	 might	 help	 to	 determine	 the	 diverse	 substrate	 specificities,	 which	 seem	 to	 be	 at	 least	
chemically	and	functionally	related.	
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4.3	Mettl21c	is	localized	within	Z-disk	structures	of	skeletal	muscle	
fibers		
A	recent	study	reported	that	overexpressed	Flag-tagged	Mettl21c	is	predominantly	localized	within	
the	nucleus.	However,	none	of	the	four	main	histones	seems	to	be	methylated	by	Mettl21c	[2]	and	
the	 observations	 made	 in	 this	 study	 revealed	 a	 pan-cellular	 localization	 of	 transiently	
overexpressed	 Flag-tagged	 Mettl21c	 in	 C2C12	 myoblasts	 and	 U2OS	 cells.	 Moreover,	 protein-
protein	 interaction	 studies	 detected	 several	 cytoplasmic	 proteins,	 indicating	 a	 localization	 of	
Mettl21c	 in	 the	cytoplasm.	 In	addition,	 immunohistochemistry	using	a	human	Mettl21c	antibody	
and	confocal	microscopy	revealed	the	endogenous	localization	in	human	skeletal	muscle	fibers.	Co-
immunostainings	for	Mettl21c,	the	M-line	protein	Myomesin	and	the	Z-disk	protein	alpha-Actinin	2	
indicated	 that	 Mettl21c	 is	 mainly	 localized	 in	 the	 Z-disk	 as	 it	 co-localizes	 with	 alpha-Actinin	 2.	
Moreover,	Mettl21c	positive	areas	were	also	observed	next	to	the	Z-disk	in	the	I-band.	The	Z-disk	is	
responsible	 for	 force	 reception,	 transduction,	 transmission	 and	 acts	 as	 a	 sensor	 for	 mechanical	
stress,	 redirecting	 chemical	 signals.	 The	 I-band	 is	 near	 the	 edge	 of	 the	 sarcomere	 and	 contains	
mainly	 thin	 filaments.	 It	 has	 been	 shown	 that	 Z-disk	 proteins	 are	 involved	 in	 signaling	 processes	
and	mutations	 of	 Z-disk	 proteins	 have	 been	 linked	 to	many	myofibrillar	 myopathies	 [226,	 227].	
Thus,	 protein	 methylation	 of	 Z-disk	 proteins	 might	 be	 a	 novel	 mechanism	 to	 modulate	 muscle	
activity	 and	 protein	 homeostasis	 as	 it	was	 shown	 for	 the	methyltransferase	 Smyd2.	 In	 a	 current	
study	it	was	postulated	that	endogenous	Smyd2	and	titin	N2A-domain	colocalize	in	cardiomyocytes	
with	methylated	Hsp90	in	the	Z-disk/I-band,	whereas	non-methylated	Hsp90	is	mainly	localized	in	
the	 cytoplasm	 [228].	Whether	Mettl21c	 shuttles	between	Z-disk	and	 I-band	 structures	 should	be	
investigated	 by	 future	 experiments.	 However,	 keeping	 in	 mind	 that	 the	 Z-disk	 is	 a	 high-density	
protein	region	that	might	result	 in	staining	artefacts,	a	careful	evaluation	of	Mettl21c	 localization	
with	 alternative	 methods,	 including	 biochemical	 fractionation	 and	 other	 imaging	 approaches,	
appears	mandatory.		
	
4.4.	Deficiency	of	slow-muscle	specific	Mettl21c	results	in	reduced	
muscle	performance		
To	characterize	the	function	of	Mettl21c	more	in	detail,	the	gene	was	inactivated	in	the	mouse	by	
homologous	 recombination.	 The	 gene	 inactivation	 strategy	 did	 also	 introduce	 a	 reporter	 for	 the	
Mettl21c	 gene	 activity	 (LacZ	 cassette)	 into	 the	 Mettl21c	 locus.	 Comparison	 of	 wild	 type	 and	
Mettl21c	deficient	animals	revealed	no	alterations	in	body	weight,	locomotor	behavior,	and	fertility	
under	baseline	conditions.	Morphometric	analysis	of	several	muscle	tissues	revealed	no	changes	of	
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muscle	 size	 and	 muscle	 weight,	 indicating	 that	 Mettl21c	 is	 dispensable	 for	 skeletal	 muscle	
development.		
Co-localization	 experiments	 with	 slow	 MyHC	 I	 (gene	 Myh7)	 and	 X-Gal	 staining	 showed	 that	
Mettl21c	is	mainly	expressed	in	slow-twitch	muscle	fibers.	Interestingly,	although	the	heart	muscle	
is	 also	 a	 “slow”	muscle,	Mettl21c	 is	 not	 expressed	 in	 heart	muscle	 or	 any	 other	muscle	 related	
tissue,	 including	 smooth	muscle,	 suggesting	 that	Mettl21c	 has	 primary	 a	 function	 in	 slow	 fibers.	
Since	Mettl21c	is	mainly	expressed	in	slow	fibers	all	subsequent	experiments	were	performed	with	
the	 slowest	 mouse	 muscle,	 the	 soleus,	 which	 contains	 ~45%	 slow	 type	 I	 fibers.	 Surprisingly,	
inactivation	 of	Mettl21c	 did	 not	 result	 in	morphological	 changes,	 including	 fiber	 diameter,	 fiber-
type	composition,	and	extracellular	matrix	proteins	of	the	soleus	muscle.		
Oxidative	 slow-twitch	muscles	 are	mainly	 involved	 in	 posture	 and	 endurance	 performance.	 Slow	
fibers	 have	 an	 increased	 level	 of	 mitochondria	 and	more	myoglobin	 for	 oxygen	 transport.	 Slow	
fibers	also	express	higher	 levels	of	heat	 shock	proteins	 to	 cope	with	 increased	metabolic	activity	
and	higher	 levels	of	 reactive	oxygen	 species.	 Similar	 to	SETD1A	and	SMYD2	 function,	 it	might	be	
possible	that	Mettl21c	is	associated	to	chaperone	functions	to	deal	with	the	higher	cellular	stress	in	
slow	fibers	compared	to	fibers	with	 lower	metabolic	activity	 [92,	131].	One	of	 the	key	findings	 in	
this	study	was	that	Mettl21c	deficient	mice	showed	a	reduced	running	capacity	 in	comparison	to	
their	 wild	 type	 littermates.	 Forced	 high-impact	 treadmill	 running	 and	 the	 moderate	 intensity	
voluntary	 wheel	 running	 experiments	 revealed	 a	 significant	 reduction	 of	 more	 than	 50%	 in	
endurance	 capacity	 of	 Mettl21c	 deficient	 animals.	 Heterozygous	 mice	 having	 only	 one	 allele	 of	
Mettl21c	showed	a	weak	dose-dependent	effect.		
The	 soleus	muscle	 acts	 as	 an	 important	 antigravity	muscle	 in	 the	 leg	 and	due	 to	 the	 anatomical	
distribution	of	these	slow	muscles	it	is	assumed	that	they	might	acts	as	a	neutral	alignment	of	the	
hindlimb	 extremity.	 It	 is	 proposed	 that	 slow	 muscles	 reduce	 the	 fatigue	 in	 adjacent	 larger	 fast	
skeletal	muscles	 and	ensure	 the	physical	 rest	 for	 situations,	when	powerful	 bursts	 of	movement	
are	needed	[229].	It	is	worth	questioning	whether	changes	in	a	rather	small	population	of	fibers	can	
affect	the	global	muscle	performance.	Earlier	experiments	showed	that	already	a	slight	transition	
from	fast-	to	slow-twitch	fibers	can	increase	the	resistance	to	fatigue	[230,	231].	For	example,	mice	
lacking	 PGC-1alpha	 showed	 a	 decrease	 of	 endurance	 exercise	 capacity	 and	 resistance	 to	 fatigue	
[232].		
A	 reduced	muscle	 performance	 is	 tightly	 associated	with	 a	 potential	 imbalance	 of	 catabolic	 and	
anabolic	processes.	The	equilibrium	between	protein	synthesis	and	protein	breakdown	is	vital	for	
all	cells	and	is	controlled	by	several	cellular	systems.	For	example,	the	ubiquitin-proteasome	system	
(UPS)	 regulates	 the	 elimination	 of	 single	 proteins	 and	 smaller	 aggregates	 by	 hydrolysis	 in	 the	
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proteasome.	 The	autophagosomal-lysosomal	pathway	 is	 able	 to	 clear	entire	organelles	 and	 large	
protein	 aggregates	 [28].	 An	 unbalanced	 regulation	 of	 the	 autophagic	 flux	 is	 detrimental	 for	 the	
global	 homeostasis	 of	 skeletal	 muscles	 under	 regular	 and	 workload	 conditions.	 Moreover,	
autophagy	is	important	for	the	maintenance	of	exercise	capacity.	Reduced	or	excessive	autophagy	
results	 in	several	muscle	diseases	with	reduced	physiological	capacity	[8-10].	Mettl21c	appears	to	
be	pivotal	for	the	molecular	homeostasis	in	slow-twitch	skeletal	muscle	fibers	and	consequently	for	
the	maintenance	of	a	physiological	balance	between	endurance	and	muscle	 fatigue.	Thus,	 future	
experiments	to	elucidate	whether	Mettl21c	expression	is	induced	by	exercise	would	help	to	better	
understand	the	function	of	this	new	protein.		
Thus,	 identification	of	Mettl21c	targets	that	promote	skeletal	muscle	homeostasis	would	increase	
our	understanding	how	metabolic	and	contractile	properties	of	muscle	 fibers	are	co-regulated.	A	
potential	mechanism	might	be	that	slow	fibers	deficient	for	Mettl21c	influence	other	fibers	by	the	
release	 or	 receipt	 of	 myokines	 as	 it	 was	 shown	 that	 autophagy	 is	 important	 for	 endosome	
trafficking	and	some	forms	of	exo-and	endocytosis	[233].		
	
4.5.	EM	analysis	reveals	massive	accumulation	of	multivesicular	
autophagosomes	and	vacuoles	
An	 assessment	 of	muscle	 biopsy	 on	 electron	microscopy	 enables	 a	 definite	 diagnosis	 of	 several	
muscular	disorders.	Since	the	analysis	with	a	confocal	microscope	did	not	show	any	morphological	
changes	between	control	and	Mettl21c	deficient	muscle	sections,	a	more	comprehensive	analysis	
with	 a	 transmission	 electron	 microscope	 of	 soleus	 muscle	 sections	 from	 30-	 and	 94-week	 old	
Mettl21c-/-	 mice	 were	 performed.	 Notably,	 the	 Mettl21c	 deficient	 soleus	 muscles	 displayed	 an	
accumulation	of	multivesicular	autophagosomes	and	vacuoles	indicating	a	dysregulation	of	protein	
degradation	via	the	autophagosomal-lysosomal	system.	The	enhanced	accumulation	of	autophagic	
vacuoles	might	 also	 reflect	 increased	 cellular	oxidative	 stress,	 since	pathological	 accumulation	of	
autophagic	 vacuoles	has	been	 implicated	 in	 several	human	diseases,	 including	ALS	 [5],	 lysosomal	
storage	 diseases	 [234],	 IBMPFD	 [235],	 and	 muscular	 dystrophies	 [234,	 236-238].	 Importantly,	
autophagosomes	are	not	detectable	under	regular	steady-state	conditions	in	muscle	fibers.	There	
are	 two	 main	 groups	 of	 autophagic	 vacuolar	 myopathies	 including	 lysosomal	 myopathies.	 One	
group	 shows	 primary	 defects	 in	 lysosomal	 proteins	 including	 Pompe	 and	 Danon	 disease.	 In	
contrast,	 autophagic	 vacuoles	 in	 rimmed	 vacuolar	 myopathies	 are	 caused	 by	 extra-lysosomal	
defects	 and	 are	 usually	 observed	 at	 later	 stages	 of	 the	 disease.	 This	 group	 includes	 sporadic	
inclusion	body	myositis	(sIBM)	and	myofibrillar	myopathies.	Thus,	the	analysis	of	the	ultrastructure	
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of	 Mettl21c	 deficient	 skeletal	 muscle	 tissue	 revealed	 a	 potential	 association	 to	 autophagy	
processes	reflected	by	the	accumulation	of	multivesicular	autophagosomes.		
	
4.6.	 Global	 proteome	 analysis	 revealed	 association	 to	 autophagy	
pathways	
In	order	 to	verify	a	potential	dysregulation	of	autophagic	pathways,	a	quantitative	 transcriptome	
and	 proteome	 analysis	 of	 the	 soleus	 muscle	 from	 control	 and	 Mettl21c	 deficient	 animals	 was	
conducted.	 The	 initial	 immunohistochemical	 experiments	 showed	 equal	 fiber-type	 compositions	
between	control	and	Mettl21c	deficient	muscles.	 In	 line	with	 these	 results	 the	quantitative	mass	
spectrometric	 analysis	 of	 MyHC	 proteins	 using	 only	 unique	 peptides	 for	 the	 different	 Myosin	
isoforms	confirmed	this	 trend.	However,	 the	 fast	myosin	heavy	chain	MyHC	 IIb	 (gene	Myh4)	was	
upregulated	on	the	transcript	and	protein	level	in	Mettl21c	deficient	fibers	compared	to	wild	type	
fibers.	 The	 identification	 of	 quantitative	 differences	 of	MyHC	 compositions	 in	Mettl21c	mutants	
might	reflect	the	high	sensitivity	of	transcriptomic	and	proteomic	approaches	which	is	not	reached	
by	immunohistochemistry.		
The	 fastest	 Myosin,	 Myh4,	 is	 optimized	 for	 maximal	 strength	 and	 speed.	 Hence,	 increased	
expression	 of	 Myh4	 in	 slow	 muscle	 fibers	 might	 reduce	 endurance.	 Strikingly,	 under	 basal	
conditions	the	type	IIb	Myh4	is	barely	detectable	in	slow	soleus	muscle	and	it	has	been	shown	that	
unweighting	 the	 soleus	 hindlimb	 by	 suspension	 or	microgravity	 results	 in	 slow	 to	 fast	 fiber-type	
conversion,	 with	 de	 novo	 expression	 of	 the	 Myh4	 isoform	 mRNA	 [239-241].	 The	 expression	 of	
myosin	 isoforms	 in	 muscle	 is	 mainly	 regulated	 by	 transcriptional	 control	 [242]	 and	 the	
understanding	 how	 myofilament	 proteins	 are	 modulated	 by	 post-translational	 protein	
modifications	just	emerges	[243-245].	For	example,	a	previous	study	showed	that	fast	fibers	have	
higher	phosphorylation	levels	in	order	to	counteract	the	quick	reduction	of	force	that	is	followed	by	
contractile	activity	[243].	Hence,	methylation	is	described	as	a	modification	with	a	slower	turnover	
than	 other	 post-translational	 modifications.	 The	 physiological	 relevance	 might	 be	 a	 long-term	
regulation	to	maintain	the	endurance	phenotype	of	slow	type	I	 fibers	[246].	The	mechanism	how	
Mett21c	suppresses	the	Myh4	gene	expression	or	protein	abundance	is	completely	unknown.		
Previously,	 systematic	 proteo-genomic	 experiments	 showed	 only	 a	 weak	 correlation	 between	
global	 gene	 expression	 patterns	 and	 protein	 abundances,	 reflecting	 the	 existence	 of	 post-
transcriptional	 and	 post-translational	 regulatory	mechanisms.	Here,	 the	 comparison	of	 transcript	
and	 protein	 levels	 of	 the	 soleus	muscle	 from	wild	 type	 and	Mettl21c	 deficient	 mice	 revealed	 a	
Pearson	correlation	of	0.29.	 Similar,	 a	 recent	global	 analysis	of	 transcript-protein	 relationships	 in	
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liver	 tissue	 of	 different	 inbred	 strains	 of	 mice	 with	 a	 variety	 of	 gene	 mutations,	 reported	 a	
correlation	between	transcript	and	protein	 levels	of	0.27,	which	varied	depending	on	the	cellular	
location	and	the	biological	function	of	the	gene	[247].	This	indicated	that	the	knowledge	of	protein	
levels	 is	 essential	 to	 estimate	 the	 real	 protein	 concentrations	 under	 regular	 and	 perturbed	
conditions.	 In	addition	to	the	different	regulatory	stages	of	transcriptome	and	proteome,	the	 low	
correlations	can	also	occur	due	to	different	technical	procedures.	
The	 combined	proteo-genomic	 analysis	 revealed	 an	overlap	 of	 2534	proteins	 from	 soleus	 tissue.	
Only	 a	 minor	 fraction	 of	 15	 proteins	 were	 equally	 and	 significantly	 regulated	 on	 transcript	 and	
protein	level	between	Mettl21c-/-	and	control	mice.	Since	the	mouse	soleus	muscle	contains	equal	
numbers	of	fast	and	slow	fibers	a	complete	lysis	will	most	likely	dilute	a	potential	phenotype	in	one	
of	the	fiber-types,	respectively.	Thus,	to	avoid	a	potential	contamination	of	proteins	derived	from	
fast	type	II	fibers,	the	soleus	of	heterozygous	(Mettl21c/LacZ)	and	homozygous	(LacZ/LacZ)	animals	
were	separated	by	collagenase	digestion	and	individual	fibers	were	stained	according	to	their	beta-
galactosidase	activity.	Notably,	the	collection	of	~30	LacZ	positive	fibers	is	sufficient	to	perform	an	
in-depth	 quantitative	 proteome	 analysis.	 Of	 note,	 this	 approach	 depends	 on	 LacZ	 positive	 fibers	
and	 wild	 type	 fibers	 without	 LacZ	 activity	 cannot	 be	 used	 as	 controls.	 However,	 heterozygous	
Mettl21c	 mice	 are	 very	 similar	 to	 wild	 type	 controls	 and	 show	 only	 a	 very	 mild	 phenotype	
concerning	reduced	voluntary	running	activity,	which	qualifies	them	for	a	control.		
The	 mass	 spectrometric	 analysis	 of	 isolated	 type	 I	 soleus	 fibers	 from	 hetero-	 and	 homozygous	
animals	 allowed	 a	 more	 focused	 view	 on	 the	 effects	 of	 Mettl21c	 deficient	 type	 I	 fibers.	
Interestingly,	 the	 inactivation	 of	Mettl21c	 resulted	 in	 reduced	 levels	 of	many	 autophagy-related	
proteins,	including	the	BCL2/Adenovirus	E1B	19kDa	Interacting	Protein	3	(Bnip3)	[28],	the	striated	
muscle-specific	tripartite	motif	(TRIM)	protein	54	(also	known	as	Murf3)	[200]	and	the	collagen	6aII	
(Col6a2)	 [8].	 These	 candidates	 were	 not	 significantly	 regulated	 when	 comparing	 intact	 soleus	
muscles	 from	 wild	 type	 and	 Mettl21c	 deficient	 mice.	 However,	 a	 direct	 association	 of	 those	
autophagy-related	proteins	 to	 the	Mettl21c	methyltransferase	activity	 is	difficult,	 since	 there	are	
no	 techniques	 available	 to	 conduct	 an	 in-depth	 enrichment	of	methylated	proteins.	 Thus,	 future	
experiments	 with	 endogenous	 antibodies	 directed	 against	 Mettl21c	 and	 immunoprecipitations	
after	 induction	of	 autophagy	will	 help	 to	 identify	whether	 those	 candidates	 are	direct	 targets	 of	
Mettl21c.		
Taken	 together,	 the	 fiber-selective	 proteome	 provides	 a	 valuable	 approach	 for	 a	 more	 focused	
analysis	 of	 specific	 fiber-types.	 Analysis	 of	 the	 proteome	 of	 Mettl21c	 mutants	 suggests	 a	 close	
association	of	Mettl21c	with	autophagy	marker	proteins.	Moreover,	Mettl21c	is	a	novel	marker	for	
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slow	type	I	fibers	and	the	Mettl21c	expression	can	be	used	as	a	reporter	for	other	mouse	models	
with	a	type	I	fiber	dependent	muscle	phenotype.		
	
4.7.	Protein-protein	interaction	studies	unraveled	a	Mettl21c–VCP	
interaction	
The	reduced	muscle	activity,	the	increased	number	of	autophagosomes,	and	the	down	regulation	
of	 several	 autophagy	 marker	 proteins	 suggests	 a	 potential	 association	 of	 Mettl21c	 to	 protein	
degradation	mechanisms.	Thus,	a	systematic	identification	of	cofactors	and	substrates	for	Mettl21c	
would	help	to	uncover	the	function	of	this	novel	methyltransferase	within	the	complex	autophagy	
network.	Hence,	I	used	SILAC	based	quantitative	interactome	screenings	coupled	to	high-resolution	
mass	spectrometry	to	identify	potential	substrates	for	Mettl21c.	Immunoprecipitations	with	tagged	
Mettl21c	 fusion	 proteins	 identified	 the	 chaperone	 VCP	 (Valosin-containing-protein)	 as	 the	 most	
significant	 interactor.	 In	 addition,	 recombinant	 Flag-tagged	 Mettl21c	 protein	 isolated	 from	 HEK	
293T	cells	was	incubated	with	mouse	soleus	lysate	to	identify	potential	in	vivo	interaction	partners.	
Interestingly,	 these	experiments	 confirmed	 the	Mettl21c-VCP	 interaction	as	well	 as	 several	other	
proteasomal	 proteins,	 chaperones,	 and	heat	 shock	proteins.	 Proteasomal	 proteins	 are	 important	
for	protein	quality	control,	ensuring	polypeptide	processing,	facilitating	correct	protein	folding	and	
changing	 the	 physiological	 state	 of	 proteins.	 In	 addition,	 earlier	 experiments	 showed	 that	 the	
methylation	of	chaperones	can	modulate	protein	interaction,	activity,	stability	and	turnover	[248].	
Defects	 in	 the	 protein	 quality	 control	 system	 induce	 proteotoxic	 cell	 stress,	 which	 is	 especially	
detrimental	for	the	skeletal	muscle	homeostasis.	Important	catabolic	factors	for	the	balance	of	the	
homeostasis	 are	 the	 ubiquitin-proteasome	 and	 autophagy-lysosome	 systems	 together	 with	 the	
large	family	of	heat	shock	proteins	and	chaperons	[8,	28].	
It	has	been	shown	that	VCP	 is	an	 important	regulator	during	the	maturation	of	autophagosomes.	
Inactivation	of	VCP	results	in	a	defect	of	lysosomal	fusion	processes	and	results	in	an	accumulation	
of	Sequestosome-1/p62	 (Sqstm1)	positive	protein	aggregates	and	non-digested	autophagosomes,	
which	 are	 called	 rimmed	 vacuoles	 [70,	 235,	 249].	 Interestingly,	 in	 many	 immunoprecipitation	
experiments	from	this	study,	the	autophagic	cargo	protein	Sequestosome-1/p62	was	identified	as	a	
potential	interaction	partner	of	Mettl21c.		
So	 far,	 several	 human	 diseases	 have	 been	 associated	 with	 mutations	 of	 VCP,	 like	 the	 IBM,	 the	
IBMPFD	 [250,	 251],	 and	 ALS	 [252,	 253].	 The	 main	 characteristics	 of	 these	 diseases	 are	 muscle	
weakness	 and	 cognitive	 delay.	 VCP	 is	 an	 essential	 protein	 conserved	 throughout	 evolution	 from	
archaea	to	mammals	and	it	is	a	cytosolic	AAA-ATPase.	VCP	has	multiple	cellular	roles,	such	as	DNA	
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replication,	 mitosis,	 protein	 degradation,	 unfolded	 protein	 response,	 endocytosis,	 membrane	
fusion,	and	organelle	biogenesis	[72,	254].		
Notably,	 VCP	 activity	 is	 tightly	 regulated	 through	 cofactor	 and	 substrate	 binding	 [255-257].	 For	
example,	 under	 regular	 conditions	 NSFL1C	 binds	 to	 the	 N-terminal	 domain	 of	 VCP,	 reduces	 the	
diameter	of	the	p97	hexameric	ring	and	results	in	the	inhibition	of	the	ATPase	activity	[206,	207].	
N-ethylmaleimide-sensitive	 factor	 (NSF)	 is	 also	 an	 ATPase	 known	 to	 be	 involved	 in	 transport	
vesicle/target	membrane	fusion	and	fusions	between	membrane	compartments.	NSFL1C	binds	as	a	
trimer	to	the	hexamer	structure	of	cytosolic	VCP	and	is	required	for	VCP-mediated	remodeling	of	
Golgi	cisternae	from	mitotic	Golgi	fragments.		
In	 order	 to	 understand	 the	 Mettl21c	 dependent	 Vcp	 activity	 in	 more	 detail,	 Vcp	
immunoprecipitation	 experiments	 from	 mouse	 soleus	 lysate	 of	 Mettl21c-/-	 and	 wild	 type	
littermates	 were	 performed.	 Consistently,	 this	 reverse	 immunoprecipitation	 confirmed	 the	
interaction	 of	 Vcp	 and	 Mettl21c	 and	 showed	 in	 addition	 the	 interaction	 with	 Nsfl1c/p47.	
Interestingly,	the	Vcp-Nsfl1c	interaction	was	drastically	downregulated	in	Mettl21c	deficient	mice.	
Mutations	 in	 VCP	 are	 closely	 associated	 with	 the	 onset	 of	 pathological	 disorders	 by	 altering	 N-
domain	 and	 D1	 conformations	 and	 cause	 defects	 in	 interdomain	 communications	 between	 the	
neighboring	 subunits	 [258].	 This	 changes	 cofactor	 binding,	 leading	 to	 substrate	 accumulation,	
which	might	indicate	that	the	Mettl21c	dependent	methylation	coordinates	the	interaction	of	the	
Nsfl1c	trimer	and	Vcp	hexamer.	
Besides	VCP	mutations	resulting	in	enhanced	cofactor	binding,	there	are	also	VCP	mutant	variants,	
which	results	 in	a	 loss	of	 the	NSFL1C	 interaction.	For	example,	 the	P137L	mutant	of	VCP,	causing	
the	 onset	 of	 the	 pathology	 of	 IBMPFD	 patients,	 completely	 abolishes	 the	 VCP	 interactions	 with	
NSFL1C	and	also	other	known	interactors	like	Ufd1	and	Npl4	[259].	In	the	latter	case	it	is	assumed	
that	the	substrate	accumulation	resulted	 in	an	 impairment	of	 transferring	degradable	proteins	to	
the	proteasome	system	for	further	processing	[259].		
Thus,	 it	 seems	 that	 VCP	 interactions	 with	 its	 substrates	 and	 cofactors	 are	 dependent	 on	 post-
translational	modifications	and	 the	Mettl21c-promoted	 trimethylation	 suggest	 a	new	mechanism	
to	modulate	VCP	activity	under	regular	and	disease-related	conditions.		
	
Another	 important	 finding	 from	 the	 SILAC	 based	 quantitative	 interactome	 screenings	 was	 the	
interaction	 between	 Mettl21c	 and	 endogenously	 expressed	 Mettl21e,	 another	 member	 of	 the	
methyltransferase	21	family.	Due	to	the	low	Mettl21c	and	Mettl21e	expression	in	mammalian	cells,	
a	 co-expression	 of	 Flag-	 and	 HA-tagged	 fusion	 proteins	 was	 performed	 in	 HEK	 293T	 cells.	 The	
observation	that	Mettl21e	was	enriched	by	Mettl21c	immunoprecipitation	and	vice	versa	suggests	
a	 hetero-dimerization	 of	 these	methyltransferases.	 Uniprot	 Blast	 search	 analysis	 revealed	 a	 40%	
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sequence	homology	for	these	two	methyltransferases.	As	 indicated	from	biogps	data	(biogps.org)	
both	methyltransferases	 are	 exclusively	 expressed	 in	 skeletal	muscle	 tissue,	 suggesting	 a	 similar	
function	 within	 the	 skeletal	 muscle.	 A	 synergistic	 function	 has	 already	 been	 described	 for	 the	
mRNA	methylation	 by	Mettl3	 and	Mettl14	 [260],	 the	 DNA	methylation	 by	 Dnmt3a	 and	 Dnmt3b	
[223],	 and	 the	 protein	 methylation	 by	 Prmt1	 and	 Prmt4	 [261].	 Furthermore,	 the	 transcriptome	
analysis	revealed	enhanced	mRNA	levels	of	Mettl21e	in	Mettl21c	deficient	animals.	This	result	will	
be	further	validated	using	real-time	PCR	assays	in	future	experiments.		
It	 remains	 elusive,	 whether	 there	 is	 a	 functional	 cooperation	 between	 Mettl21c	 and	Mettl21e,	
which	 will	 provide	 an	 insight	 into	 the	 dynamic	methylome	 of	 different	muscle	 fiber-types	 [262-
264].	 Although	Mettl21c-/-	 animals	 showed	 only	 a	mild	 phenotype	 under	 regular	 conditions,	 the	
induction	of	 stress	 conditions	 like	physical	 exercise	and	atrophy	 revealed	 that	Mettl21e	 can	only	
partially	 compensate	 for	 the	 loss	 of	 Mettl21c.	 However,	 a	 simultaneous	 inactivation	 of	 both	
methyltransferases	 by	 homologous	 recombination	 would	 be	 challenging	 since	 both	 genes	 are	
localized	on	chromosome	1	in	200	kb	proximity.	Alternatively,	future	experiments	with	the	Crisper-
Cas	technology	inactivating	Mettl21e	in	a	Mettl21c-/-	background	will	help	to	investigate	a	potential	
functional	 compensation	 between	 both	 proteins.	 Taken	 together,	 the	 quantitative	 interactome	
studies	 showed	 a	 potential	 hetero-dimerization	 between	 two	 methyltransferases	 and	 depict	 a	
functional	role	of	Mettl21c	during	protein	degradation	in	slow	muscle	fibers	by	the	interaction	with	
the	known	autophagy	markers	Vcp,	Sqstm1	and	several	heat	shock	proteins.	
	
4.8.	Trimethylation	of	lysine-315	of	VCP	facilitates	cofactor	binding	
Coupling	in	vitro	methylation	assays	to	mass	spectrometry	allows	the	identification	of	methylated	
peptides	 by	 the	 characteristic	 multiple	 14	 Da	 mass	 shifts.	 As	 a	 novel	 finding	 the	 MTase	 assay	
showed	that	Mettl21c	does	not	only	interact	but	also	trimethylates	the	mammalian	VCP	on	lysine-
315	residue.	Notably,	VCP	methylation	was	reduced	when	using	a	SAM	binding	mutant	of	Mettl21c.	
The	 in	 vitro	 SAM	 assay	 for	 the	 potential	 interaction	 partners	 Sqstm1	 and	Mettl21e	 showed	 no	
methylation	sites	in	respect	to	the	controls,	indicating	that	Mettl21c	specifically	trimethylates	VCP.	
In	addition,	the	incubation	of	Mettl21e	and	VCP	did	not	show	any	methylated	peptides.	Although	it	
is	 possible	 that	 potential	Mettl21e	 dependent	methylation	 sites	 are	 not	 accessible	 for	 the	mass	
spectrometric	measurements,	 it	 is	 likely	 that	VCP	 is	not	a	 substrate	of	Mettl21e.	Alternatively,	 it	
might	be	possible	that	a	co-factor	for	Mettl21e	was	missing.	However,	the	combined	incubation	of	
Mettl21c	and	Mettl21e	did	not	enhance	the	methylation	of	VCP.		
It	 has	 been	 shown	 that	 the	 family	 member	METTL21D	 can	 trimethylate	 VCP	 and	 results	 in	 the	
reduction	of	the	ATPase	activity	[2,	3].	It	might	be	possible	that	VCP	is	methylated	by	tissue-specific	
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methyltransferases	 in	 order	 to	differentially	 regulate	 its	 cellular	 function.	 Since	VCP	 is	 expressed	
ubiquitously,	a	 tissue	specific	methylation	might	be	a	potential	 regulator	 for	 the	VCP	activity	[28,	
72].	 In	 addition,	 it	 has	 been	 reported	 that	 the	 deletion	 or	 the	 loss	 of	 function	 of	 VCP	 leads	 to	
disturbed	aggresome	formation	and	defects	in	the	degradation	pathways	[265-267].	Therefore,	the	
specific	 regulation	 by	 selective	 methylation	 might	 be	 the	 explanation	 for	 the	 varying	 effects	 in	
different	muscles	and	muscle	fiber-types	in	response	to	the	same	stimulus	[1,	268].		
	
Until	 now	 the	effect	of	 the	 trimethylation	on	 lysine-315	 for	 the	ATPase	activity	 is	 controversially	
discussed.	VCP	consists	of	two	ATPase	domains	(denoted	as	D1	and	D2)	and	an	N-terminal	adaptor	
domain	[269].	The	identified	trimethylation	site,	lysine-315,	lies	in	proximity	to	the	Walker	B	motif	
of	 the	 first	ATPase/D1	domain	[2].	A	recent	study	suggested	that	 the	trimethylation	mediated	by	
METTL21D	negatively	 impacts	 the	 activity	 of	 the	ATPase/D1	domain,	 but	 it	 had	no	effect	 on	 the	
activity	of	 the	ATPase/D2	domain	 [2].	Conversely,	 two	studies	 showed	no	changes	of	 the	ATPase	
activity	in	METTL21D	deficient	cells	compared	to	wild	type	control	cells	[3,	270].		
In	 the	 presented	 study	 the	 Vcp	 immunoprecipitation	 from	 Mettl21c	 deficient	 soleus	 muscles	
showed	 a	 clear	 reduction	 of	 Vcp	 trimethylation	 using	 a	 pan-trimethyl	 antibody.	 The	 remaining	
signal	 can	 be	 explained	 by	 the	 presence	 of	 other	 trimethylation	 sites	 on	 this	 protein	 or	 from	
trimethylated	Vcp	originating	from	fast	fibers	of	the	soleus	muscle.	It	was	shown	that	methylation	
leads	 to	 a	 modulation	 of	 cofactor	 and	 substrate	 binding	 [271,	 272].	 Hence,	 the	 reduced	
trimethylation	 of	 lysine-315	 of	 Vcp	 results	 in	 impaired	 function	 due	 to	 loss	 of	 the	 inhibitory	
Nsfl1c/p47	cofactor	binding	which	might	enhance	the	ATPase	activity	of	Vcp	in	disease	models	like	
IBMPFD.	 The	ATPase	 activity	 of	Vcp	 is	 the	primary	defect	 causing	 the	pathological	 phenotype	of	
accumulation	 of	 non-degradable	 proteins	 [11].	 Future	 aims	 are	 the	measurement	 of	 the	 ATPase	
activity	of	Vcp	and	the	correct	 formation	of	 the	hexameric	structure	of	Vcp	 in	Mettl21c	deficient	
mice	in	order	to	detect	the	in	vivo	effects	of	the	reduced	trimethylation	on	lysine-315.	
Another	 example	 for	 trimethylation	 is	 given	 by	 several	 human	HSP70	 (HSPA)	 proteins	which	 are	
trimethylated	by	METTL21A,	another	Mettl21	 family	member,	which	 regulates	 the	affinity	of	 the	
chaperone	for	the	monomeric	and	fibrillar	forms	of	the	Parkinson	disease	associated	protein	alpha-
synuclein.	This	chaperone-targeting	by	specific	methyltransferases	suggests	the	existence	of	a	post-
translational	modification	 code	 for	 chaperons	 that	 was	 termed	 “chaperone	 code”	 similar	 to	 the	
well-known	 “histone-code”.	 Thus,	 the	 functional	 characterization	 of	 methylation	 patterns	 on	
proteins	 involved	 in	 protein	 stability	will	 decipher	 the	 pathophysiological	mechanisms	 in	 several	
disease	 models.	 The	 reduced	 trimethylation	 on	 lysine-315	 of	 Vcp	 in	 Mettl21c	 deficient	 mice	
resulted	 in	 the	 loss	of	 cofactor	binding	and	 this	 suggests	 that	 the	 trimethylation	might	modulate	
the	ATPase	activity	of	Vcp.	
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4.9.	Accumulation	of	mitochondria	in	Mettl21c	deficient	mice	
Autophagy	 is	 an	 important	 mechanism	 to	 clear	 large	 protein	 aggregates	 and	 entire	 organelles,	
accompanied	 with	 an	 efficient	 recycling	 of	 amino	 acids	 [28].	 In	 contrast	 to	 the	 ubiquitin–
proteasome	 system,	 the	 formation	 of	 autophagosomes	 enables	 the	 cell	 to	 degrade	 whole	
mitochondria	and	the	depletion	of	those	structures.		
The	 quantitative	 proteome	 analysis	 comparing	Mettl21c-/-	 and	wild	 type	 littermates	 under	 basal	
conditions	 revealed	 a	 significant	 upregulation	 of	 several	 mitochondrial	 proteins,	 including	
mitochondrial	 core	 proteins	 of	 the	 oxidative	 phosphorylation	 complex	 as	 well	 as	 metabolic	
components.	Mitochondria	are	 crucial	 for	 aerobic	energy	production,	 regulation	of	 cell	 signaling,	
apoptosis	 and	 mitophagy.	 Thus,	 a	 correct	 balance	 between	 mitochondrial	 fusion,	 mixing	 of	
mitochondrial	 material	 and	 the	 division	 of	 mitochondria	 into	 smaller	 components	 (fission)	 is	
essential	 for	 the	 homeostasis	 and	 performance	 of	 the	 whole	 skeletal	 muscle	 tissue	 [273].	 A	
possible	 explanation	 for	 the	 accumulation	 of	 mitochondrial	 proteins	 in	 Mettl21c	 deficient	 mice	
might	 be	 a	 dysregulation	 in	 mitochondrial	 clearance	 processes.	 For	 example,	 the	 deletion	 of	
important	 autophagy	 key	 players	 shows	 dysfunctional	 elimination	 of	 aged	 and	 defective	
mitochondria	 [274,	 275].	 Alternatively,	 the	 reduced	 muscle	 performance	 in	 Mettl21c-/-	 animals	
might	 be	 compensated	 by	 an	 increased	 level	 of	 mitochondrial	 proteins.	 Thus,	 a	 reduced	
methylation	 of	 so	 far	 unknown	 target	 proteins	 may	 be	 responsible	 to	 regulate	 the	 dynamic	 of	
mitochondrial	 biogenesis	 and	 degradation.	 In	 order	 to	 assess	 mitochondrial	 ATP	 synthesis	
investigation	 of	 oxidative	 phosphorylation	 of	 intact	 cells	 or	 isolated	mitochondria	might	 help	 to	
explain	 the	 physiological	 relevance	 of	 Mettl21c	 for	 mitochondrial	 functions.	 However,	 Mettl21c	
expression	is	restricted	to	slow	fibers	and	the	isolation	of	mitochondria	from	intact	soleus	muscle	
will	result	in	many	mitochondria	from	fast	fibers,	which	do	not	express	Mettl21c.	Alternatively,	one	
could	 also	 isolate	 single	 fibers	 and	 measure	 first	 the	 mitochondrial	 respiration	 followed	 by	 the	
analysis	of	the	fiber-type	composition	by	single	fiber	proteomics.		
In	 contrast	 to	 the	 steady	 state	 situation,	 muscle	 atrophy	 induced	 by	 denervation,	 results	 in	 an	
enhanced	clearance	of	mitochondrial	proteins	in	Mettl21c	deficient	mice	compared	to	denervated	
control	 animals.	 This	 conflicting	 result	 might	 be	 caused	 by	 a	 different	 mechanism	 that	 allows	
mitochondria	to	commit	suicide	(termed	as	mitoptosis).	It	was	shown	that	mitoptosis	is	induced	by	
reactive	oxygen	species	 (ROS).	This	causes	an	opening	of	 the	permeability	 transition	pores	 in	 the	
inner	mitochondrial	membrane.	Massive	mitoptosis	can	result	in	apoptosis,	programmed	cell	death	
due	to	release	of	proapoptotic	proteins	from	the	mitochondrial	intermembrane	space	[276].		
	
In	addition,	cellular	stress	is	accompanied	with	an	enhanced	unfolded	protein	response	(UPR)	and	
ubiquitin	proteasome	system	(UPS)	activity.	Since	Vcp	 is	closely	associated	with	the	UPR	and	UPS	
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function,	 a	 reduced	 level	 of	 trimethylation	 in	 Mettl21c	 deficient	 animals	 might	 enhance	 the	
degradation	 of	mitochondria	 under	 denervated	 conditions.	 Reduced	 Vcp	 levels	 induce	 ER	 stress	
and	 increase	 the	 abundance	 of	 polyubiquitinated	 proteins	 [277].	 Although	 Vcp	 levels	 were	 not	
changed	 between	 control	 and	 Mettl21c-/-	 animals	 under	 regular	 and	 denervated	 conditions,	
reduced	 trimethylation	 might	 be	 responsible	 for	 the	 faster	 down	 regulation	 of	 mitochondrial	
proteins	 upon	 neuronal	 denervation.	 Thus,	 further	 analysis	 is	 required	 to	 elucidate	 the	 link	
between	Mettl21c	dependent	methylation	and	programmed	organelle	degradation	under	cellular	
stress	conditions.	
	
Another	 class	 of	 proteins,	 which	 was	 strikingly	 regulated	 upon	 denervation,	 were	 phagosomal	
proteins,	 such	 as	 V-type	 ATPases	 and	 proteins	 from	 the	 tubulin	 network.		
The	 acidic	 conditions	 in	 the	 autolysosome	 are	 provided	 by	 activation	 of	 hydrolases	 and	 are	
important	to	degrade	the	cargo	consisting	of	proteins	and	organelles.	To	produce	a	low	pH	within	
the	 lysosome	 the	activity	of	 several	ATP-dependent	proton	pump	V-ATPases	 is	essential	 and	 this	
macro-protein	complex	consists	of	eight	V1,	six	V0	and	two	accessory	subunits	[278].		
The	 presented	 study	 revealed	 a	 clear	 upregulation	 of	 7	 ATPase	 subunits	 upon	 sciatic	 nerve	
denervation	in	wild	type	mice,	whereas	Mettl21c-/-	mutants	do	not	respond	to	this	stimulus	and	the	
identified	 ATPase	 subunits	 were	 not	 upregulated.	 This	 suggests	 that	 the	 formation	 or	 correct	
function	of	autolysosomes	is	disturbed	in	the	absence	of	Mettl21c.	Although	it	is	long	known	that	
Vcp	 governs	 critical	 steps	 in	 the	 ubiquitin-dependent	 protein	 quality	 control	 like	 the	 delivery	 of	
protein	 substrates	 to	 the	 proteasome,	 recent	 finding	 now	 have	 uncovered	 that	 Vcp	 also	 fulfills	
important	functions	 in	the	autophagosomal-lysosomal	pathway.	One	key	step	in	autophagy	is	the	
lipidation	 of	 the	 ubiquitin-like	 modifier	 LC3/Atg8	 which	 decorates	 autophagosomal	 membranes.	
This	is	performed	with	the	help	of	autophagic	adaptor	molecules	like	Sqstm1	and	Nbr1,	which	link	
LC3	 to	 ubiquitin-labeled	 structures,	 thereby	 initiating	 the	 recruitment	 of	 autophagosomal	
membranes	 and	 engulfment.	 It	was	 shown	 that	 in	 patients	 carrying	 a	missense	mutation	 in	VCP	
suffers	 from	 impaired	 autophagy,	 causing	 an	 accumulation	 of	 SQSTM1	 and	 lipidated	 LC3,	 and	
inducing	LC3-positive	vacuoles	that	failed	to	mature	[279].		
Furthermore,	 in	 a	 recent	 study	 Johnson	 et	 al.	 gave	 insights	 into	 the	 molecular	 mechanism	
underlying	 the	 action	 of	 Vcp	 in	 the	 autophagy	 pathway.	 They	 used	 the	 fly	 muscle	 as	 a	 model	
organism	 and	 could	 show	 that	 lysosomes	 consist	 of	 a	 highly	 dynamic	 network	 of	 tubules	 that	
changes	 constantly	 upon	 a	 given	 stimuli.	 Reduced	 levels	 of	 Vcp	 resulted	 in	 impaired	 lysosomal	
vesicle	formation	and	this	implicates	that	the	AAA-ATPase	Vcp	is	a	key	player	for	the	dynamics	and	
integrity	 of	 the	 tubular	 lysosomal	 network.	 Vcp	 deficient	 flies	 show	 aggregates	 of	 damaged	
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proteins	and	their	ability	to	move	was	reduced	[71].	Although	the	quantitative	proteome	analysis	
revealed	no	changes	of	Vcp	 in	Mettl21c-/-,	 the	reduced	trimethylation	 in	the	absence	of	Mettl21c	
might	 be	 crucial	 for	 the	 activity	 of	 Vcp	 and	 hampers	 the	 formation	 and/or	 activity	 of	
autolysosomes.		
In	 order	 to	 investigate	 the	 impairment	 of	 autophagy	 induction	 upon	 denervation	 of	 Mettl21c-/-	
mice	in	more	detail,	the	lipid	association	of	the	autophagy	marker	protein	Microtubule-associated	
protein	 light	 chain	 3	 (LC3)	 was	 used	 for	 western	 blot	 analysis.	 During	 denervation-induced	
autophagy,	cytosolic	LC3	(LC3-I)	covalently	conjugates	to	phosphatidylethanolamine	to	generate	a	
lipidated	form	of	LC3	(LC3-II),	which	displays	a	higher	electrophoretic	mobility	and	is	 indicative	of	
autophagy	[280].	For	Mettl21c	deficient	mice,	immunoblot	analysis	revealed	a	significant	reduction	
in	 LC3-II	 levels	 compared	 to	 lipidated	 LC3-II	 levels	 in	 the	 denervated	 wild	 type	 situation.	 This	
indicates	a	reduced	induction	of	the	autophagic	process.	However,	a	direct	association	of	Mettl21c	
and	LC3	 is	not	known.	 Importantly,	 inactivation	of	key	players	of	 the	autophagosomal	biogenesis	
like	the	autophagy	related	protein	Atg7	also	abolishes	LC3	processing.	Atg7	 is	a	key	player	 in	 the	
biogenesis	 of	 autophagy	 and	 functions	 as	 an	 E1-like	 ligase,	 which	 conjugates	 Atg5	 to	 Atg12,	 a	
necessary	 step	 for	 the	 formation	 of	 a	 functional	 autophagosome.	 Furthermore,	 it	 converts	 LC3	
(Atg8)	 from	 an	 immature,	 cytosolic	 form	 to	 a	 mature	 autophagosomal	 membrane	 protein	 by	
adding	a	phosphatidylethanolamine	group	[281].		
While	 loss	 of	 function	 of	 Mettl21c	 in	 the	 mouse	 resulted	 in	 autophagic	 impairment,	 gain-of-
function-studies	 by	 overexpressing	 Mettl21c	 in	 HEK	 293T	 cells	 have	 also	 shown	 to	 modulate	
autophagy.	 In	 this	 complementary	 cell	 culture	assay,	 control	 cells	were	 compared	 to	Flag-tagged	
Mettl21c	overexpressed	cells.	 In	order	to	monitor	autophagic	flux,	the	lipidation	of	LC3	as	well	as	
the	expression	of	the	autophagosomal	cargo	proteins	SQSTM1	and	VCP	was	analyzed.	In	order	to	
induce	autophagy	 rapamycin	was	used,	a	 lipophilic	macrolide	antibiotic	 that	 is	a	well-established	
and	potent	inducer	of	autophagy.	Autophagy	is	negatively	regulated	by	mTOR,	a	kinase	that	senses	
the	 availability	 of	 nutrients	 and	 energy	 and	 integrates	 inputs	 from	 growth	 factors	 and	 stress	
signaling.	 Rapamycin	 functions	 as	 an	 allosteric	 inhibitor	 of	 the	 kinase	 activity	 of	 mTOR	 [48].	 In	
addition,	 the	 combinatory	 treatment	 of	 Rapamycin,	 an	 autophagy	 inducer,	 and	 Bafilomycin	 A1,	
that	 neutralizes	 lysosomal	 acidification	 and	 stalls	 autophagy,	 results	 in	 accumulation	 of	
autophagosomes	 by	 blocking	 autophagosome-lysosome	 fusion.	 This	 technique	 is	 named	
“autophagometer”	as	 it	provides	one	with	static	 levels	of	endogenous	LC3-II,	and	helps	to	render	
misinterpretations	due	to	possible	alteration	in	LC3-II	levels	upon	autophagic	induction	[282].	
As	 a	 clear	 indication	 for	 the	 upregulation	 of	 autophagy	 in	 control	 and	Mettl21c	 overexpression	
cells,	 lipidated	 LC3-II	 and	 SQSTM1	 was	 found	 to	 be	 accumulated	 after	 the	 treatment	 with	
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Rapamycin	and	even	more	after	 the	combinatory	treatment	with	Rapamycin	and	Bafilomycin	A1;	
while	expression	of	VCP	was	not	affected.	Interestingly,	the	accumulation	of	LC3	and	SQSTM1	was	
more	pronounced	in	Mettl21c	overexpressing	cells.		
Strikingly,	 the	 accumulation	 of	 SQSTM1,	 an	 indicator	 for	 ubiquitinated	 proteins	 [77],	 is	 usually	
described	 as	 inhibition	 of	 autophagy	 [48].	 In	 our	 cell	 culture	 based	 assay	 it	 seems	 that	 the	
expression	 level	 of	 SQSTM1	 is	 restored.	 Similar	 results	were	obtained	 in	 other	 studies	 indicating	
that	 upon	 starvation	 the	 level	 of	 SQSTM1	 does	 not	 always	 inversely	 correlate	 with	 autophagic	
activity.	This	suggests	that	three	factors,	autophagic	degradation,	transcriptional	upregulation,	and	
availability	 of	 lysosomal-derived	 amino	 acids	 lead	 to	 restoration	 of	 SQSTM1	 during	 autophagy	
[283].	 Furthermore,	 it	 was	 shown	 that	 cells	 can	 use	 the	 key	 autophagic	 cargo	 adaptor	 protein	
SQSTM1	itself	to	regulate	autophagic	activity.	Overexpression	of	SQSTM1	significantly	increases	the	
basal	level	of	autophagy	in	mammalian	cells	by	disrupting	the	association	between	Bcl-2	and	Beclin	
1	[284].	
Enhanced	 autophagy	 activity	 was	 also	 found	 after	 overexpression	 of	 the	 two	 autophagic	 key	
players	Atg7	and	Atg5,	which	are	essential	for	the	autophagosome	formation	[281,	285].	Enhanced	
autophagy	proved	to	be	beneficial	for	the	mammalian	lifespan	by	presumably	reducing	misfolded	
proteins	 and	 aggregates,	 improving	 insulin	 sensitivity	 and	 reducing	 oxidative	 stress.	 For	 future	
experiments,	 it	 would	 be	 of	 great	 interest	 to	 elucidate	 whether	 a	 moderate	 Mettl21c	
overexpression	functions	beneficial	for	a	balanced	homeostasis	of	the	skeletal	muscle	and	thereby	
improves	 the	physical	activity	 in	mammalians.	Taken	 together,	 this	gain-of-function	assay	proved	
that	Mettl21c	is	able	to	regulate	the	autophagic	flux	in	cell	culture.		
	
4.10.	Conclusions	
Muscle	can	rapidly	respond	to	physiological	changes	by	fine-tuning	the	balance	between	catabolic	
and	 anabolic	 processes,	 a	 process	 known	as	muscle	 plasticity.	 Autophagy	 is	 a	 pathway	by	which	
cytoplasmic	 components	 including	 macromolecules	 and	 organelles	 are	 degraded	 by	 the	
autophagosome-lysosome	system.	The	proper	regulation	of	autophagy	flux	is	important	for	whole	
body	 homeostasis	 under	 basal	 and	 stress	 conditions.	 Skeletal	 muscle	 acts	 as	 an	 indispensable	
metabolic	 center	 that	 responds	 to	 global	 energy	demands.	Defective	 and	excessive	 autophagy	 is	
both	 referred	 to	 be	 harmful	 and	 is	 associated	 to	 several	 human	 muscle	 diseases	 and	 the	
understanding	 of	 the	molecular	mechanisms	 that	 control	 autophagy	 in	 skeletal	muscle	 has	 only	
recently	begun	to	emerge.	
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The	proposed	study	demonstrates	the	phenotypic	consequences	of	slow-muscle	specific	Mettl21c	
deletion	 in	mice.	 The	 inactivation	 results	 in	 the	physiological	 impairment	of	muscular	 endurance	
and	 the	 accumulation	of	 autophagic	 vacuoles.	 In	 addition,	Mettl21c	deficient	mice	 suffer	 from	a	
lysosomal	 defect	 indicated	 by	 the	 occurrence	 of	 impaired	 lysosomal	 vesicles	 after	 denervation-
induced	 atrophy.	 Dysfunctional	 autophagy	 is	 associated	with	many	 pathologies,	 where	 impaired	
muscle	performance	and	health	is	the	first	diagnose.		
In	this	study	Vcp	was	identified	as	a	novel	substrate	for	Mettl21c,	which	trimethylates	Vcp	at	lysine-
315.	The	molecular	mechanism,	underlying	the	observed	effects	on	the	impairment	of	autophagic	
flux	 in	 slow-twitch	 muscle	 fibers	 in	 mice	 deficient	 for	 Mettl21c,	 is	 probably	 based	 on	 reduced	
trimethylation	of	Vcp	on	 lysine-315.	This	 site	 lies	 in	 close	proximity	 to	 the	Walker	B	motif	of	 the	
ATPase/D1	domain.	The	reduced	trimethylation	of	Vcp	in	slow-twitch	muscle	fibers	might	results	in	
the	 loss	of	 cofactor	binding,	 like	 it	was	 shown	here	 for	 the	 interaction	of	Vcp	and	 the	 inhibitory	
cofactor	Nsfl1c/p47.	In	addition,	alterations	in	cofactor	binding	might	modulate	the	ATPase	activity	
of	VCP.	 Several	disease	models	 like	 IBMPFD	and	ALS	 show	 that	 the	ATPase	activity	of	VCP	 is	 the	
primary	 defect	 causing	 the	 pathological	 phenotype	 of	 accumulation	 of	 non-degradable	 proteins	
[11].	
Hence,	the	understanding	about	fiber-type	specific	regulation	of	autophagy	will	help	to	understand	
muscle	homeostasis	as	well	as	 the	onset	of	degenerative	diseases	 in	humans	 that	are	associated	
with	 disrupted	 VCP	 function,	 resulting	 in	 muscle	 weakness	 as	 a	 first	 symptom.	 Thus,	 the	 tissue	
specific	 expression	 of	 methyltransferases	 defines	 a	 novel	 mechanism	 regulating	 proteostasis	 in	
skeletal	muscle	tissue	and	the	extension	of	this	study	will	help	to	elucidate	the	complex	network	of	
protein	methylation	and	muscle	 loss	under	diseased	conditions.	 In	addition,	 the	dissection	of	 the	
autophagy	pathway	and	its	role	in	metabolic	disorders	and	myopathies	is	of	great	clinical	relevance	
and	has	great	therapeutic	potential.		
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